These terms and conditions govern your use of the website alphaminr.com and its related
services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr,
(“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms
include the provisions in this document as well as those in the Privacy Policy. These terms may
be modified at any time.
Subscription
Your subscription will be on a month to month basis and automatically renew every month. You may
terminate your subscription at any time through your account.
Fees
We will provide you with advance notice of any change in fees.
Usage
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Limitation of Liability
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The
service is provided “As is”. The materials and information accessible through the Service are
solely for informational purposes. While we strive to provide good information and data, we make
no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO
YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY
OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR
(2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE
CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR
CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision
shall not affect the validity or enforceability of the remaining provisions herein.
Privacy Policy
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal
information when we provide our service (“Service”). This Privacy Policy explains how
information is collected about you either directly or indirectly. By using our service, you
acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy
Policy, please do not use our Service. You should contact us if you have questions about it. We
may modify this Privacy Policy periodically.
Personal Information
When you register for our Service, we collect information from you such as your name, email
address and credit card information.
Usage
Like many other websites we use “cookies”, which are small text files that are stored on your
computer or other device that record your preferences and actions, including how you use the
website. You can set your browser or device to refuse all cookies or to alert you when a cookie
is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not
function properly. We collect information when you use our Service. This includes which pages
you visit.
Sharing of Personal Information
We use Google Analytics and we use Stripe for payment processing. We will not share the
information we collect with third parties for promotional purposes.
We may share personal information with law enforcement as required or permitted by law.
0001534254
false
12/31
2022
Q3
0.5
0.5
twenty-four months
0.5
0.3333
0.6666
0001534254
2022-01-01
2022-09-30
0001534254
dei:FormerAddressMember
2022-01-01
2022-09-30
0001534254
2022-11-03
xbrli:shares
0001534254
us-gaap-supplement:InvestmentUnaffiliatedIssuerMember
2022-09-30
iso4217:USD
0001534254
us-gaap-supplement:InvestmentUnaffiliatedIssuerMember
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2021-12-31
0001534254
2022-09-30
0001534254
2021-12-31
iso4217:USD
xbrli:shares
0001534254
us-gaap-supplement:InvestmentUnaffiliatedIssuerMember
2022-07-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentUnaffiliatedIssuerMember
2021-07-01
2021-09-30
0001534254
us-gaap-supplement:InvestmentUnaffiliatedIssuerMember
2022-01-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentUnaffiliatedIssuerMember
2021-01-01
2021-09-30
0001534254
us-gaap-supplement:InvestmentUnaffiliatedIssuerMember
2021-01-01
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-07-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-07-01
2021-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2022-07-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2021-07-01
2021-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2022-01-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2021-01-01
2021-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2021-01-01
2021-12-31
0001534254
2022-07-01
2022-09-30
0001534254
2021-07-01
2021-09-30
0001534254
2021-01-01
2021-09-30
0001534254
2021-01-01
2021-12-31
0001534254
2022-09-21
2022-09-21
xbrli:pure
0001534254
2022-06-30
0001534254
2021-06-30
0001534254
2020-12-31
0001534254
2021-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
2022-09-30
0001534254
Adapt Laser Acquisition, Inc., Senior Secured First Lien Debt, 12/31/2023 Maturity, 1
2022-09-30
0001534254
Adapt Laser Acquisition, Inc., Senior Secured First Lien Debt, 12/31/2023 Maturity, 2
2022-09-30
0001534254
Aegis Toxicology Sciences Corp., Senior Secured First Lien Debt, 5/9/2025 Maturity
2022-09-30
0001534254
AHF Parent Holding, Inc., Senior Secured First Lien Debt, 2/1/2028 Maturity
2022-09-30
0001534254
Allen Media, LLC, Senior Secured First Lien Debt, 2/10/2027 Maturity
2022-09-30
0001534254
ALM Media, LLC 1, Senior Secured First Lien Debt, 11/25/2024 Maturity
2022-09-30
0001534254
ALM Media, LLC, Senior Secured First Lien Debt, 11/25/2024 Maturity
2022-09-30
0001534254
Alpine US Bidco, LLC, Senior Secured First Lien Debt, 5/3/2028 Maturity
2022-09-30
0001534254
American Clinical Solutions LLC, Senior Secured First Lien Debt, 12/31/2022 Maturity
2022-09-30
0001534254
American Consolidated Natural Resources, Inc., Senior Secured First Lien Debt, 9/16/2025 Maturity
2022-09-30
0001534254
American Health Staffing Group, Inc., Senior Secured First Lien Debt, 11/19/2026 Maturity, 1
2022-09-30
0001534254
American Health Staffing Group, Inc. Senior Secured First Lien Debt, 11/19/2026 Maturity, 2
2022-09-30
0001534254
American Teleconferencing Services, Ltd., Senior Secured First Lien Debt, 6/30/2022 Maturity, 1
2022-09-30
0001534254
American Teleconferencing Services, Ltd. Senior Secured First Lien Debt, 6/30/2022 Maturity, 2
2022-09-30
0001534254
American Teleconferencing Services, Ltd., Senior Secured First Lien Debt, 6/8/2023 Maturity, 3
2022-09-30
0001534254
Analogic Corp., Senior Secured First Lien Debt, 6/21/2024 Maturity
2022-09-30
0001534254
Ancile Solutions, Inc., Senior Secured First Lien Debt, 6/22/2026 Maturity
2022-09-30
0001534254
Anthem Sports & Entertainment Inc., Senior Secured First Lien Debt, 11/15/2026 Maturity, 1
2022-09-30
0001534254
Anthem Sports & Entertainment Inc., Senior Secured First Lien Debt, 11/15/2026 Maturity, 2
2022-09-30
0001534254
Anthem Sports & Entertainment Inc., Senior Secured First Lien Debt, 11/15/2026 Maturity, 3
2022-09-30
0001534254
Appalachian Resource Company, LLC, Senior Secured First Lien Debt, 9/10/2023 Maturity, 1
2022-09-30
0001534254
Appalachian Resource Company, LLC, Senior Secured First Lien Debt, 9/10/2023 Maturity, 2
2022-09-30
0001534254
Archer Systems, LLC, Senior Secured First Lien Debt, 8/11/2027 Maturity, 1
2022-09-30
0001534254
Archer Systems, LLC, Senior Secured First Lien Debt, 8/11/2027 Maturity, 2
2022-09-30
0001534254
Archer Systems, LLC, Senior Secured First Lien Debt, 8/11/2027 Maturity, 3
2022-09-30
0001534254
Associated Asphalt Partners, LLC, Senior Secured First Lien Debt, 4/5/2024 Maturity
2022-09-30
0001534254
Atlas Supply LLC, Senior Secured First Lien Debt, 4/29/2025 Maturity
2022-09-30
0001534254
Avison Young (USA) Inc., Senior Secured First Lien Debt, 1/31/2026 Maturity
2022-09-30
0001534254
BDS Solutions Intermediateco, LLC, Senior Secured First Lien Debt, 2/7/2027 Maturity, 1
2022-09-30
0001534254
BDS Solutions Intermediateco, LLC, Senior Secured First Lien Debt, 2/7/2027 Maturity, 2
2022-09-30
0001534254
BDS Solutions Intermediateco, LLC, Senior Secured First Lien Debt, 2/7/2027 Maturity, 3
2022-09-30
0001534254
Berlitz Holdings, Inc., Senior Secured First Lien Debt, 2/14/2025 Maturity
2022-09-30
0001534254
Bradshaw International Parent Corp., Senior Secured First Lien Debt, 10/21/2026 Maturity, 1
2022-09-30
0001534254
Bradshaw International Parent Corp., Senior Secured First Lien Debt, 10/21/2026 Maturity, 2
2022-09-30
0001534254
Bradshaw International Parent Corp., Senior Secured First Lien Debt, 10/21/2027 Maturity, 3
2022-09-30
0001534254
Cabi, LLC, Senior Secured First Lien Debt, 2/28/2027 Maturity
2022-09-30
0001534254
Cadence Aerospace, LLC, Senior Secured First Lien Debt, 11/14/2023 Maturity
2022-09-30
0001534254
Carestream Health, Inc., Senior Secured First Lien Debt, 9/30/2027 Maturity
2022-09-30
0001534254
CB URS Holdings Corp., Senior Secured First Lien Debt, 9/01/2024 Maturity
2022-09-30
0001534254
Celerity Acquisition Holdings, LLC, Senior Secured First Lien Debt, 5/28/2026 Maturity
2022-09-30
0001534254
Cennox, Inc., Senior Secured First Lien Debt, 5/4/2026 Maturity, 1
2022-09-30
0001534254
Cennox, Inc., Senior Secured First Lien Debt, 5/4/2026 Maturity, 2
2022-09-30
0001534254
Cennox, Inc., Senior Secured First Lien Debt, 5/4/2026 Maturity, 3
2022-09-30
0001534254
Cennox, Inc., Senior Secured First Lien Debt, 11/22/2023 Maturity, 4
2022-09-30
0001534254
Cennox, Inc., Senior Secured First Lien Debt, 5/4/2026 Maturity, 5
2022-09-30
0001534254
Charming Charlie LLC., Senior Secured First Lien Debt, 4/24/2023 Maturity
2022-09-30
0001534254
CHC Solutions Inc., Senior Secured First Lien Debt, 7/20/2023 Maturity
2022-09-30
0001534254
CION/EagleTree Partners, LLC., Senior Secured First Lien Debt, 12/21/2026 Maturity
2022-09-30
0001534254
CircusTrix Holdings, LLC., Senior Secured First Lien Debt, 1/16/2024 Maturity, 1
2022-09-30
0001534254
CircusTrix Holdings, LLC., Senior Secured First Lien Debt, 1/16/2024 Maturity, 2
2022-09-30
0001534254
CircusTrix Holdings, LLC., Senior Secured First Lien Debt, 7/16/2023 Maturity, 3
2022-09-30
0001534254
Community Tree Service, LLC., Senior Secured First Lien Debt, 6/17/2027 Maturity
2022-09-30
0001534254
Country Fresh Holdings, LLC., Senior Secured First Lien Debt, 4/29/2023 Maturity, 1
2022-09-30
0001534254
Country Fresh Holdings, LLC., Senior Secured First Lien Debt, 4/29/2023 Maturity, 2
2022-09-30
0001534254
Coyote Buyer, LLC., Senior Secured First Lien Debt, 2/6/2025 Maturity, 1
2022-09-30
0001534254
Coyote Buyer, LLC., Senior Secured First Lien Debt, 8/6/2026 Maturity, 2
2022-09-30
0001534254
Coyote Buyer, LLC., Senior Secured First Lien Debt, 2/6/2025 Maturity, 3
2022-09-30
0001534254
Critical Nurse Staffing, LLC., Senior Secured First Lien Debt, 11/1/2026 Maturity, 1
2022-09-30
0001534254
Critical Nurse Staffing, LLC., Senior Secured First Lien Debt, 11/1/2026 Maturity, 2
2022-09-30
0001534254
Critical Nurse Staffing, LLC., Senior Secured First Lien Debt, 11/1/2026 Maturity, 3
2022-09-30
0001534254
Critical Nurse Staffing, LLC., Senior Secured First Lien Debt, 11/1/2026 Maturity, 4
2022-09-30
0001534254
David's Bridal, LLC., Senior Secured First Lien Debt, 5/23/2024 Maturity, 1
2022-09-30
0001534254
David's Bridal, LLC., Senior Secured First Lien Debt, 6/23/2023 Maturity, 2
2022-09-30
0001534254
David's Bridal, LLC., Senior Secured First Lien Debt, 6/30/2023 Maturity, 3
2022-09-30
0001534254
Deluxe Entertainment Services, Inc., Senior Secured First Lien Debt, 3/25/2024 Maturity
2022-09-30
0001534254
Dermcare Management, LLC., Senior Secured First Lien Debt, 4/22/2028 Maturity, 1
2022-09-30
0001534254
Dermcare Management, LLC., Senior Secured First Lien Debt, 4/22/2028 Maturity, 2
2022-09-30
0001534254
Dermcare Management, LLC., Senior Secured First Lien Debt, 4/22/2028 Maturity, 3
2022-09-30
0001534254
Dermcare Management, LLC., Senior Secured First Lien Debt, 10/22/2023 Maturity, 4
2022-09-30
0001534254
Dermcare Management, LLC., Senior Secured First Lien Debt, 4/22/2028 Maturity, 5
2022-09-30
0001534254
DMT Solutions Global Corp., Senior Secured First Lien Debt, 7/2/2024 Maturity
2022-09-30
0001534254
Emerald Technologies (U.S.) Acquisitionco, Inc.., Senior Secured First Lien Debt, 12/29/2027 Maturity
2022-09-30
0001534254
Entertainment Studios P&A LLC., Senior Secured First Lien Debt, 5/18/2037 Maturity, 1
2022-09-30
0001534254
Entertainment Studios P&A LLC., Senior Secured First Lien Debt, 9/28/2027 Maturity, 2
2022-09-30
0001534254
Extreme Reach, Inc., Senior Secured First Lien Debt, 3/29/2024 Maturity, 1
2022-09-30
0001534254
Extreme Reach, Inc., Senior Secured First Lien Debt, 3/29/2024 Maturity, 2
2022-09-30
0001534254
Foundation Consumer Healthcare, LLC., Senior Secured First Lien Debt, 2/12/2027 Maturity, 1
2022-09-30
0001534254
Foundation Consumer Healthcare, LLC., Senior Secured First Lien Debt, 2/12/2027 Maturity, 2
2022-09-30
0001534254
FuseFX, LLC., Senior Secured First Lien Debt, 10/1/2024 Maturity
2022-09-30
0001534254
Fusion Connect Inc., Senior Secured First Lien Debt, 1/18/2027 Maturity
2022-09-30
0001534254
Future Pak, LLC., Senior Secured First Lien Debt, 7/2/2024 Maturity
2022-09-30
0001534254
Gold Medal Holdings, Inc., Senior Secured First Lien Debt, 3/17/2027 Maturity
2022-09-30
0001534254
GSC Technologies Inc., Senior Secured First Lien Debt, 9/30/2025 Maturity, 1
2022-09-30
0001534254
GSC Technologies Inc., Senior Secured First Lien Debt, 9/30/2025 Maturity, 2
2022-09-30
0001534254
GSC Technologies Inc., Senior Secured First Lien Debt, 9/30/2025 Maturity, 3
2022-09-30
0001534254
H.W. Lochner, Inc., Senior Secured First Lien Debt, 7/2/2027 Maturity, 1
2022-09-30
0001534254
H.W. Lochner, Inc., Senior Secured First Lien Debt, 7/2/2027 Maturity, 2
2022-09-30
0001534254
H.W. Lochner, Inc., Senior Secured First Lien Debt, 7/2/2027 Maturity, 3
2022-09-30
0001534254
Harland Clarke Holdings Corp., Senior Secured First Lien Debt, 6/16/2026 Maturity
2022-09-30
0001534254
Heritage Power, LLC., Senior Secured First Lien Debt, 7/30/2026 Maturity
2022-09-30
0001534254
Hilliard, Martinez & Gonzales, LLP., Senior Secured First Lien Debt, 12/17/2022 Maturity
2022-09-30
0001534254
Hollander Intermediate LLC., Senior Secured First Lien Debt, 9/19/2026 Maturity
2022-09-30
0001534254
Homer City Generation, L.P., Senior Secured First Lien Debt, 4/5/2023 Maturity, 1
2022-09-30
0001534254
Homer City Generation, L.P., Senior Secured First Lien Debt, 1/29/2023 Maturity, 2
2022-09-30
0001534254
Hoover Group, Inc., Senior Secured First Lien Debt, 10/1/2024 Maturity
2022-09-30
0001534254
HUMC Holdco, LLC., Senior Secured First Lien Debt, 12/31/2022 Maturity
2022-09-30
0001534254
HW Acquisition, LLC., Senior Secured First Lien Debt, 9/28/2026 Maturity, 1
2022-09-30
0001534254
HW Acquisition, LLC., Senior Secured First Lien Debt, 9/28/2026 Maturity, 2
2022-09-30
0001534254
HW Acquisition, LLC., Senior Secured First Lien Debt, 9/28/2026 Maturity, 3
2022-09-30
0001534254
Independent Pet Partners Intermediate Holdings, LLC., Senior Secured First Lien Debt, 11/20/2023 Maturity, 1
2022-09-30
0001534254
Independent Pet Partners Intermediate Holdings, LLC., Senior Secured First Lien Debt, 12/22/2022 Maturity, 2
2022-09-30
0001534254
Independent Pet Partners Intermediate Holdings, LLC., Senior Secured First Lien Debt, 12/22/2022 Maturity, 3
2022-09-30
0001534254
Infogroup Inc., Senior Secured First Lien Debt, 4/3/2023 Maturity
2022-09-30
0001534254
Inotiv, Inc., Senior Secured First Lien Debt, 11/5/2026 Maturity, 1
2022-09-30
0001534254
Inotiv, Inc., Senior Secured First Lien Debt, 11/5/2026 Maturity, 2
2022-09-30
0001534254
Inotiv, Inc., Senior Secured First Lien Debt, 5/5/2023 Maturity, 3
2022-09-30
0001534254
Instant Web, LLC., Senior Secured First Lien Debt, 2/25/2027 Maturity, 1
2022-09-30
0001534254
Instant Web, LLC., Senior Secured First Lien Debt, 2/25/2027 Maturity, 2
2022-09-30
0001534254
Instant Web, LLC., Senior Secured First Lien Debt, 2/25/2027 Maturity, 3
2022-09-30
0001534254
Instant Web, LLC., Senior Secured First Lien Debt, 2/25/2027 Maturity, 4
2022-09-30
0001534254
Instant Web, LLC., Senior Secured First Lien Debt, 2/25/2027 Maturity, 5
2022-09-30
0001534254
Invincible Boat Company LLC., Senior Secured First Lien Debt, 8/28/2025 Maturity, 1
2022-09-30
0001534254
Invincible Boat Company LLC., Senior Secured First Lien Debt, 8/28/2025 Maturity, 2
2022-09-30
0001534254
Invincible Boat Company LLC., Senior Secured First Lien Debt, 8/28/2025 Maturity, 3
2022-09-30
0001534254
INW Manufacturing, LLC., Senior Secured First Lien Debt, 5/7/2027 Maturity
2022-09-30
0001534254
Isagenix International, LLC., Senior Secured First Lien Debt, 6/14/2025 Maturity
2022-09-30
0001534254
Jenny C Acquisition, Inc., Senior Secured First Lien Debt, 10/1/2024 Maturity
2022-09-30
0001534254
JP Intermediate B, LLC., Senior Secured First Lien Debt, 11/20/2025 Maturity
2022-09-30
0001534254
K&N Parent, Inc., Senior Secured First Lien Debt, 10/20/2023 Maturity
2022-09-30
0001534254
Klein Hersh, LLC., Senior Secured First Lien Debt, 4/27/2027 Maturity
2022-09-30
0001534254
KNB Holdings Corp., Senior Secured First Lien Debt, 4/26/2024 Maturity
2022-09-30
0001534254
LaserAway Intermediate Holdings II, LLC., Senior Secured First Lien Debt, 10/12/2027 Maturity
2022-09-30
0001534254
LAV Gear Holdings, Inc., Senior Secured First Lien Debt, 10/31/2024 Maturity, 1
2022-09-30
0001534254
LAV Gear Holdings, Inc., Senior Secured First Lien Debt, 10/31/2024 Maturity, 2
2022-09-30
0001534254
LGC US Finco, LLC., Senior Secured First Lien Debt, 12/20/2025 Maturity
2022-09-30
0001534254
Lift Brands, Inc., Senior Secured First Lien Debt, 6/29/2025 Maturity, 1
2022-09-30
0001534254
Lift Brands, Inc., Senior Secured First Lien Debt, 6/29/2025 Maturity, 2
2022-09-30
0001534254
Lift Brands, Inc., Senior Secured First Lien Debt, 6/29/2025 Maturity, 3
2022-09-30
0001534254
Longview Power, LLC., Senior Secured First Lien Debt, 7/30/2025 Maturity
2022-09-30
0001534254
MacNeill Pride Group Corp., Senior Secured First Lien Debt, 4/28/2026 Maturity, 1
2022-09-30
0001534254
MacNeill Pride Group Corp., Senior Secured First Lien Debt, 4/28/2026 Maturity, 2
2022-09-30
0001534254
MacNeill Pride Group Corp., Senior Secured First Lien Debt, 4/30/2024 Maturity, 3
2022-09-30
0001534254
Manus Bio Inc., Senior Secured First Lien Debt, 8/20/2026 Maturity
2022-09-30
0001534254
Marble Point Credit Management LLC., Senior Secured First Lien Debt, 8/11/2028 Maturity, 1
2022-09-30
0001534254
Marble Point Credit Management LLC., Senior Secured First Lien Debt, 8/11/2028 Maturity, 3
2022-09-30
0001534254
Mimeo.com, Inc., Senior Secured First Lien Debt, 12/21/2024 Maturity, 1
2022-09-30
0001534254
Mimeo.com, Inc., Senior Secured First Lien Debt, 12/21/2024 Maturity, 2
2022-09-30
0001534254
Mimeo.com, Inc., Senior Secured First Lien Debt, 12/21/2024 Maturity, 3
2022-09-30
0001534254
Moss Holding Company., Senior Secured First Lien Debt, 4/17/2024 Maturity, 1
2022-09-30
0001534254
Moss Holding Company, Senior Secured First Lien Debt, 4/17/2024 Maturity, 2
2022-09-30
0001534254
NASCO Healthcare Inc., Senior Secured First Lien Debt, 6/30/2023 Maturity
2022-09-30
0001534254
Neptune Flood Inc., Senior Secured First Lien Debt, 10/21/2026 Maturity
2022-09-30
0001534254
NewsCycle Solutions, Inc., Senior Secured First Lien Debt, 12/29/2022 Maturity
2022-09-30
0001534254
NWN Parent Holdings LLC., Senior Secured First Lien Debt, 5/7/2026 Maturity, 1
2022-09-30
0001534254
NWN Parent Holdings LLC., Senior Secured First Lien Debt, 5/7/2026 Maturity, 2
2022-09-30
0001534254
NWN Parent Holdings LLC., Senior Secured First Lien Debt, 5/7/2026 Maturity, 3
2022-09-30
0001534254
OpCo Borrower, LLC., Senior Secured First Lien Debt, 8/19/2027 Maturity, 1
2022-09-30
0001534254
OpCo Borrower, LLC., Senior Secured First Lien Debt, 8/19/2027 Maturity, 2
2022-09-30
0001534254
OpCo Borrower, LLC., Senior Secured First Lien Debt, 8/19/2027 Maturity, 3
2022-09-30
0001534254
Optio Rx, LLC., Senior Secured First Lien Debt, 6/28/2028 Maturity, 1
2022-09-30
0001534254
Optio Rx, LLC., Senior Secured First Lien Debt, 6/28/2028 Maturity, 2
2022-09-30
0001534254
Optio Rx, LLC., Senior Secured First Lien Debt, 12/21/2022 Maturity, 3
2022-09-30
0001534254
Pentec Acquisition Corp., Senior Secured First Lien Debt, 10/8/2026 Maturity
2022-09-30
0001534254
PH Beauty Holdings III. Inc., Senior Secured First Lien Debt, 9/28/2025 Maturity
2022-09-30
0001534254
Playboy Enterprises, Inc., Senior Secured First Lien Debt, 5/25/2027 Maturity
2022-09-30
0001534254
Project Castle, Inc., Senior Secured First Lien Debt, 6/1/2029 Maturity
2022-09-30
0001534254
RA Outdoors, LLC., Senior Secured First Lien Debt, 4/8/2026 Maturity, 1
2022-09-30
0001534254
RA Outdoors, LLC., Senior Secured First Lien Debt, 4/8/2026 Maturity, 2
2022-09-30
0001534254
Retail Services WIS Corp., Senior Secured First Lien Debt, 5/20/2025 Maturity
2022-09-30
0001534254
Robert C. Hilliard, L.L.P., Senior Secured First Lien Debt, 12/17/2022 Maturity
2022-09-30
0001534254
Rogers Mechanical Contractors, LLC., Senior Secured First Lien Debt, 9/9/2025 Maturity, 1
2022-09-30
0001534254
Rogers Mechanical Contractors, LLC., Senior Secured First Lien Debt, 9/9/2025 Maturity, 2
2022-09-30
0001534254
Rogers Mechanical Contractors, LLC., Senior Secured First Lien Debt, 9/9/2022 Maturity, 3
2022-09-30
0001534254
RumbleOn, Inc., Senior Secured First Lien Debt, 8/31/2026 Maturity, 1
2022-09-30
0001534254
RumbleOn, Inc., Senior Secured First Lien Debt, 8/31/2026 Maturity, 2
2022-09-30
0001534254
RumbleOn, Inc., Senior Secured First Lien Debt, 2/28/2023 Maturity, 3
2022-09-30
0001534254
Securus Technologies Holdings, Inc., Senior Secured First Lien Debt, 11/1/2024 Maturity
2022-09-30
0001534254
Sequoia Healthcare Management, LLC., Senior Secured First Lien Debt, 8/21/2023 Maturity
2022-09-30
0001534254
Service Compression, LLC., Senior Secured First Lien Debt, 5/5/2027 Maturity, 1
2022-09-30
0001534254
Service Compression, LLC., Senior Secured First Lien Debt, 2
2022-09-30
0001534254
Service Compression, LLC., Senior Secured First Lien Debt, 5/5/2025 Maturity, 3
2022-09-30
0001534254
Sleep Opco, LLC., Senior Secured First Lien Debt, 10/12/2026 Maturity, 1
2022-09-30
0001534254
Sleep Opco, LLC., Senior Secured First Lien Debt, 10/12/2026 Maturity, 2
2022-09-30
0001534254
Spinal USA, Inc. / Precision Medical Inc., Senior Secured First Lien Debt, 10/1/2022 Maturity, 1
2022-09-30
0001534254
Spinal USA, Inc. / Precision Medical Inc., Senior Secured First Lien Debt, 10/1/2022 Maturity, 2
2022-09-30
0001534254
Spinal USA, Inc. / Precision Medical Inc., Senior Secured First Lien Debt, 10/1/2022 Maturity, 3
2022-09-30
0001534254
Spinal USA, Inc. / Precision Medical Inc., Senior Secured First Lien Debt, 10/1/2022 Maturity, 4
2022-09-30
0001534254
Spinal USA, Inc. / Precision Medical Inc., Senior Secured First Lien Debt, 10/1/2022 Maturity, 5
2022-09-30
0001534254
STATinMED, LLC., Senior Secured First Lien Debt, 7/1/2027 Maturity
2022-09-30
0001534254
Thrill Holdings LLC., Senior Secured First Lien Debt, 5/27/2027 Maturity, 1
2022-09-30
0001534254
Thrill Holdings LLC., Senior Secured First Lien Debt, 5/27/2024 Maturity, 2
2022-09-30
0001534254
Thrill Holdings LLC., Senior Secured First Lien Debt, 5/27/2027 Maturity, 3
2022-09-30
0001534254
Trademark Global, LLC., Senior Secured First Lien Debt, 7/30/2024 Maturity, 1
2022-09-30
0001534254
Trademark Global, LLC., Senior Secured First Lien Debt, 7/30/2023 Maturity, 2
2022-09-30
0001534254
Trammell, P.C., Senior Secured First Lien Debt, 4/28/2026 Maturity
2022-09-30
0001534254
Usalco, LLC., Senior Secured First Lien Debt, 10/19/2027 Maturity
2022-09-30
0001534254
Vesta Holdings, LLC., Senior Secured First Lien Debt, 2/25/2024 Maturity
2022-09-30
0001534254
Volta Charging, LLC., Senior Secured First Lien Debt, 6/19/2024 Maturity, 1
2022-09-30
0001534254
Volta Charging, LLC., Senior Secured First Lien Debt, 6/19/2024 Maturity, 2
2022-09-30
0001534254
Williams Industrial Services Group, Inc., Senior Secured First Lien Debt, 12/16/2025 Maturity
2022-09-30
0001534254
Wind River Systems, Inc., Senior Secured First Lien Debt, 6/24/2024 Maturity
2022-09-30
0001534254
Wok Holdings Inc., Senior Secured First Lien Debt, 3/1/2026 Maturity
2022-09-30
0001534254
WorkGenius, Inc., Senior Secured First Lien Debt, 6/7/2027 Maturity
2022-09-30
0001534254
Xenon Arc, Inc., Senior Secured First Lien Debt, 12/17/2027 Maturity
2022-09-30
0001534254
Yak Access, LLC., Senior Secured First Lien Debt, 7/11/2025 Maturity
2022-09-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
2022-09-30
0001534254
Deluxe Entertainment Services, Inc., Senior Secured Second Lien Debt, 9/25/2024 Maturity
2022-09-30
0001534254
Global Tel*Link Corp., Senior Secured Second Lien Debt, 11/29/2026 Maturity
2022-09-30
0001534254
OpCo Borrower, LLC., Senior Secured Second Lien Debt, 2/19/2028 Maturity
2022-09-30
0001534254
Premiere Global Services, Inc., Senior Secured Second Lien Debt, 6/6/2024 Maturity
2022-09-30
0001534254
RA Outdoors, LLC., Senior Secured Second Lien Debt, 10/8/2026 Maturity
2022-09-30
0001534254
Securus Technologies Holdings, Inc., Senior Secured Second Lien Debt, 11/1/2025 Maturity
2022-09-30
0001534254
TMK Hawk Parent, Corp., Senior Secured Second Lien Debt, 8/28/2025 Maturity
2022-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-09-30
0001534254
APIDOS CLO XVI Subordinated Notes., Collateralized Securities and Structured Products - Equity, 1/19/2025 Maturity
2022-09-30
0001534254
Galaxy XV CLO Ltd. Class A Subordinated Notes., Collateralized Securities and Structured Products - Equity, 4/15/2025 Maturity
2022-09-30
0001534254
us-gaap:UnsecuredDebtMember
2022-09-30
0001534254
Lucky Bucks Holdings LLC., Unsecured Debt, 5/29/2028 Maturity
2022-09-30
0001534254
WPLM Acquisition Corp., Unsecured Debt, 11/24/2025 Maturity
2022-09-30
0001534254
us-gaap:EquitySecuritiesMember
2022-09-30
0001534254
ARC Financial Partners, LLC., Equity
us-gaap:EquitySecuritiesMember
2022-09-30
0001534254
ARC Financial Partners, LLC, Membership Interests., Equity
2022-09-30
0001534254
Ascent Resources - Marcellus, LLC, Membership Units., Equity
2022-09-30
0001534254
Ascent Resources - Marcellus, LLC, Warrants., Equity
2022-09-30
0001534254
Carestream Health Holdings Inc., Common Stock, Equity Securities
2022-09-30
0001534254
CF Arch Holdings LLC., Equity
2022-09-30
0001534254
CION/EagleTree Partners, LLC, Participating Preferred Shares Equity
2022-09-30
0001534254
CION/EagleTree Partners, LLC, Membership Units Equity
2022-09-30
0001534254
DBI Investors, Inc., Series A1 Preferred Stock., Equity
2022-09-30
0001534254
DBI Investors, Inc., Series A2 Preferred Stock., Equity
2022-09-30
0001534254
DBI Investors, Inc., Series A Preferred Stock., Equity
2022-09-30
0001534254
DBI Investors, Inc., Series B Preferred Stock., Equity
2022-09-30
0001534254
DBI Investors, Inc., Common Stock., Equity
2022-09-30
0001534254
DBI Investors, Inc., Reallocation Rights., Equity
2022-09-30
0001534254
GSC Technologies Inc., Common Shares., Equity
2022-09-30
0001534254
Independent Pet Partners Intermediate Holdings, LLC, Class A Preferred Units., Equity
2022-09-30
0001534254
Independent Pet Partners Intermediate Holdings, LLC, Class B-2 Preferred Units., Equity
2022-09-30
0001534254
Independent Pet Partners Intermediate Holdings, LLC, Class C Preferred Units., Equity,
2022-09-30
0001534254
Independent Pet Partners Intermediate Holdings, LLC, Warrants., Equity
2022-09-30
0001534254
Instant Web Holdings, LLC, Class A Common Units., Equity
2022-09-30
0001534254
Language Education Holdings GP LLC, Common Units., Equity
2022-09-30
0001534254
Language Education Holdings LP, Ordinary Common Units., Equity
2022-09-30
0001534254
Longview Intermediate Holdings C, LLC, Membership Units., Equity
2022-09-30
0001534254
Mount Logan Capital Inc., Common Stock., Equity
2022-09-30
0001534254
New Giving Acquisition, Inc., Equity
2022-09-30
0001534254
NS NWN Acquisition, LLC, Class A Preferred Units., Equity
2022-09-30
0001534254
NS NWN Acquisition, LLC, Non-Voting Units., Equity
2022-09-30
0001534254
NS NWN Holdco LLC, Voting Units., Equity
2022-09-30
0001534254
NSG Co-Invest (Bermuda) LP, Partnership Interests., Equity
2022-09-30
0001534254
Palmetto Clean Technology, Inc., Warrants., Equity
2022-09-30
0001534254
RumbleOn, Inc., Warrants., Equity
2022-09-30
0001534254
Service Compression, LLC, Warrants., Equity
2022-09-30
0001534254
SIMR Parent, LLC, Class A Common Units., Equity
2022-09-30
0001534254
SIMR Parent, LLC, Class B Common Units., Equity
2022-09-30
0001534254
Snap Fitness Holdings, Inc., Class A Common Stock., Equity
2022-09-30
0001534254
Snap Fitness Holdings, Inc., Warrants., Equity
2022-09-30
0001534254
WorkGenius, LLC, Class A Units., Equity
2022-09-30
0001534254
us-gaap:ShortTermInvestmentsMember
2022-09-30
0001534254
First American Treasury Obligations Fund., Short Term Investments
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
ARC Financial, LLC, Membership Interests
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
ARC Financial, LLC, Membership Interests
2022-01-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
ARC Financial, LLC, Membership Interests
2022-09-30
0001534254
Berlitz Holdings, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Berlitz Holdings, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Berlitz Holdings, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
Carestream Health, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Carestream Health, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Carestream Health, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
Carestream, Common Shares
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Carestream, Common Shares
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Carestream, Common Shares
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
Charming Charlie, LLC, Vendor Payment Financing Facility
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Charming Charlie, LLC, Vendor Payment Financing Facility
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Charming Charlie, LLC, Vendor Payment Financing Facility
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
DESG Holdings, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
DESG Holdings, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
DESG Holdings, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
DESG Holdings, Inc., Second Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
DESG Holdings, Inc., Second Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
DESG Holdings, Inc., Second Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
GSC Technologies Inc., Incremental Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
GSC Technologies Inc., Incremental Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
GSC Technologies Inc., Incremental Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
GSC Technologies Inc., First Lien Term Loan A
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
GSC Technologies Inc., First Lien Term Loan A
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
GSC Technologies Inc., First Lien Term Loan A
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
GSC Technologies Inc., First Lien Term Loan B
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
GSC Technologies Inc., First Lien Term Loan B
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
GSC Technologies Inc., First Lien Term Loan B
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
GSC Technologies Inc., Common Shares
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
GSC Technologies Inc., Common Shares
2022-01-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
GSC Technologies Inc., Common Shares
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Instant Web Holdings, LLC, Class A Common Units
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Instant Web Holdings, LLC, Class A Common Units
2022-01-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Instant Web Holdings, LLC, Class A Common Units
2022-09-30
0001534254
Instant Web, LLC, Revolving Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Instant Web, LLC, Revolving Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Instant Web, LLC, Revolving Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Instant Web, LLC, Priming Term Loan
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Instant Web, LLC, Priming Term Loan
2022-01-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Instant Web, LLC, Priming Term Loan
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Instant Web, LLC, First Lien Term Loan
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Instant Web, LLC, First Lien Term Loan
2022-01-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Instant Web, LLC, First Lien Term Loan
2022-09-30
0001534254
Instant Web, LLC, First Lien Delayed Draw Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Instant Web, LLC, First Lien Delayed Draw Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Instant Web, LLC, First Lien Delayed Draw Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
Language Education Holdings GP LLC, Common Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Language Education Holdings GP LLC, Common Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Language Education Holdings GP LLC, Common Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
Language Education Holdings LP, Ordinary Common Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Language Education Holdings LP, Ordinary Common Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Language Education Holdings LP, Ordinary Common Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Lift Brands, Inc., Term Loan A
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Lift Brands, Inc., Term Loan A
2022-01-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Lift Brands, Inc., Term Loan A
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Lift Brands, Inc., Term Loan B
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Lift Brands, Inc., Term Loan B
2022-01-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Lift Brands, Inc., Term Loan B
2022-09-30
0001534254
Lift Brands, Inc., Term Loan C
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Lift Brands, Inc., Term Loan C
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Lift Brands, Inc., Term Loan C
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
Longview Intermediate Holdings C, LLC, Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Longview Intermediate Holdings C, LLC, Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Longview Intermediate Holdings C, LLC, Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
Longview Power, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Longview Power, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Longview Power, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Mount Logan Capital Inc., Common Stock
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Mount Logan Capital Inc., Common Stock
2022-01-01
2022-09-30
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Mount Logan Capital Inc., Common Stock
2022-09-30
0001534254
SIMR, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
SIMR, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
SIMR, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
SIMR Parent, LLC, Class B Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
SIMR Parent, LLC, Class B Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
SIMR Parent, LLC, Class B Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
SIMR Parent, LLC, Class W Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
SIMR Parent, LLC, Class W Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
SIMR Parent, LLC, Class W Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
Snap Fitness Holdings, Inc., Class A Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Snap Fitness Holdings, Inc., Class A Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Snap Fitness Holdings, Inc., Class A Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
Snap Fitness Holdings, Inc., Warrants
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Snap Fitness Holdings, Inc., Warrants
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
Snap Fitness Holdings, Inc., Warrants
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
STATinMED, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
STATinMED, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
STATinMED, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
STATinMed Parent, LLC, Class A Preferred Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
STATinMed Parent, LLC, Class A Preferred Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
STATinMed Parent, LLC, Class A Preferred Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
STATinMed Parent, LLC, Class B Preferred Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
STATinMed Parent, LLC, Class B Preferred Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-01-01
2022-09-30
0001534254
STATinMed Parent, LLC, Class B Preferred Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2022-09-30
0001534254
CION/EagleTree Partners, LLC, Senior Secured Note
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2021-12-31
0001534254
CION/EagleTree Partners, LLC, Senior Secured Note
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2022-01-01
2022-09-30
0001534254
CION/EagleTree Partners, LLC, Senior Secured Note
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2022-09-30
0001534254
CION/EagleTree Partners, LLC, Participating Preferred Shares
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2021-12-31
0001534254
CION/EagleTree Partners, LLC, Participating Preferred Shares
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2022-01-01
2022-09-30
0001534254
CION/EagleTree Partners, LLC, Participating Preferred Shares
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2022-09-30
0001534254
CION/EagleTree Partners, LLC, Common Shares
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2021-12-31
0001534254
CION/EagleTree Partners, LLC, Common Shares
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2022-01-01
2022-09-30
0001534254
CION/EagleTree Partners, LLC, Common Shares
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Adapt Laser Acquisition, Inc.
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
American Consolidated Natural Resources, Inc.
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Ancile Solutions, Inc.
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Anthem Sports & Entertainment Inc.
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Cadence Aerospace, LLC
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
CHC Solutions Inc.
2022-09-30
0001534254
cion:SeniorSecuredNoteMember
CION/EagleTree Partners, LLC
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
David's Bridal, LLC 1
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
David's Bridal, LLC 2
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Deluxe Entertainment Services, Inc.
2022-09-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
Deluxe Entertainment Services, Inc.
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
GSC Technologies Inc., 1
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
GSC Technologies Inc., 2
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Hilliard, Martinez & Gonzales, LLP
2022-09-30
0001534254
Homer City Generation, L.P.
cion:SeniorSecuredFirstLienDebtMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Independent Pet Partners Intermediate Holdings, LLC, 1
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Independent Pet Partners Intermediate Holdings, LLC, 2
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Independent Pet Partners Intermediate Holdings, LLC, 3
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Instant Web, LLC
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Jenny C Acquisition, Inc.
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
LAV Gear Holdings, Inc.
2022-09-30
0001534254
us-gaap:UnsecuredDebtMember
Lucky Bucks Holdings LLC
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Moss Holding Company
2022-09-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
Premiere Global Services, Inc.
2022-09-30
0001534254
Robert C. Hilliard, L.L.P.
cion:SeniorSecuredFirstLienDebtMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Service Compression, LLC
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Spinal USA, Inc. / Precision Medical Inc.
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
STATinMED, LLC
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
Trammell, P.C.
2022-09-30
0001534254
Vesta Holdings, LLC
cion:SeniorSecuredFirstLienDebtMember
2022-09-30
0001534254
WPLM Acquisition Corp.
us-gaap:UnsecuredDebtMember
2022-09-30
0001534254
cion:OneMonthLIBORMember
DMT Solutions Global Corp., Senior Secured First Lien Debt, 7/2/2024 Maturity
2022-09-30
0001534254
cion:ThreeMonthLIBORMember
DMT Solutions Global Corp., Senior Secured First Lien Debt, 7/2/2024 Maturity
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
2021-12-31
0001534254
ABB/CON-CISE Optical Group LLC., Senior Secured First Lien Debt, 6/15/2023 Maturity
2021-12-31
0001534254
Adapt Laser Acquisition, Inc., Senior Secured First Lien Debt, 12/31/2023 Maturity, 1
2021-12-31
0001534254
Adapt Laser Acquisition, Inc., Senior Secured First Lien Debt, 12/31/2023 Maturity, 2
2021-12-31
0001534254
Aegis Toxicology Sciences Corp., Senior Secured First Lien Debt, 5/9/2025 Maturity
2021-12-31
0001534254
Alchemy US Holdco 1, LLC., Senior Secured First Lien Debt, 10/10/2025 Maturity
2021-12-31
0001534254
Allen Media, LLC., Senior Secured First Lien Debt, 2/10/2027 Maturity
2021-12-31
0001534254
ALM Media, LLC., Senior Secured First Lien Debt, 11/25/2024 Maturity
2021-12-31
0001534254
American Clinical Solutions LLC., Senior Secured First Lien Debt, 12/31/2022 Maturity
2021-12-31
0001534254
American Consolidated Natural Resources, Inc., Senior Secured First Lien Debt, 9/16/2025 Maturity
2021-12-31
0001534254
American Health Staffing Group, Inc., Senior Secured First Lien Debt, 11/19/2026 Maturity, 1
2021-12-31
0001534254
American Health Staffing Group, Inc., Senior Secured First Lien Debt, 11/19/2026 Maturity, 2
2021-12-31
0001534254
American Health Staffing Group, Inc., Senior Secured First Lien Debt, 11/19/2026 Maturity 3
2021-12-31
0001534254
American Media, LLC., Senior Secured First Lien Debt, 12/31/2023 Maturity 1
2021-12-31
0001534254
American Media, LLC., Senior Secured First Lien Debt, 12/31/2023 Maturity 2
2021-12-31
0001534254
American Teleconferencing Services, Ltd., Senior Secured First Lien Debt, 6/8/2023 Maturity 1
2021-12-31
0001534254
American Teleconferencing Services, Ltd., Senior Secured First Lien Debt, 3/31/2022 Maturity 2
2021-12-31
0001534254
American Teleconferencing Services, Ltd., Senior Secured First Lien Debt, 3/31/2022 Maturity 3
2021-12-31
0001534254
Analogic Corp., Senior Secured First Lien Debt, 6/21/2024 Maturity
2021-12-31
0001534254
Ancile Solutions, Inc., Senior Secured First Lien Debt, 6/22/2026 Maturity
2021-12-31
0001534254
Anthem Sports & Entertainment Inc., Senior Secured First Lien Debt, 11/15/2026 Maturity 1
2021-12-31
0001534254
Anthem Sports & Entertainment Inc., Senior Secured First Lien Debt, 11/15/2026 Maturity 2
2021-12-31
0001534254
Anthem Sports & Entertainment Inc., Senior Secured First Lien Debt, 11/15/2026 Maturity 3
2021-12-31
0001534254
Appalachian Resource Company, LLC., Senior Secured First Lien Debt, 9/10/2023 Maturity 1
2021-12-31
0001534254
Appalachian Resource Company, LLC., Senior Secured First Lien Debt, 9/10/2023 Maturity 2
2021-12-31
0001534254
Associated Asphalt Partners, LLC., Senior Secured First Lien Debt, 4/5/2024 Maturity
2021-12-31
0001534254
Avison Young (USA) Inc., Senior Secured First Lien Debt, 1/31/2026 Maturity
2021-12-31
0001534254
Bradshaw International Parent Corp., Senior Secured First Lien Debt, 10/21/2027 Maturity 1
2021-12-31
0001534254
Bradshaw International Parent Corp., Senior Secured First Lien Debt, 10/21/2026 Maturity 2
2021-12-31
0001534254
Bradshaw International Parent Corp., Senior Secured First Lien Debt, 10/21/2026 Maturity 3
2021-12-31
0001534254
Cadence Aerospace, LLC., Senior Secured First Lien Debt, 11/14/2023 Maturity
2021-12-31
0001534254
Cardenas Markets LLC., Senior Secured First Lien Debt, 6/3/2027 Maturity
2021-12-31
0001534254
CB URS Holdings Corp., Senior Secured First Lien Debt, 9/1/2024 Maturity
2021-12-31
0001534254
Celerity Acquisition Holdings, LLC., Senior Secured First Lien Debt, 5/28/2026 Maturity
2021-12-31
0001534254
Charming Charlie LLC., Senior Secured First Lien Debt, 4/24/2023 Maturity
2021-12-31
0001534254
CHC Solutions Inc., Senior Secured First Lien Debt, 7/20/2023 Maturity
2021-12-31
0001534254
CION/EagleTree Partners, LLC., Senior Secured First Lien Debt, 12/21/2026 Maturity
2021-12-31
0001534254
CircusTrix Holdings, LLC., Senior Secured First Lien Debt, 1/16/2024 Maturity, 1
2021-12-31
0001534254
CircusTrix Holdings, LLC., Senior Secured First Lien Debt, 1/16/2024 Maturity, 2
2021-12-31
0001534254
CircusTrix Holdings, LLC., Senior Secured First Lien Debt, 7/16/2023 Maturity, 3
2021-12-31
0001534254
Country Fresh Holdings, LLC., Senior Secured First Lien Debt, 4/29/2023 Maturity, 1
2021-12-31
0001534254
Country Fresh Holdings, LLC., Senior Secured First Lien Debt, 4/29/2023 Maturity, 2
2021-12-31
0001534254
Coyote Buyer , LLC., Senior Secured First Lien Debt, 2/6/2026 Maturity, 1
2021-12-31
0001534254
Coyote Buyer , LLC., Senior Secured First Lien Debt, 8/6/2026 Maturity, 2
2021-12-31
0001534254
Coyote Buyer , LLC., Senior Secured First Lien Debt, 2/6/2025 Maturity, 3
2021-12-31
0001534254
Critical Nurse Staffing, LLC., Senior Secured First Lien Debt, 11/1/2026 Maturity, 1
2021-12-31
0001534254
Critical Nurse Staffing, LLC., Senior Secured First Lien Debt, 11/1/2026 Maturity, 2
2021-12-31
0001534254
Critical Nurse Staffing, LLC., Senior Secured First Lien Debt, 11/1/2026 Maturity, 3
2021-12-31
0001534254
Critical Nurse Staffing, LLC., Senior Secured First Lien Debt, 11/1/2026 Maturity, 4
2021-12-31
0001534254
David's Bridal, LLC., Senior Secured First Lien Debt, 6/23/2023 Maturity, 1
2021-12-31
0001534254
David's Bridal, LLC., Senior Secured First Lien Debt, 5/23/2024 Maturity, 2
2021-12-31
0001534254
David's Bridal, LLC., Senior Secured First Lien Debt, 6/30/2023 Maturity, 3
2021-12-31
0001534254
Deluxe Entertainment Services, Inc., Senior Secured First Lien Debt, 3/25/2024 Maturity
2021-12-31
0001534254
DMT Solutions Global Corp., Senior Secured First Lien Debt, 7/2/2024 Maturity
2021-12-31
0001534254
Entertainment Studios P&A LLC., Senior Secured First Lien Debt, 5/18/2037 Maturity, 1
2021-12-31
0001534254
Entertainment Studios P&A LLC., Senior Secured First Lien Debt, 5/18/2037 Maturity, 2
2021-12-31
0001534254
EnTrans International, LLC., Senior Secured First Lien Debt, 11/1/2024 Maturity
2021-12-31
0001534254
Extreme Reach, Inc., Senior Secured First Lien Debt, 3/29/2024 Maturity, 1
2021-12-31
0001534254
Extreme Reach, Inc., Senior Secured First Lien Debt, 3/29/2024 Maturity, 2
2021-12-31
0001534254
Foundation Consumer Healthcare, LLC., Senior Secured First Lien Debt, 2/12/2027 Maturity, 1
2021-12-31
0001534254
Foundation Consumer Healthcare, LLC., Senior Secured First Lien Debt, 11/2/2023 Maturity, 2
2021-12-31
0001534254
FuseFX, LLC, Senior Secured First Lien Debt, 10/1/2024 Maturity
2021-12-31
0001534254
Future Pak, LLC, Senior Secured First Lien Debt, 7/2/2024 Maturity
2021-12-31
0001534254
Genesis Healthcare, Inc., Senior Secured First Lien Debt, 3/6/2023 Maturity
2021-12-31
0001534254
GSC Technologies Inc., Senior Secured First Lien Debt, 9/30/2025 Maturity, 1
2021-12-31
0001534254
GSC Technologies Inc., Senior Secured First Lien Debt, 9/30/2025 Maturity, 2
2021-12-31
0001534254
GSC Technologies Inc., Senior Secured First Lien Debt, 9/30/2025 Maturity, 3
2021-12-31
0001534254
H.W. Lochner, Inc., Senior Secured First Lien Debt, 7/2/2027 Maturity, 1
2021-12-31
0001534254
H.W. Lochner, Inc, Senior Secured First Lien Debt, 7/2/2027 Maturity, 2
2021-12-31
0001534254
H.W. Lochner, Inc, Senior Secured First Lien Debt, 7/2/2027 Maturity, 3
2021-12-31
0001534254
Harland Clarke Holdings Corp., Senior Secured First Lien Debt, 6/16/2026 Maturity
2021-12-31
0001534254
Heritage Power, LLC., Senior Secured First Lien Debt, 7/30/2026 Maturity
2021-12-31
0001534254
Hilliard, Martinez & Gonzales, LLP., Senior Secured First Lien Debt, 12/17/2022 Maturity
2021-12-31
0001534254
Homer City Generation, L.P., Senior Secured First Lien Debt, 4/5/2023 Maturity
2021-12-31
0001534254
Hoover Group, Inc., Senior Secured First Lien Debt, 10/1/2024 Maturity
2021-12-31
0001534254
HUMC Holdco, LLC., Senior Secured First Lien Debt, 1/14/2022 Maturity
2021-12-31
0001534254
HW Acquisition, LLC., Senior Secured First Lien Debt, 9/28/2026 Maturity, 1
2021-12-31
0001534254
HW Acquisition, LLC., Senior Secured First Lien Debt, 9/28/2026 Maturity, 2
2021-12-31
0001534254
Independent Pet Partners Intermediate Holdings, LLC., Senior Secured First Lien Debt, 11/20/2023 Maturity. 1
2021-12-31
0001534254
Independent Pet Partners Intermediate Holdings, LLC., Senior Secured First Lien Debt, 12/22/2022 Maturity. 2
2021-12-31
0001534254
Independent Pet Partners Intermediate Holdings, LLC., Senior Secured First Lien Debt, 12/22/2022 Maturity. 3
2021-12-31
0001534254
InfoGroup Inc., Senior Secured First Lien Debt, 4/3/2023 Maturity
2021-12-31
0001534254
Inotiv, Inc., Senior Secured First Lien Debt, 11/5/2026 Maturity. 1
2021-12-31
0001534254
Inotiv, Inc., Senior Secured First Lien Debt, 5/5/2023 Maturity. 2
2021-12-31
0001534254
Instant Web, LLC., Senior Secured First Lien Debt, 12/15/2022 Maturity. 1
2021-12-31
0001534254
Instant Web, LLC., Senior Secured First Lien Debt, 12/15/2022 Maturity. 2
2021-12-31
0001534254
Invincible Boat Company LLC., Senior Secured First Lien Debt, 8/28/2025 Maturity, 1
2021-12-31
0001534254
Invincible Boat Company LLC., Senior Secured First Lien Debt, 8/28/2025 Maturity, 2
2021-12-31
0001534254
INW Manufacturing, LLC., Senior Secured First Lien Debt, 5/7/2027 Maturity
2021-12-31
0001534254
Isagenix International, LLC., Senior Secured First Lien Debt, 6/14/2025 Maturity
2021-12-31
0001534254
Island Medical Management Holdings, LLC., Senior Secured First Lien Debt, 9/1/2023 Maturity
2021-12-31
0001534254
Jenny C Acquisition, Inc., Senior Secured First Lien Debt, 10/1/2024 Maturity
2021-12-31
0001534254
JP Intermediate B, LLC., Senior Secured First Lien Debt, 11/20/2025 Maturity
2021-12-31
0001534254
K&N Parent, Inc., Senior Secured First Lien Debt, 10/20/2023 Maturity
2021-12-31
0001534254
KNB Holdings Corp., Senior Secured First Lien Debt, 4/26/2024 Maturity
2021-12-31
0001534254
LaserAway Intermediate Holdings II, LLC., Senior Secured First Lien Debt, 10/12/2027 Maturity
2021-12-31
0001534254
LAV Gear Holdings, Inc., Senior Secured First Lien Debt, 10/31/2024 Maturity, 1
2021-12-31
0001534254
LAV Gear Holdings, Inc., Senior Secured First Lien Debt, 10/31/2024 Maturity, 2
2021-12-31
0001534254
LGC US Finco, LLC., Senior Secured First Lien Debt, 12/20/2025 Maturity
2021-12-31
0001534254
LH Intermediate Corp., Senior Secured First Lien Debt, 6/2/2026 Maturity
2021-12-31
0001534254
Lift Brands, Inc., Senior Secured First Lien Debt, 6/29/2025 Maturity, 1
2021-12-31
0001534254
Lift Brands, Inc., Senior Secured First Lien Debt, 6/29/2025 Maturity, 2
2021-12-31
0001534254
Lift Brands, Inc., Senior Secured First Lien Debt, 6/29/2025 Maturity, 3
2021-12-31
0001534254
Longview Power, LLC., Senior Secured First Lien Debt, 7/30/2025 Maturity
2021-12-31
0001534254
MacNeill Pride Group Corp., Senior Secured First Lien Debt, 4/20/2026 Maturity, 1
2021-12-31
0001534254
MacNeill Pride Group Corp., Senior Secured First Lien Debt, 4/20/2026 Maturity, 2
2021-12-31
0001534254
Manus Bio Inc., Senior Secured First Lien Debt, 8/20/2026 Maturity
2021-12-31
0001534254
Marble Point Credit Management LLC., Senior Secured First Lien Debt, 8/11/2028 Maturity, 1
2021-12-31
0001534254
Marble Point Credit Management LLC., Senior Secured First Lien Debt, 8/11/2028 Maturity, 2
2021-12-31
0001534254
Marble Point Credit Management LLC., Senior Secured First Lien Debt, 8/11/2028 Maturity, 3
2021-12-31
0001534254
Mimeo.com, Inc., Senior Secured First Lien Debt, 12/21/2023 Maturity, 1
2021-12-31
0001534254
Mimeo.com, Inc., Senior Secured First Lien Debt, 12/21/2023 Maturity, 2
2021-12-31
0001534254
Mimeo.com, Inc., Senior Secured First Lien Debt, 12/21/2023 Maturity, 3
2021-12-31
0001534254
Molded Devices, Inc., Senior Secured First Lien Debt, 11/1/2026 Maturity, 1
2021-12-31
0001534254
Molded Devices, Inc., Senior Secured First Lien Debt, 11/1/2026 Maturity, 2
2021-12-31
0001534254
Molded Devices, Inc., Senior Secured First Lien Debt, 11/1/2026 Maturity, 3
2021-12-31
0001534254
Moss Holding Company., Senior Secured First Lien Debt, 4/17/2024 Maturity, 1
2021-12-31
0001534254
Moss Holding Company., Senior Secured First Lien Debt, 4/17/2024 Maturity, 2
2021-12-31
0001534254
Moss Holding Company., Senior Secured First Lien Debt, 4/17/2024 Maturity, 3
2021-12-31
0001534254
Napa Management Services Corp., Senior Secured First Lien Debt, 4/19/2023 Maturity
2021-12-31
0001534254
NASCO Healthcare Inc., Senior Secured First Lien Debt, 6/30/2023 Maturity
2021-12-31
0001534254
Neptune Flood Inc., Senior Secured First Lien Debt, 10/21/2026 Maturity
2021-12-31
0001534254
NewsCycle Solutions, Inc., Senior Secured First Lien Debt, 12/29/2022 Maturity
2021-12-31
0001534254
NWN Parent Holdings LLC., Senior Secured First Lien Debt, 5/7/2026 Maturity, 1
2021-12-31
0001534254
NWN Parent Holdings LLC., Senior Secured First Lien Debt, 5/7/2026 Maturity, 2
2021-12-31
0001534254
NWN Parent Holdings LLC., Senior Secured First Lien Debt, 5/7/2026 Maturity, 3
2021-12-31
0001534254
Optio Rx, LLC., Senior Secured First Lien Debt, 6/28/2024 Maturity, 1
2021-12-31
0001534254
Optio Rx, LLC., Senior Secured First Lien Debt, 6/28/2024 Maturity, 2
2021-12-31
0001534254
Pentec Acquisition Corp., Senior Secured First Lien Debt, 10/8/2026 Maturity
2021-12-31
0001534254
PetroChoice Holdings, Inc., Senior Secured First Lien Debt, 8/20/2022 Maturity
2021-12-31
0001534254
PH Beauty Holdings III. Inc., Senior Secured First Lien Debt, 9/28/2025 Maturity
2021-12-31
0001534254
Playboy Enterprises, Inc., Senior Secured First Lien Debt, 5/25/2027 Maturity
2021-12-31
0001534254
Polymer Additives, Inc., Senior Secured First Lien Debt, 7/31/2025 Maturity
2021-12-31
0001534254
RA Outdoors, LLC., Senior Secured First Lien Debt, 4/8/2026 Maturity, 1
2021-12-31
0001534254
RA Outdoors, LLC., Senior Secured First Lien Debt, 4/8/2026 Maturity, 2
2021-12-31
0001534254
Retail Services WIS Corp., Senior Secured First Lien Debt, 5/20/2025 Maturity
2021-12-31
0001534254
Robert C. Hilliard, L.L.P., Senior Secured First Lien Debt, 12/17/2022 Maturity
2021-12-31
0001534254
Rogers Mechanical Contractors, LLC., Senior Secured First Lien Debt, 9/9/2025 Maturity, 1
2021-12-31
0001534254
Rogers Mechanical Contractors, LLC., Senior Secured First Lien Debt, 9/9/2025 Maturity, 2
2021-12-31
0001534254
Rogers Mechanical Contractors, LLC., Senior Secured First Lien Debt, 9/9/2025 Maturity, 3
2021-12-31
0001534254
RumbleOn, Inc., Senior Secured First Lien Debt, 8/31/2026 Maturity, 1
2021-12-31
0001534254
RumbleOn, Inc., Senior Secured First Lien Debt, 2/28/2023 Maturity, 2
2021-12-31
0001534254
Securus Technologies Holdings, Inc., Senior Secured First Lien Debt, 11/1/2024 Maturity
2021-12-31
0001534254
Sequoia Healthcare Management, LLC., Senior Secured First Lien Debt, 8/21/2023 Maturity
2021-12-31
0001534254
SIMR, LLC., Senior Secured First Lien Debt, 9/7/2023 Maturity
2021-12-31
0001534254
Sleep Opco, LLC., Senior Secured First Lien Debt, 10/12/2026 Maturity, 1
2021-12-31
0001534254
Sleep Opco, LLC., Senior Secured First Lien Debt, 10/12/2026 Maturity, 2
2021-12-31
0001534254
Spinal USA, Inc. / Precision Medical Inc., Senior Secured First Lien Debt, 10/1/2022 Maturity, 1
2021-12-31
0001534254
Spinal USA, Inc. / Precision Medical Inc., Senior Secured First Lien Debt, 10/1/2022 Maturity, 2
2021-12-31
0001534254
Spinal USA, Inc. / Precision Medical Inc., Senior Secured First Lien Debt, 10/1/2022 Maturity, 3
2021-12-31
0001534254
Spinal USA, Inc. / Precision Medical Inc., Senior Secured First Lien Debt, 10/1/2022 Maturity, 4
2021-12-31
0001534254
Spinal USA, Inc. / Precision Medical Inc., Senior Secured First Lien Debt, 10/1/2022 Maturity, 5
2021-12-31
0001534254
Tenere Inc., Senior Secured First Lien Debt, 7/1/2025 Maturity
2021-12-31
0001534254
Tensar Corp., Senior Secured First Lien Debt, 11/20/2025 Maturity
2021-12-31
0001534254
Trademark Global, LLC., Senior Secured First Lien Debt, 7/30/2024 Maturity, 1
2021-12-31
0001534254
Trademark Global, LLC., Senior Secured First Lien Debt, 7/30/2023 Maturity, 2
2021-12-31
0001534254
Trammell, P.C., Senior Secured First Lien Debt, 6/25/2022 Maturity
2021-12-31
0001534254
USALCO, LLC., Senior Secured First Lien Debt, 10/19/2027 Maturity
2021-12-31
0001534254
Vesta Holdings, LLC., Senior Secured First Lien Debt, 2/25/2024 Maturity
2021-12-31
0001534254
Volta Charging, LLC., Senior Secured First Lien Debt, 6/19/2024 Maturity, 1
2021-12-31
0001534254
Volta Charging, LLC., Senior Secured First Lien Debt, 6/19/2024 Maturity, 2
2021-12-31
0001534254
West Dermatology Management Holdings, LLC., Senior Secured First Lien Debt, 2/11/2025 Maturity, 1
2021-12-31
0001534254
West Dermatology Management Holdings, LLC., Senior Secured First Lien Debt, 2/11/2025 Maturity, 2
2021-12-31
0001534254
West Dermatology Management Holdings, LLC., Senior Secured First Lien Debt, 2/11/2025 Maturity, 3
2021-12-31
0001534254
West Dermatology Management Holdings, LLC., Senior Secured First Lien Debt, 2/11/2025 Maturity, 4
2021-12-31
0001534254
West Dermatology Management Holdings, LLC., Senior Secured First Lien Debt, 2/11/2025 Maturity, 5
2021-12-31
0001534254
West Dermatology Management Holdings, LLC., Senior Secured First Lien Debt, 2/11/2022 Maturity, 6
2021-12-31
0001534254
Williams Industrial Services Group, Inc., Senior Secured First Lien Debt, 12/16/2025 Maturity, 1
2021-12-31
0001534254
Williams Industrial Services Group, Inc., Senior Secured First Lien Debt, 12/16/2025 Maturity, 2
2021-12-31
0001534254
Wind River Systems, Inc., Senior Secured First Lien Debt, 6/24/2024 Maturity
2021-12-31
0001534254
Wok Holdings Inc., Senior Secured First Lien Debt, 3/1/2026 Maturity
2021-12-31
0001534254
Xenon Arc, Inc., Senior Secured First Lien Debt, 12/17/2027 Maturity
2021-12-31
0001534254
cion:SeniorSecuredSecondLienDebtMember
2021-12-31
0001534254
Deluxe Entertainment Services, Inc., Senior Secured Second Lien Debt, 9/25/2024 Maturity
2021-12-31
0001534254
Global Tel*Link Corp., Senior Secured Second Lien Debt, 11/29/2026 Maturity
2021-12-31
0001534254
PetroChoice Holdings, Inc., Senior Secured Second Lien Debt, 8/21/2023 Maturity
2021-12-31
0001534254
Premiere Global Services, Inc., Senior Secured Second Lien Debt, 6/6/2024 Maturity
2021-12-31
0001534254
Securus Technologies Holdings, Inc., Senior Secured Second Lien Debt, 11/1/2025 Maturity
2021-12-31
0001534254
TMK Hawk Parent, Corp., Senior Secured Second Lien Debt, 8/28/2025 Maturity
2021-12-31
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-12-31
0001534254
APIDOS CLO XVI Subordinated Notes., Collateralized Securities and Structured Products - Equity, Maturity, 1/19/2025 Maturity
2021-12-31
0001534254
Galaxy XV CLO Ltd. Class A Subordinated Notes., Collateralized Securities and Structured Products - Equity, Maturity, 4/15/2025 Maturity
2021-12-31
0001534254
us-gaap:UnsecuredDebtMember
2021-12-31
0001534254
Lucky Bucks Holdings LLC., Unsecured Debt, 5/29/2028 Maturity
2021-12-31
0001534254
WPLM Acquisition Corp., Unsecured Debt, 11/24/2025 Maturity
2021-12-31
0001534254
us-gaap:EquitySecuritiesMember
2021-12-31
0001534254
ARC Financial Partners, LLC., Equity
us-gaap:EquitySecuritiesMember
2021-12-31
0001534254
ARC Financial Partners, LLC., Equity
2021-12-31
0001534254
Ascent Resources - Marcellus, LLC, Membership Units., Equity
2021-12-31
0001534254
Ascent Resources - Marcellus, LLC, Warrants., Equity
2021-12-31
0001534254
CION/EagleTree Partners, LLC, Participating Preferred Shares., Equity
2021-12-31
0001534254
CION/EagleTree Partners, LLC., Equity
us-gaap:EquitySecuritiesMember
2021-12-31
0001534254
CION/EagleTree Partners, LLC., Equity
2021-12-31
0001534254
DBI Investors, Inc., Series A1 Preferred Stock., Equity
2021-12-31
0001534254
DBI Investors, Inc., Series A2 Preferred Stock., Equity
2021-12-31
0001534254
DBI Investors, Inc., Series A Preferred Stock., Equity
2021-12-31
0001534254
DBI Investors, Inc., Series B Preferred Stock., Equity
2021-12-31
0001534254
DBI Investors, Inc., Common Stock., Equity
2021-12-31
0001534254
DBI Investors, Inc., Reallocation Rights., Equity
2021-12-31
0001534254
GSC Technologies Inc., Common Shares., Equity
2021-12-31
0001534254
Independent Pet Partners Intermediate Holdings, LLC, Class A Preferred Units., Equity
2021-12-31
0001534254
Independent Pet Partners Intermediate Holdings, LLC, Class B-2 Preferred Units., Equity
2021-12-31
0001534254
Independent Pet Partners Intermediate Holdings, LLC, Class C Preferred Units., Equity,
2021-12-31
0001534254
Independent Pet Partners Intermediate Holdings, LLC, Warrants., Equity
2021-12-31
0001534254
Longview Intermediate Holdings C, LLC, Membership Units., Equity
2021-12-31
0001534254
Mooregate ITC Acquisition, LLC, Class A Units., Equity
2021-12-31
0001534254
Mount Logan Capital Inc., Common Stock., Equity
2021-12-31
0001534254
NS NWN Acquisition, LLC, Class A Preferred Units., Equity
2021-12-31
0001534254
NS NWN Acquisition, LLC, Non-voting Units., Equity
2021-12-31
0001534254
NS NWN Holdco LLC, Voting Units., Equity
2021-12-31
0001534254
NSG Co-Invest (Bermuda) LP, Partnership Interests., Equity
2021-12-31
0001534254
Palmetto Clean Technology, Inc., Warrants., Equity
2021-12-31
0001534254
RumbleOn, Inc., Warrants., Equity
2021-12-31
0001534254
SIMR Parent, LLC, Class B Common Units., Equity
2021-12-31
0001534254
SIMR Parent, LLC, Class W Units., Equity
2021-12-31
0001534254
Snap Fitness Holdings, Inc., Class A Common Stock., Equity
2021-12-31
0001534254
Snap Fitness Holdings, Inc., Warrants., Equity
2021-12-31
0001534254
us-gaap:ShortTermInvestmentsMember
2021-12-31
0001534254
First American Treasury Obligations Fund, Class Z Shares., Short Term Investments M
2021-12-31
0001534254
First Americn Treasury Obligations Fund, Class Z Shares., Short Term Investments, Maturity
2021-12-31
0001534254
Alert 360 Opco, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
Alert 360 Opco, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
Alert 360 Opco, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Alert 360 Opco, Inc., Common Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
Alert 360 Opco, Inc., Common Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
Alert 360 Opco, Inc., Common Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
American Clinical Solutions LLC, Tranche I Term Loan
2020-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
American Clinical Solutions LLC, Tranche I Term Loan
2021-01-01
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
American Clinical Solutions LLC, Tranche I Term Loan
2021-12-31
0001534254
American Clinical Solutions LLC, First Amendment Tranche I Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
American Clinical Solutions LLC, First Amendment Tranche I Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
American Clinical Solutions LLC, First Amendment Tranche I Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
American Clinical Solutions LLC, Class A Membership Interests
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
American Clinical Solutions LLC, Class A Membership Interests
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
American Clinical Solutions LLC, Class A Membership Interests
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
ARC Financial, LLC, Membership Interests
2020-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
ARC Financial, LLC, Membership Interests
2021-01-01
2021-12-31
0001534254
BCP Great Lakes Fund LP, Membership Interests
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
BCP Great Lakes Fund LP, Membership Interests
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
BCP Great Lakes Fund LP, Membership Interests
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Charming Charlie, LLC, Vendor Payment Financing Facility
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
Charming Charlie, LLC, Vendor Payment Financing Facility
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
Conisus Holdings, Inc., Series B Preferred Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
Conisus Holdings, Inc., Series B Preferred Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
Conisus Holdings, Inc., Series B Preferred Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
Conisus Holdings, Inc., Common Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
Conisus Holdings, Inc., Common Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
Conisus Holdings, Inc., Common Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
DESG Holdings, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
DESG Holdings, Inc., First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
DESG Holdings, Inc., Second Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
DESG Holdings, Inc., Second Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
DESG Holdings, Inc., Common Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
DESG Holdings, Inc., Common Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
DESG Holdings, Inc., Common Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
F+W Media, Inc., First Lien Term Loan B-1
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
F+W Media, Inc., First Lien Term Loan B-1
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
F+W Media, Inc., First Lien Term Loan B-1
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-12-31
0001534254
GSC Technologies Inc., Incremental Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
GSC Technologies Inc., Incremental Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
GSC Technologies Inc., First Lien Term Loan A
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
GSC Technologies Inc., First Lien Term Loan A
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
GSC Technologies Inc., First Lien Term Loan B
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
GSC Technologies Inc., First Lien Term Loan B
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
GSC Technologies Inc., Common Shares
2020-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
GSC Technologies Inc., Common Shares
2021-01-01
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Lift Brands, Inc., Term Loan A
2020-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Lift Brands, Inc., Term Loan A
2021-01-01
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Lift Brands, Inc., Term Loan B
2020-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Lift Brands, Inc., Term Loan B
2021-01-01
2021-12-31
0001534254
Lift Brands, Inc., Term Loan C
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
Lift Brands, Inc., Term Loan C
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
Longview Power, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
Longview Power, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
Longview Intermediate Holdings C, LLC, Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
Longview Intermediate Holdings C, LLC, Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Mount Logan Capital Inc., Common Stock
2020-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
Mount Logan Capital Inc., Common Stock
2021-01-01
2021-12-31
0001534254
SIMR, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
SIMR, LLC, First Lien Term Loan
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
SIMR Parent, LLC, Class B Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
SIMR Parent, LLC, Class B Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
SIMR Parent, LLC, Class W Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
SIMR Parent, LLC, Class W Membership Units
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
Snap Fitness Holdings, Inc., Class A Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
Snap Fitness Holdings, Inc., Class A Stock
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
Snap Fitness Holdings, Inc., Warrants
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
Snap Fitness Holdings, Inc., Warrants
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2021-01-01
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerNoncontrolledMember
2020-12-31
0001534254
CION SOF Funding, LLC, Membership Interests
2020-12-31
0001534254
CION SOF Funding, LLC, Membership Interests
2021-01-01
2021-12-31
0001534254
CION SOF Funding, LLC, Membership Interests
2021-12-31
0001534254
CION/EagleTree Partners, LLC, Senior Secured Note
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2020-12-31
0001534254
CION/EagleTree Partners, LLC, Senior Secured Note
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2021-01-01
2021-12-31
0001534254
CION/EagleTree Partners, LLC, Participating Preferred Shares
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2020-12-31
0001534254
CION/EagleTree Partners, LLC, Participating Preferred Shares
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2021-01-01
2021-12-31
0001534254
CION/EagleTree Partners, LLC, Common Shares
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2020-12-31
0001534254
CION/EagleTree Partners, LLC, Common Shares
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2021-01-01
2021-12-31
0001534254
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2020-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
Adapt Laser Acquisition, Inc.
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
American Consolidated Natural Resources, Inc.
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
Ancile Solutions, Inc.
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
Anthem Sports & Entertainment Inc.
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
Cadence Aerospace, LLC
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
CHC Solutions Inc.
2021-12-31
0001534254
cion:SeniorSecuredNoteMember
CION/EagleTree Partners, LLC
2021-12-31
0001534254
CircusTrix Holdings, LLC
cion:SeniorSecuredFirstLienDebtMember
2021-12-31
0001534254
David's Bridal, LLC
cion:SeniorSecuredFirstLienDebtMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
David's Bridal, LLC 1
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
Deluxe Entertainment Services, Inc.
2021-12-31
0001534254
cion:SeniorSecuredSecondLienDebtMember
Deluxe Entertainment Services, Inc.
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
GSC Technologies Inc.
2021-12-31
0001534254
GSC Technologies Inc. 1
cion:SeniorSecuredFirstLienDebtMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
Hilliard, Martinez & Gonzales, LLP
2021-12-31
0001534254
Homer City Generation, L.P.
cion:SeniorSecuredFirstLienDebtMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
Independent Pet Partners Intermediate Holdings, LLC
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
LAV Gear Holdings, Inc.
2021-12-31
0001534254
Lift Brands, Inc.
cion:SeniorSecuredFirstLienDebtMember
2021-12-31
0001534254
us-gaap:UnsecuredDebtMember
Lucky Bucks Holdings LLC
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
Moss Holding Company
2021-12-31
0001534254
cion:SeniorSecuredSecondLienDebtMember
Premiere Global Services, Inc.
2021-12-31
0001534254
Robert C. Hilliard, L.L.P.
cion:SeniorSecuredFirstLienDebtMember
2021-12-31
0001534254
RumbleOn, Inc.
cion:SeniorSecuredFirstLienDebtMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
SIMR, LLC
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
Spinal USA, Inc. / Precision Medical Inc.
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
Trammell, P.C.
2021-12-31
0001534254
Vesta Holdings, LLC
cion:SeniorSecuredFirstLienDebtMember
2021-12-31
0001534254
WPLM Acquisition Corp.
us-gaap:UnsecuredDebtMember
2021-12-31
0001534254
cion:OneMonthLIBORMember
DMT Solutions Global Corp., Senior Secured First Lien Debt, 7/2/2024 Maturity
2021-12-31
0001534254
cion:ThreeMonthLIBORMember
DMT Solutions Global Corp., Senior Secured First Lien Debt, 7/2/2024 Maturity
2021-12-31
0001534254
2012-12-17
2012-12-17
0001534254
cion:CIONInvestmentManagementLLCMember
cion:ApolloInvestmentManagementLPMember
2017-07-11
0001534254
cion:CIONInvestmentManagementLLCMember
cion:CIONInvestmentGroupLLCMember
2017-07-11
0001534254
2021-04-05
2021-04-05
0001534254
2021-10-04
2021-10-04
0001534254
2021-10-05
2021-10-05
0001534254
2012-07-02
2022-09-30
0001534254
cion:PublicStockOfferingMember
2012-07-02
2022-09-30
0001534254
cion:PublicStockOfferingMember
2022-09-30
0001534254
cion:PublicStockOfferingReinvestedShareholderDistributionsMember
2012-07-02
2022-09-30
0001534254
cion:PublicStockOfferingReinvestedShareholderDistributionsMember
2022-01-01
2022-09-30
0001534254
2022-09-15
2022-09-15
0001534254
2021-09-20
0001534254
2021-09-21
0001534254
2021-10-05
utr:D
0001534254
2021-09-15
0001534254
2022-06-24
0001534254
2021-01-01
2021-03-31
0001534254
2021-04-01
2021-06-30
0001534254
2021-10-01
2021-12-31
0001534254
2022-01-01
2022-03-31
0001534254
2022-04-01
2022-06-30
0001534254
us-gaap:SubsequentEventMember
2022-10-01
2022-11-03
0001534254
us-gaap:SubsequentEventMember
2022-11-03
2022-11-03
0001534254
cion:CIMManagementFeeMember
srt:AffiliatedEntityMember
2022-07-01
2022-09-30
0001534254
cion:CIMManagementFeeMember
srt:AffiliatedEntityMember
2021-07-01
2021-09-30
0001534254
cion:CIMManagementFeeMember
srt:AffiliatedEntityMember
2022-01-01
2022-09-30
0001534254
cion:CIMManagementFeeMember
srt:AffiliatedEntityMember
2021-01-01
2021-09-30
0001534254
cion:CIMManagementFeeMember
srt:AffiliatedEntityMember
2021-01-01
2021-12-31
0001534254
cion:CIMIncentiveFeeMember
srt:AffiliatedEntityMember
2022-07-01
2022-09-30
0001534254
cion:CIMIncentiveFeeMember
srt:AffiliatedEntityMember
2021-07-01
2021-09-30
0001534254
cion:CIMIncentiveFeeMember
srt:AffiliatedEntityMember
2022-01-01
2022-09-30
0001534254
cion:CIMIncentiveFeeMember
srt:AffiliatedEntityMember
2021-01-01
2021-09-30
0001534254
cion:CIMIncentiveFeeMember
srt:AffiliatedEntityMember
2021-01-01
2021-12-31
0001534254
srt:AffiliatedEntityMember
cion:CIMAdministrativeServiceExpenseMember
2022-07-01
2022-09-30
0001534254
srt:AffiliatedEntityMember
cion:CIMAdministrativeServiceExpenseMember
2021-07-01
2021-09-30
0001534254
srt:AffiliatedEntityMember
cion:CIMAdministrativeServiceExpenseMember
2022-01-01
2022-09-30
0001534254
srt:AffiliatedEntityMember
cion:CIMAdministrativeServiceExpenseMember
2021-01-01
2021-09-30
0001534254
srt:AffiliatedEntityMember
cion:CIMAdministrativeServiceExpenseMember
2021-01-01
2021-12-31
0001534254
srt:AffiliatedEntityMember
cion:ApolloInvestmentAdministrationTransactionCostsMember
2022-07-01
2022-09-30
0001534254
srt:AffiliatedEntityMember
cion:ApolloInvestmentAdministrationTransactionCostsMember
2021-07-01
2021-09-30
0001534254
srt:AffiliatedEntityMember
cion:ApolloInvestmentAdministrationTransactionCostsMember
2022-01-01
2022-09-30
0001534254
srt:AffiliatedEntityMember
cion:ApolloInvestmentAdministrationTransactionCostsMember
2021-01-01
2021-09-30
0001534254
srt:AffiliatedEntityMember
cion:ApolloInvestmentAdministrationTransactionCostsMember
2021-01-01
2021-12-31
0001534254
cion:InvestmentAdvisoryAgreementMember
2021-04-05
2021-04-05
0001534254
cion:InvestmentAdvisoryAgreementAnnualBaseManagementFeeMember
2021-04-05
2021-04-05
0001534254
cion:InvestmentAdvisoryAgreementAnnualBaseManagementFeeMember
2021-10-05
2021-10-05
0001534254
cion:InvestmentAdvisoryAgreementAssetCoverageRatioMember
2021-10-05
2021-10-05
0001534254
cion:InvestmentAdvisoryAgreementAnnualBaseManagementFeeStepDownMember
2021-10-05
2021-10-05
0001534254
cion:InvestmentAdvisoryAgreementAssetCoverageRatioMember
2021-12-31
2021-12-31
0001534254
cion:InvestmentAdvisoryAgreementHurdleRatePerQuarterMember
2021-08-10
2021-08-10
0001534254
cion:InvestmentAdvisoryAgreementHurdleRatePerYearMember
2021-08-10
2021-08-10
0001534254
cion:InvestmentAdvisoryAgreementPreIncentiveFeeUpToThresholdMember
2021-08-10
2021-08-10
0001534254
cion:InvestmentAdvisoryFeeHurdleRateThresholdMember
2021-08-10
2021-08-10
0001534254
cion:InvestmentAdvisoryAgreementPreIncentiveFeeAfterThresholdMember
2021-08-10
2021-08-10
0001534254
cion:InvestmentAdvisoryAgreementSecondAmendmentHurdleRatePerQuarterMember
2021-08-10
2021-08-10
0001534254
cion:InvestmentAdvisoryAgreementSecondAmendmentHurdleRatePerYearMember
2021-08-10
2021-08-10
0001534254
cion:InvestmentAdvisoryAgreementSecondAmendmentPreIncentiveFeeUpToThresholdMember
2021-08-10
2021-08-10
0001534254
cion:InvestmentAdvisoryFeeSecondAmendmentHurdleRateThresholdMember
2021-08-10
2021-08-10
0001534254
cion:InvestmentAdvisoryAgreementSecondAmendmentPreIncentiveFeeAfterThresholdMember
2021-08-10
2021-08-10
0001534254
cion:ServicingAgreementMember
2019-01-01
2019-01-01
0001534254
cion:ExpenseSupportAndConditionalReimbursementAgreementMember
2018-01-02
2018-01-02
0001534254
cion:InvestmentAdvisoryAgreementMember
srt:AffiliatedEntityMember
2022-01-01
2022-09-30
0001534254
cion:InvestmentAdvisoryAgreementMember
srt:AffiliatedEntityMember
2021-01-01
2021-12-31
0001534254
cion:InvestmentPortfolioConcentrationMember
cion:SeniorSecuredFirstLienDebtMember
cion:InvestmentsAtCostAndFairValueMember
2022-01-01
2022-09-30
0001534254
cion:InvestmentPortfolioConcentrationMember
cion:SeniorSecuredFirstLienDebtMember
cion:InvestmentsAtCostAndFairValueMember
2021-01-01
2021-12-31
0001534254
cion:InvestmentPortfolioConcentrationMember
cion:SeniorSecuredSecondLienDebtMember
cion:InvestmentsAtCostAndFairValueMember
2022-01-01
2022-09-30
0001534254
cion:InvestmentPortfolioConcentrationMember
cion:SeniorSecuredSecondLienDebtMember
cion:InvestmentsAtCostAndFairValueMember
2021-01-01
2021-12-31
0001534254
us-gaap:CollateralizedSecuritiesMember
2022-09-30
0001534254
cion:InvestmentPortfolioConcentrationMember
us-gaap:CollateralizedSecuritiesMember
cion:InvestmentsAtCostAndFairValueMember
2022-01-01
2022-09-30
0001534254
us-gaap:CollateralizedSecuritiesMember
2021-12-31
0001534254
cion:InvestmentPortfolioConcentrationMember
us-gaap:CollateralizedSecuritiesMember
cion:InvestmentsAtCostAndFairValueMember
2021-01-01
2021-12-31
0001534254
cion:InvestmentPortfolioConcentrationMember
us-gaap:UnsecuredDebtMember
cion:InvestmentsAtCostAndFairValueMember
2022-01-01
2022-09-30
0001534254
cion:InvestmentPortfolioConcentrationMember
us-gaap:UnsecuredDebtMember
cion:InvestmentsAtCostAndFairValueMember
2021-01-01
2021-12-31
0001534254
cion:InvestmentPortfolioConcentrationMember
cion:InvestmentsAtCostAndFairValueMember
us-gaap:EquitySecuritiesMember
2022-01-01
2022-09-30
0001534254
cion:InvestmentPortfolioConcentrationMember
cion:InvestmentsAtCostAndFairValueMember
us-gaap:EquitySecuritiesMember
2021-01-01
2021-12-31
0001534254
cion:InvestmentsExcludingShortTermInvestmentsMember
2022-09-30
0001534254
cion:InvestmentPortfolioConcentrationMember
cion:InvestmentsAtCostAndFairValueMember
2022-01-01
2022-09-30
0001534254
cion:InvestmentsExcludingShortTermInvestmentsMember
2021-12-31
0001534254
cion:InvestmentPortfolioConcentrationMember
cion:InvestmentsAtCostAndFairValueMember
2021-01-01
2021-12-31
0001534254
cion:ServicesBusinessMember
2022-09-30
0001534254
cion:ServicesBusinessMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:ServicesBusinessMember
2021-12-31
0001534254
cion:ServicesBusinessMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:HealthcarePharmaceuticalsMember
2022-09-30
0001534254
cion:HealthcarePharmaceuticalsMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:HealthcarePharmaceuticalsMember
2021-12-31
0001534254
cion:HealthcarePharmaceuticalsMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:MediaDiversifiedProductionMember
2022-09-30
0001534254
cion:MediaDiversifiedProductionMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:MediaDiversifiedProductionMember
2021-12-31
0001534254
cion:MediaDiversifiedProductionMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:ServicesConsumerMember
2022-09-30
0001534254
cion:ServicesConsumerMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:ServicesConsumerMember
2021-12-31
0001534254
cion:ServicesConsumerMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:DiversifiedFinancialsMember
2022-09-30
0001534254
cion:IndustryConcentrationRiskMember
cion:DiversifiedFinancialsMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:DiversifiedFinancialsMember
2021-12-31
0001534254
cion:IndustryConcentrationRiskMember
cion:DiversifiedFinancialsMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:HighTechIndustriesMember
2022-09-30
0001534254
cion:HighTechIndustriesMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:HighTechIndustriesMember
2021-12-31
0001534254
cion:HighTechIndustriesMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:MediaAdvertisingPrintingPublishingMember
2022-09-30
0001534254
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
cion:MediaAdvertisingPrintingPublishingMember
2022-01-01
2022-09-30
0001534254
cion:MediaAdvertisingPrintingPublishingMember
2021-12-31
0001534254
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
cion:MediaAdvertisingPrintingPublishingMember
2021-01-01
2021-12-31
0001534254
cion:ChemicalsPlasticsRubberMember
2022-09-30
0001534254
cion:IndustryConcentrationRiskMember
cion:ChemicalsPlasticsRubberMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:ChemicalsPlasticsRubberMember
2021-12-31
0001534254
cion:IndustryConcentrationRiskMember
cion:ChemicalsPlasticsRubberMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:RetailsMember
2022-09-30
0001534254
cion:RetailsMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:RetailsMember
2021-12-31
0001534254
cion:RetailsMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:EnergyOilGasMember
2022-09-30
0001534254
cion:EnergyOilGasMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:EnergyOilGasMember
2021-12-31
0001534254
cion:EnergyOilGasMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:ConsumerGoodsDurableMember
2022-09-30
0001534254
cion:ConsumerGoodsDurableMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:ConsumerGoodsDurableMember
2021-12-31
0001534254
cion:ConsumerGoodsDurableMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:HotelGamingLeisureMember
2022-09-30
0001534254
cion:HotelGamingLeisureMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:HotelGamingLeisureMember
2021-12-31
0001534254
cion:HotelGamingLeisureMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:BeverageFoodTobaccoMember
2022-09-30
0001534254
cion:BeverageFoodTobaccoMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:BeverageFoodTobaccoMember
2021-12-31
0001534254
cion:BeverageFoodTobaccoMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:ConstructionBuildingMember
2022-09-30
0001534254
cion:ConstructionBuildingMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:ConstructionBuildingMember
2021-12-31
0001534254
cion:ConstructionBuildingMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:CapitalEquipmentMember
2022-09-30
0001534254
cion:CapitalEquipmentMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:CapitalEquipmentMember
2021-12-31
0001534254
cion:CapitalEquipmentMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:BankingFinanceInsuranceRealEstateMember
2022-09-30
0001534254
cion:BankingFinanceInsuranceRealEstateMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:BankingFinanceInsuranceRealEstateMember
2021-12-31
0001534254
cion:BankingFinanceInsuranceRealEstateMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:AerospaceDefenseMember
2022-09-30
0001534254
cion:AerospaceDefenseMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:AerospaceDefenseMember
2021-12-31
0001534254
cion:AerospaceDefenseMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:ConsumerGoodsNonDurableMember
2022-09-30
0001534254
cion:ConsumerGoodsNonDurableMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:ConsumerGoodsNonDurableMember
2021-12-31
0001534254
cion:ConsumerGoodsNonDurableMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:TelecommunicationsMember
2022-09-30
0001534254
cion:IndustryConcentrationRiskMember
cion:TelecommunicationsMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:TelecommunicationsMember
2021-12-31
0001534254
cion:IndustryConcentrationRiskMember
cion:TelecommunicationsMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:AutomotiveMember
2022-09-30
0001534254
cion:AutomotiveMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:AutomotiveMember
2021-12-31
0001534254
cion:AutomotiveMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:MetalsMiningMember
2022-09-30
0001534254
cion:MetalsMiningMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:MetalsMiningMember
2021-12-31
0001534254
cion:MetalsMiningMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:TransportationCargoMember
2022-09-30
0001534254
cion:TransportationCargoMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:TransportationCargoMember
2021-12-31
0001534254
cion:TransportationCargoMember
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
cion:IndustryConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
country:US
2022-09-30
0001534254
country:US
us-gaap:GeographicConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
country:US
2021-12-31
0001534254
country:US
us-gaap:GeographicConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
country:CA
2022-09-30
0001534254
country:CA
us-gaap:GeographicConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
country:CA
2021-12-31
0001534254
country:CA
us-gaap:GeographicConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
country:KY
2022-09-30
0001534254
country:KY
us-gaap:GeographicConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
country:KY
2021-12-31
0001534254
country:KY
us-gaap:GeographicConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
country:BM
2022-09-30
0001534254
country:BM
us-gaap:GeographicConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2022-01-01
2022-09-30
0001534254
country:BM
2021-12-31
0001534254
country:BM
us-gaap:GeographicConcentrationRiskMember
cion:InvestmentsAtFairValueMember
2021-01-01
2021-12-31
0001534254
cion:InvestmentsAtFairValueMember
us-gaap:GeographicConcentrationRiskMember
2022-01-01
2022-09-30
0001534254
cion:InvestmentsAtFairValueMember
us-gaap:GeographicConcentrationRiskMember
2021-01-01
2021-12-31
0001534254
cion:UnfundedCommitmentsMember
2022-09-30
0001534254
cion:UnfundedCommitmentsMember
2021-12-31
0001534254
us-gaap:SubsequentEventMember
cion:UnfundedCommitmentsMember
2022-11-03
0001534254
cion:CIONEagleTreeMember
2022-09-30
0001534254
cion:ETBCMember
cion:CIONEagleTreeMember
2022-09-30
cion:member
0001534254
cion:CIONEagleTreeNotesMember
us-gaap:SeniorNotesMember
cion:CIONEagleTreeMember
2021-12-21
0001534254
cion:CIONEagleTreeNotesMember
cion:ETBCMember
us-gaap:SeniorNotesMember
cion:CIONEagleTreeMember
2021-12-21
0001534254
Berlitz Holdings, Inc, Senior Secured First Lien Debt
cion:CIONEagleTreeMember
2022-09-30
0001534254
cion:CIONEagleTreeMember
Community Tree Service, LLC, Senior Secured First Lien Debt
2022-09-30
0001534254
Future Pak, LLC, Senior Secured First Lien Debt
cion:CIONEagleTreeMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
cion:CIONEagleTreeMember
2022-09-30
0001534254
Access CIG, LLC, Senior Secured Second Lien Debt
cion:CIONEagleTreeMember
2022-09-30
0001534254
Dayton Superior Corp, Senior Secured Second Lien Debt
cion:CIONEagleTreeMember
2022-09-30
0001534254
MedPlast Holdings, Inc, Senior Secured Second Lien Debt
cion:CIONEagleTreeMember
2022-09-30
0001534254
Zest Acquisition Corp, Senior Secured Second Lien Debt
cion:CIONEagleTreeMember
2022-09-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
cion:CIONEagleTreeMember
2022-09-30
0001534254
Ivy Hill Middle Market Credit Fund VIII, Ltd. Subordinated Loan, Collateralized Securities and Structured Products - Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
cion:CIONEagleTreeMember
2022-09-30
0001534254
American Clinical Solutions LLC, Class A Membership Interests, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
Anthem Sports and Entertainment Inc., Class A Preferred Stock Warrants, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
Anthem Sports and Entertainment Inc., Class B Preferred Stock Warrants, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
Anthem Sports and Entertainment Inc., Common Stock Warrants, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
BCP Great Lakes Fund LP, Partnership Interests, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
Carestream Health Holdings, Inc., Common Stock, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
cion:CIONEagleTreeMember
CHC Medical Partners, Inc., Series C Preferred Stock, Equity
2022-09-30
0001534254
CTS Ultimate Holdings LLC, Class A Preferred Units, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
Dayton HoldCo, LLC, Membership Units, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
HDNet Holdco LLC, Preferred Unit Call Option, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
HW Ultimate Holdings, LP, Class A Membership Units, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
Language Education Holdings GP LLC, Common Units, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
Language Education Holdings LP, Ordinary Common Units, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
Skillsoft Corp., Class A Common Stock, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
Spinal USA, Inc. / Precision Medical Inc., Warrants, Equity
cion:CIONEagleTreeMember
2022-09-30
0001534254
cion:CIONEagleTreeMember
us-gaap:EquityMember
2022-09-30
0001534254
cion:CIONEagleTreeMember
2022-09-30
0001534254
Access CIG, LLC, Senior Secured Second Lien Debt
cion:CIONEagleTreeMember
2021-12-31
0001534254
Carestream Health, Inc., Senior Secured Second Lien Debt
cion:CIONEagleTreeMember
2021-12-31
0001534254
Dayton Superior Corp., Senior Secured Second Lien Debt
cion:CIONEagleTreeMember
2021-12-31
0001534254
MedPlast Holdings, Inc., Senior Secured Second Lien Debt
cion:CIONEagleTreeMember
2021-12-31
0001534254
Ministry Brands, LLC, Senior Secured Second Lien Debt
cion:CIONEagleTreeMember
2021-12-31
0001534254
Zest Acquisition Corp., Senior Secured Second Lien Debt
cion:CIONEagleTreeMember
2021-12-31
0001534254
cion:SeniorSecuredSecondLienDebtMember
cion:CIONEagleTreeMember
2021-12-31
0001534254
cion:CIONEagleTreeMember
Zest Acquisition Corp., Collateralized Securities and Structured Products - Equity
2021-12-31
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
cion:CIONEagleTreeMember
2021-12-31
0001534254
American Clinical Solutions LLC, Class A Membership Interests, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
Anthem Sports and Entertainment Inc., Class A Preferred Stock Warrants, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
Anthem Sports and Entertainment Inc., Class B Preferred Stock Warrants, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
Anthem Sports and Entertainment Inc., Common Stock Warrants, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
BCP Great Lakes Fund LP, Partnership Interests, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
Carestream Health Holdings, Inc., Warrants, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
cion:CIONEagleTreeMember
CHC Medical Partners, Inc., Series C Preferred Stock, Equity
2021-12-31
0001534254
Dayton HoldCo, LLC, Membership Units, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
HDNet Holdco LLC, Preferred Unit Call Option, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
HW Ultimate Holdings, LP, Class A Membership Units, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
Skillsoft Corp., Class A Common Stock, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
Spinal USA, Inc. / Precision Medical Inc., Warrants, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
Tenere Inc., Warrants, Equity
cion:CIONEagleTreeMember
2021-12-31
0001534254
cion:CIONEagleTreeMember
us-gaap:EquityMember
2021-12-31
0001534254
cion:CIONEagleTreeMember
2021-12-31
0001534254
cion:CIONEagleTreeMember
2022-07-01
2022-09-30
0001534254
cion:CIONEagleTreeMember
2022-01-01
2022-09-30
0001534254
cion:CIONEagleTreeMember
2021-01-01
2021-12-31
0001534254
cion:CIONSOFFundingLLCMember
2019-10-02
0001534254
cion:CIONSOFFundingLLCMember
cion:BCPMember
2019-10-02
0001534254
cion:CIONSOFFundingLLCMember
2022-09-30
0001534254
us-gaap:LineOfCreditMember
cion:CIONSOFMember
cion:SOFCreditFacilityMember
2019-10-02
0001534254
cion:ThroughOctober12022Member
us-gaap:LineOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
cion:CIONSOFMember
cion:SOFCreditFacilityMember
2019-10-02
2019-10-02
0001534254
us-gaap:LineOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
cion:CIONSOFMember
cion:ThereafterOctober12022ThroughOctober22024Member
cion:SOFCreditFacilityMember
2019-10-02
2019-10-02
0001534254
cion:CIONSOFMember
2022-01-01
2022-09-30
0001534254
cion:CIONSOFMember
2021-01-01
2021-09-30
0001534254
cion:CIONSOFMember
2021-01-01
2021-12-31
0001534254
us-gaap:LondonInterbankOfferedRateLIBORMember
us-gaap:SecuredDebtMember
cion:JPMCreditFacilityLIBORMember
2021-02-26
2021-02-26
0001534254
cion:JPMCreditFacilityLIBORMember
2022-09-30
0001534254
us-gaap:SecuredDebtMember
cion:JPMCreditFacilitySOFRMember
us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
2022-03-28
2022-03-28
0001534254
cion:JPMCreditFacilitySOFRMember
2022-09-30
0001534254
cion:A2026NotesMember
us-gaap:UnsecuredDebtMember
2021-02-11
0001534254
cion:A2026NotesMember
us-gaap:UnsecuredDebtMember
2022-09-30
0001534254
cion:A2026NotesMember
2022-09-30
0001534254
us-gaap:LondonInterbankOfferedRateLIBORMember
cion:UBSFacilityMember
2022-01-01
2022-09-30
0001534254
cion:UBSFacilityMember
2022-09-30
0001534254
us-gaap:UnsecuredDebtMember
cion:A2022MoreTermLoanMember
us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
2022-04-27
2022-04-27
0001534254
cion:A2022MoreTermLoanMember
2022-09-30
0001534254
cion:A2021MoreTermLoanMember
us-gaap:UnsecuredDebtMember
2022-04-14
0001534254
cion:A2021MoreTermLoanMember
2022-09-30
0001534254
us-gaap:LineOfCreditMember
cion:JPMCreditFacilityMember
us-gaap:SecuredDebtMember
2016-08-26
0001534254
us-gaap:LineOfCreditMember
cion:JPMCreditFacilityMember
us-gaap:RevolvingCreditFacilityMember
2016-08-26
0001534254
us-gaap:LineOfCreditMember
cion:JPMCreditFacilityMember
2016-08-26
2016-08-26
0001534254
us-gaap:LineOfCreditMember
cion:JPMCreditFacilityMember
us-gaap:SecuredDebtMember
2016-09-30
0001534254
us-gaap:LineOfCreditMember
cion:JPMCreditFacilityMember
us-gaap:RevolvingCreditFacilityMember
2016-09-30
0001534254
us-gaap:LineOfCreditMember
cion:JPMCreditFacilityMember
us-gaap:SecuredDebtMember
2018-05-23
0001534254
us-gaap:LineOfCreditMember
cion:JPMCreditFacilityMember
us-gaap:RevolvingCreditFacilityMember
2018-05-23
0001534254
us-gaap:SecuredDebtMember
cion:UBSFacilityMember
2020-05-15
2020-05-15
0001534254
us-gaap:LineOfCreditMember
cion:JPMCreditFacilityMember
us-gaap:SecuredDebtMember
2020-05-15
0001534254
us-gaap:LineOfCreditMember
cion:JPMCreditFacilityMember
us-gaap:RevolvingCreditFacilityMember
2020-05-15
0001534254
us-gaap:LondonInterbankOfferedRateLIBORMember
cion:JPMCreditFacilityMember
us-gaap:SecuredDebtMember
2020-05-15
2020-05-15
0001534254
us-gaap:LineOfCreditMember
cion:JPMCreditFacilityMember
us-gaap:SecuredDebtMember
2021-02-26
0001534254
us-gaap:LineOfCreditMember
cion:JPMCreditFacilityMember
us-gaap:SecuredDebtMember
2022-03-28
0001534254
us-gaap:LondonInterbankOfferedRateLIBORMember
cion:JPMCreditFacilityMember
us-gaap:SecuredDebtMember
2022-03-28
2022-03-28
0001534254
cion:JPMCreditFacilityMember
us-gaap:SecuredDebtMember
2022-03-28
2022-03-28
0001534254
cion:JPMCreditFacilityMember
us-gaap:SecuredDebtMember
2022-09-30
0001534254
cion:JPMCreditFacilityMember
us-gaap:SecuredDebtMember
2021-12-31
0001534254
cion:JPMCreditFacilityMember
2022-07-01
2022-09-30
0001534254
cion:JPMCreditFacilityMember
2021-07-01
2021-09-30
0001534254
cion:JPMCreditFacilityMember
2022-01-01
2022-09-30
0001534254
cion:JPMCreditFacilityMember
2021-01-01
2021-09-30
0001534254
cion:JPMCreditFacilityMember
2021-01-01
2021-12-31
0001534254
cion:A2026NotesMember
us-gaap:UnsecuredDebtMember
2021-02-11
2021-02-11
0001534254
cion:A2026NotesMember
us-gaap:UnsecuredDebtMember
cion:OnOrBeforeFebruary112024Member
2021-02-11
2021-02-11
0001534254
cion:A2026NotesMember
us-gaap:UnsecuredDebtMember
cion:AfterFebruary112024ButOnOrBeforeFebruary112025Member
2021-02-11
2021-02-11
0001534254
cion:A2026NotesMember
cion:AfterFebruary112025ButOnOrBeforeAugust112025Member
us-gaap:UnsecuredDebtMember
2021-02-11
2021-02-11
0001534254
cion:A2026NotesMember
us-gaap:UnsecuredDebtMember
cion:AfterAugust112025Member
2021-02-11
2021-02-11
0001534254
cion:A2026NotesMember
2022-07-01
2022-09-30
0001534254
cion:A2026NotesMember
2021-07-01
2021-09-30
0001534254
cion:A2026NotesMember
2022-01-01
2022-09-30
0001534254
cion:A2026NotesMember
2021-01-01
2021-09-30
0001534254
cion:A2026NotesMember
2021-01-01
2021-12-31
0001534254
cion:UBSFacilityMember
2017-05-19
0001534254
cion:MurrayHillFundingIIMember
cion:UBSFacilityMember
2017-05-19
0001534254
cion:UBSFacilityMember
2017-05-19
2017-05-19
0001534254
us-gaap:LondonInterbankOfferedRateLIBORMember
cion:UBSFacilityMember
2017-05-19
2017-05-19
0001534254
cion:MurrayHillFundingIIMember
cion:UBSFacilityMember
2017-12-01
0001534254
cion:UBSFacilityMember
2017-12-15
2018-04-02
0001534254
cion:UBSFacilityMember
2018-04-02
0001534254
us-gaap:LondonInterbankOfferedRateLIBORMember
cion:UBSFacilityMember
2020-11-09
2020-11-09
0001534254
cion:UBSFacilityMember
2020-05-19
0001534254
cion:UBSFacilityMember
2020-12-31
0001534254
cion:ARNotesMember
us-gaap:RevolvingCreditFacilityMember
2020-12-17
0001534254
us-gaap:LondonInterbankOfferedRateLIBORMember
cion:ARNotesMember
us-gaap:RevolvingCreditFacilityMember
2020-12-17
2020-12-17
0001534254
cion:ARNotesMember
us-gaap:RevolvingCreditFacilityMember
2020-12-17
2020-12-17
0001534254
cion:ARNotesMember
2022-01-01
2022-09-30
0001534254
cion:ARNotesMember
us-gaap:RevolvingCreditFacilityMember
2021-07-01
0001534254
cion:ARNotesMember
us-gaap:RevolvingCreditFacilityMember
2021-12-14
0001534254
cion:ARNotesMember
us-gaap:RevolvingCreditFacilityMember
2022-04-19
0001534254
cion:ARNotesMember
2021-08-20
0001534254
cion:ARNotesMember
2021-08-20
2021-08-20
0001534254
cion:UBSFacilityMember
2020-12-17
2020-12-17
0001534254
cion:MurrayHillFundingIIMember
cion:UBSFacilityMember
2020-12-17
0001534254
cion:MurrayHillFundingIIMember
2022-09-30
0001534254
cion:UBSFacilityMember
2022-07-01
2022-09-30
0001534254
cion:UBSFacilityMember
2021-07-01
2021-09-30
0001534254
cion:UBSFacilityMember
2022-01-01
2022-09-30
0001534254
cion:UBSFacilityMember
2021-01-01
2021-09-30
0001534254
cion:UBSFacilityMember
2021-01-01
2021-12-31
0001534254
us-gaap:UnsecuredDebtMember
cion:A2022MoreTermLoanMember
2022-04-27
0001534254
us-gaap:UnsecuredDebtMember
cion:A2022MoreTermLoanMember
2022-04-19
0001534254
cion:A2022MoreTermLoanMember
2022-04-27
2022-04-27
0001534254
cion:SOFRFloorRateMember
us-gaap:UnsecuredDebtMember
cion:A2022MoreTermLoanMember
2022-04-27
2022-04-27
0001534254
us-gaap:UnsecuredDebtMember
cion:A2022MoreTermLoanMember
2022-04-27
2022-04-27
0001534254
us-gaap:UnsecuredDebtMember
cion:A2022MoreTermLoanMember
2022-09-30
0001534254
cion:A2022MoreTermLoanMember
2022-07-01
2022-09-30
0001534254
cion:A2022MoreTermLoanMember
2022-04-27
2022-09-30
0001534254
cion:A2021MoreTermLoanMember
us-gaap:UnsecuredDebtMember
2022-04-14
2022-04-14
0001534254
cion:A2021MoreTermLoanMember
us-gaap:UnsecuredDebtMember
2022-09-30
0001534254
cion:A2021MoreTermLoanMember
2022-07-01
2022-09-30
0001534254
cion:A2021MoreTermLoanMember
2021-07-01
2021-09-30
0001534254
cion:A2021MoreTermLoanMember
2022-01-01
2022-09-30
0001534254
cion:A2021MoreTermLoanMember
2021-01-01
2021-09-30
0001534254
cion:A2021MoreTermLoanMember
2021-01-01
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel1Member
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel2Member
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel1Member
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel2Member
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel1Member
cion:SeniorSecuredSecondLienDebtMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel2Member
cion:SeniorSecuredSecondLienDebtMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
cion:SeniorSecuredSecondLienDebtMember
2022-09-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel1Member
cion:SeniorSecuredSecondLienDebtMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel2Member
cion:SeniorSecuredSecondLienDebtMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
cion:SeniorSecuredSecondLienDebtMember
2021-12-31
0001534254
cion:SeniorSecuredSecondLienDebtMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel1Member
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel2Member
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel1Member
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel2Member
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-12-31
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel1Member
cion:DebtSecuritiesUnsecuredDebtMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel2Member
cion:DebtSecuritiesUnsecuredDebtMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
cion:DebtSecuritiesUnsecuredDebtMember
2022-09-30
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel1Member
cion:DebtSecuritiesUnsecuredDebtMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel2Member
cion:DebtSecuritiesUnsecuredDebtMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
cion:DebtSecuritiesUnsecuredDebtMember
2021-12-31
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel1Member
us-gaap:EquitySecuritiesMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel2Member
us-gaap:EquitySecuritiesMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
2022-09-30
0001534254
us-gaap:EquitySecuritiesMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel1Member
us-gaap:EquitySecuritiesMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel2Member
us-gaap:EquitySecuritiesMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
2021-12-31
0001534254
us-gaap:EquitySecuritiesMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel1Member
us-gaap:ShortTermInvestmentsMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel2Member
us-gaap:ShortTermInvestmentsMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:ShortTermInvestmentsMember
2022-09-30
0001534254
us-gaap:ShortTermInvestmentsMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel1Member
us-gaap:ShortTermInvestmentsMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel2Member
us-gaap:ShortTermInvestmentsMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:ShortTermInvestmentsMember
2021-12-31
0001534254
us-gaap:ShortTermInvestmentsMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel1Member
2022-09-30
0001534254
us-gaap:FairValueInputsLevel2Member
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
2022-09-30
0001534254
us-gaap:FairValueInputsLevel1Member
2021-12-31
0001534254
us-gaap:FairValueInputsLevel2Member
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
2021-12-31
0001534254
cion:CIONEagleTreePartnersLLCMember
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2022-09-30
0001534254
cion:CIONEagleTreePartnersLLCMember
us-gaap-supplement:InvestmentAffiliatedIssuerControlledMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
2022-06-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
2022-06-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-06-30
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2022-06-30
0001534254
us-gaap:EquitySecuritiesMember
2022-06-30
0001534254
us-gaap:InvestmentsMember
2022-06-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
2022-07-01
2022-09-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
2022-07-01
2022-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-07-01
2022-09-30
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2022-07-01
2022-09-30
0001534254
us-gaap:EquitySecuritiesMember
2022-07-01
2022-09-30
0001534254
us-gaap:InvestmentsMember
2022-07-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:SeniorSecuredFirstLienDebtMember
2022-07-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:SeniorSecuredSecondLienDebtMember
2022-07-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-07-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:DebtSecuritiesUnsecuredDebtMember
2022-07-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
us-gaap:EquitySecuritiesMember
2022-07-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
us-gaap:InvestmentsMember
2022-07-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:SeniorSecuredFirstLienDebtMember
2022-07-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:SeniorSecuredSecondLienDebtMember
2022-07-01
2022-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
2022-07-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:DebtSecuritiesUnsecuredDebtMember
2022-07-01
2022-09-30
0001534254
us-gaap:EquitySecuritiesMember
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
2022-07-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
us-gaap:InvestmentsMember
2022-07-01
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
2022-09-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
2022-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-09-30
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2022-09-30
0001534254
us-gaap:EquitySecuritiesMember
2022-09-30
0001534254
us-gaap:InvestmentsMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
2021-12-31
0001534254
cion:SeniorSecuredSecondLienDebtMember
2021-12-31
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-12-31
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2021-12-31
0001534254
us-gaap:EquitySecuritiesMember
2021-12-31
0001534254
us-gaap:InvestmentsMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
2022-01-01
2022-09-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
2022-01-01
2022-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-01-01
2022-09-30
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2022-01-01
2022-09-30
0001534254
us-gaap:EquitySecuritiesMember
2022-01-01
2022-09-30
0001534254
us-gaap:InvestmentsMember
2022-01-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:SeniorSecuredFirstLienDebtMember
2022-01-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:SeniorSecuredSecondLienDebtMember
2022-01-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-01-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:DebtSecuritiesUnsecuredDebtMember
2022-01-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
us-gaap:EquitySecuritiesMember
2022-01-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
us-gaap:InvestmentsMember
2022-01-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:SeniorSecuredFirstLienDebtMember
2022-01-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:SeniorSecuredSecondLienDebtMember
2022-01-01
2022-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
2022-01-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:DebtSecuritiesUnsecuredDebtMember
2022-01-01
2022-09-30
0001534254
us-gaap:EquitySecuritiesMember
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
2022-01-01
2022-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
us-gaap:InvestmentsMember
2022-01-01
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
2021-06-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
2021-06-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-06-30
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2021-06-30
0001534254
us-gaap:EquitySecuritiesMember
2021-06-30
0001534254
us-gaap:InvestmentsMember
2021-06-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
2021-07-01
2021-09-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
2021-07-01
2021-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-07-01
2021-09-30
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2021-07-01
2021-09-30
0001534254
us-gaap:EquitySecuritiesMember
2021-07-01
2021-09-30
0001534254
us-gaap:InvestmentsMember
2021-07-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:SeniorSecuredFirstLienDebtMember
2021-07-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:SeniorSecuredSecondLienDebtMember
2021-07-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-07-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:DebtSecuritiesUnsecuredDebtMember
2021-07-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
us-gaap:EquitySecuritiesMember
2021-07-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
us-gaap:InvestmentsMember
2021-07-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:SeniorSecuredFirstLienDebtMember
2021-07-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:SeniorSecuredSecondLienDebtMember
2021-07-01
2021-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
2021-07-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:DebtSecuritiesUnsecuredDebtMember
2021-07-01
2021-09-30
0001534254
us-gaap:EquitySecuritiesMember
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
2021-07-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
us-gaap:InvestmentsMember
2021-07-01
2021-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
2021-09-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
2021-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-09-30
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2021-09-30
0001534254
us-gaap:EquitySecuritiesMember
2021-09-30
0001534254
us-gaap:InvestmentsMember
2021-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
2020-12-31
0001534254
cion:SeniorSecuredSecondLienDebtMember
2020-12-31
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2020-12-31
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2020-12-31
0001534254
us-gaap:EquitySecuritiesMember
2020-12-31
0001534254
us-gaap:InvestmentsMember
2020-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
2021-01-01
2021-09-30
0001534254
cion:SeniorSecuredSecondLienDebtMember
2021-01-01
2021-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-01-01
2021-09-30
0001534254
cion:DebtSecuritiesUnsecuredDebtMember
2021-01-01
2021-09-30
0001534254
us-gaap:EquitySecuritiesMember
2021-01-01
2021-09-30
0001534254
us-gaap:InvestmentsMember
2021-01-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:SeniorSecuredFirstLienDebtMember
2021-01-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:SeniorSecuredSecondLienDebtMember
2021-01-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-01-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
cion:DebtSecuritiesUnsecuredDebtMember
2021-01-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
us-gaap:EquitySecuritiesMember
2021-01-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesRealizedGainLossMember
us-gaap:InvestmentsMember
2021-01-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:SeniorSecuredFirstLienDebtMember
2021-01-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:SeniorSecuredSecondLienDebtMember
2021-01-01
2021-09-30
0001534254
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
2021-01-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
cion:DebtSecuritiesUnsecuredDebtMember
2021-01-01
2021-09-30
0001534254
us-gaap:EquitySecuritiesMember
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
2021-01-01
2021-09-30
0001534254
cion:DebtAndEquitySecuritiesUnrealizedGainLossMember
us-gaap:InvestmentsMember
2021-01-01
2021-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:MaximumMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
srt:WeightedAverageMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
cion:MeasurementInputBrokerQuotesMember
us-gaap:FairValueInputsLevel3Member
cion:ValuationTechniqueBrokerQuotesMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
srt:MaximumMember
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
srt:WeightedAverageMember
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
cion:MeasurementInputDollerPerKWMember
us-gaap:MarketApproachValuationTechniqueMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
srt:MaximumMember
us-gaap:MarketApproachValuationTechniqueMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
srt:WeightedAverageMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
cion:OtherValuationTechniqueMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
cion:SeniorSecuredSecondLienDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2022-09-30
0001534254
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
cion:SeniorSecuredSecondLienDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
cion:SeniorSecuredSecondLienDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:MaximumMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
srt:WeightedAverageMember
cion:SeniorSecuredSecondLienDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
cion:DebtSecuritiesUnsecuredDebtMember
2022-09-30
0001534254
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
cion:DebtSecuritiesUnsecuredDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
cion:DebtSecuritiesUnsecuredDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:MaximumMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
srt:WeightedAverageMember
cion:DebtSecuritiesUnsecuredDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2022-09-30
0001534254
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:EquitySecuritiesMember
srt:MaximumMember
us-gaap:MarketApproachValuationTechniqueMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
srt:WeightedAverageMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
cion:MeasurementInputDollerPerKWMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2022-09-30
0001534254
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
srt:MaximumMember
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2022-09-30
0001534254
us-gaap:FairValueInputsLevel3Member
srt:WeightedAverageMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2022-09-30
0001534254
cion:MeasurementInputBrokerQuotesMember
us-gaap:FairValueInputsLevel3Member
cion:ValuationTechniqueBrokerQuotesMember
us-gaap:EquitySecuritiesMember
2022-09-30
0001534254
us-gaap:ValuationTechniqueOptionPricingModelMember
cion:MeasurementInputExpectedVolatilityMember
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
2022-09-30
0001534254
us-gaap:ValuationTechniqueOptionPricingModelMember
srt:MinimumMember
cion:MeasurementInputExpectedVolatilityMember
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
2022-09-30
0001534254
us-gaap:ValuationTechniqueOptionPricingModelMember
cion:MeasurementInputExpectedVolatilityMember
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
srt:MaximumMember
2022-09-30
0001534254
us-gaap:ValuationTechniqueOptionPricingModelMember
cion:MeasurementInputExpectedVolatilityMember
us-gaap:FairValueInputsLevel3Member
srt:WeightedAverageMember
us-gaap:EquitySecuritiesMember
2022-09-30
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:MaximumMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
srt:WeightedAverageMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
cion:MeasurementInputBrokerQuotesMember
us-gaap:FairValueInputsLevel3Member
cion:ValuationTechniqueBrokerQuotesMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
srt:MaximumMember
us-gaap:MarketApproachValuationTechniqueMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
srt:WeightedAverageMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2021-12-31
0001534254
cion:SeniorSecuredFirstLienDebtMember
us-gaap:FairValueInputsLevel3Member
cion:OtherValuationTechniqueMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
cion:SeniorSecuredSecondLienDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2021-12-31
0001534254
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
cion:SeniorSecuredSecondLienDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
cion:SeniorSecuredSecondLienDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:MaximumMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
srt:WeightedAverageMember
cion:SeniorSecuredSecondLienDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2021-12-31
0001534254
cion:MeasurementInputBrokerQuotesMember
us-gaap:FairValueInputsLevel3Member
cion:ValuationTechniqueBrokerQuotesMember
cion:SeniorSecuredSecondLienDebtMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
cion:CollateralizedSecuritiesAndStructuredProductsEquityMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
cion:DebtSecuritiesUnsecuredDebtMember
2021-12-31
0001534254
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
cion:DebtSecuritiesUnsecuredDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
cion:DebtSecuritiesUnsecuredDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:MaximumMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputDiscountRateMember
srt:WeightedAverageMember
cion:DebtSecuritiesUnsecuredDebtMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2021-12-31
0001534254
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:EquitySecuritiesMember
srt:MaximumMember
us-gaap:MarketApproachValuationTechniqueMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
srt:WeightedAverageMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
cion:MeasurementInputDollerPerKWMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2021-12-31
0001534254
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
srt:MaximumMember
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2021-12-31
0001534254
us-gaap:FairValueInputsLevel3Member
srt:WeightedAverageMember
us-gaap:EquitySecuritiesMember
us-gaap:MarketApproachValuationTechniqueMember
us-gaap:MeasurementInputRevenueMultipleMember
2021-12-31
0001534254
us-gaap:ValuationTechniqueOptionPricingModelMember
cion:MeasurementInputExpectedVolatilityMember
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
2021-12-31
0001534254
us-gaap:ValuationTechniqueOptionPricingModelMember
srt:MinimumMember
cion:MeasurementInputExpectedVolatilityMember
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
2021-12-31
0001534254
us-gaap:ValuationTechniqueOptionPricingModelMember
cion:MeasurementInputExpectedVolatilityMember
us-gaap:FairValueInputsLevel3Member
us-gaap:EquitySecuritiesMember
srt:MaximumMember
2021-12-31
0001534254
us-gaap:ValuationTechniqueOptionPricingModelMember
cion:MeasurementInputExpectedVolatilityMember
us-gaap:FairValueInputsLevel3Member
srt:WeightedAverageMember
us-gaap:EquitySecuritiesMember
2021-12-31
0001534254
Cennox, Inc.
2022-09-30
0001534254
Cennox, Inc.
2021-12-31
0001534254
Service Compression, LLC
2022-09-30
0001534254
Service Compression, LLC
2021-12-31
0001534254
Critical Nurse Staffing, LLC
2022-09-30
0001534254
Critical Nurse Staffing, LLC
2021-12-31
0001534254
Instant Web, LLC
2022-09-30
0001534254
Instant Web, LLC
2021-12-31
0001534254
Thrill Holdings LLC
2022-09-30
0001534254
Thrill Holdings LLC
2021-12-31
0001534254
Rogers Mechanical Contractors, LLC
2022-09-30
0001534254
Rogers Mechanical Contractors, LLC
2021-12-31
0001534254
Trademark Global, LLC
2022-09-30
0001534254
Trademark Global, LLC
2021-12-31
0001534254
Dermcare Management, LLC
2022-09-30
0001534254
Dermcare Management, LLC
2021-12-31
0001534254
Homer City Holdings LLC
2022-09-30
0001534254
Homer City Holdings LLC
2021-12-31
0001534254
American Health Staffing Group, Inc.
2022-09-30
0001534254
American Health Staffing Group, Inc.
2021-12-31
0001534254
Mimeo.com, Inc.
2022-09-30
0001534254
Mimeo.com, Inc.
2021-12-31
0001534254
Coyote Buyer, LLC
2022-09-30
0001534254
Coyote Buyer, LLC
2021-12-31
0001534254
Moss Holding Company
2022-09-30
0001534254
Moss Holding Company
2021-12-31
0001534254
HW Acquisition, LLC
2022-09-30
0001534254
HW Acquisition, LLC
2021-12-31
0001534254
Inotiv, Inc.
2022-09-30
0001534254
Inotiv, Inc.
2021-12-31
0001534254
Foundation Consumer Healthcare, LLC
2022-09-30
0001534254
Foundation Consumer Healthcare, LLC
2021-12-31
0001534254
MacNeill Pride Group Corp.
2022-09-30
0001534254
MacNeill Pride Group Corp.
2021-12-31
0001534254
RumbleOn, Inc.
2022-09-30
0001534254
RumbleOn, Inc.
2021-12-31
0001534254
Sleep Opco, LLC
2022-09-30
0001534254
Sleep Opco, LLC
2021-12-31
0001534254
Extreme Reach, Inc.
2022-09-30
0001534254
Extreme Reach, Inc.
2021-12-31
0001534254
Archer Systems, LLC
2022-09-30
0001534254
Archer Systems, LLC
2021-12-31
0001534254
Optio Rx, LLC
2022-09-30
0001534254
Optio Rx, LLC
2021-12-31
0001534254
Bradshaw International Parent Corp.
2022-09-30
0001534254
Bradshaw International Parent Corp.
2021-12-31
0001534254
RA Outdoors, LLC
2022-09-30
0001534254
RA Outdoors, LLC
2021-12-31
0001534254
NWN Parent Holdings LLC
2022-09-30
0001534254
NWN Parent Holdings LLC
2021-12-31
0001534254
OpCo Borrower, LLC
2022-09-30
0001534254
OpCo Borrower, LLC
2021-12-31
0001534254
BDS Solutions Intermediateco, LLC
2022-09-30
0001534254
BDS Solutions Intermediateco, LLC
2021-12-31
0001534254
Invincible Boat Company LLC
2022-09-30
0001534254
Invincible Boat Company LLC
2021-12-31
0001534254
American Teleconferencing Services, Ltd.
2022-09-30
0001534254
American Teleconferencing Services, Ltd.
2021-12-31
0001534254
H.W. Lochner, Inc.
2022-09-30
0001534254
H.W. Lochner, Inc.
2021-12-31
0001534254
Anthem Sports & Entertainment Inc.
2022-09-30
0001534254
Anthem Sports & Entertainment Inc.
2021-12-31
0001534254
Genesis Healthcare, Inc.
2022-09-30
0001534254
Genesis Healthcare, Inc.
2021-12-31
0001534254
West Dermatology Management Holdings, LLC
2022-09-30
0001534254
West Dermatology Management Holdings, LLC
2021-12-31
0001534254
Williams Industrial Services Group, Inc.
2022-09-30
0001534254
Williams Industrial Services Group, Inc.
2021-12-31
0001534254
Molded Devices, Inc.
2022-09-30
0001534254
Molded Devices, Inc.
2021-12-31
0001534254
American Media, Inc.
2022-09-30
0001534254
American Media, Inc.
2021-12-31
0001534254
Marble Point Credit Management LLC
2022-09-30
0001534254
Marble Point Credit Management LLC
2021-12-31
0001534254
Appalachian Resource Company, LLC
2022-09-30
0001534254
Appalachian Resource Company, LLC
2021-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
September 30, 2022
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File Number
000-54755
CĪON Investment Corporation
(Exact name of registrant as specified in its charter)
Maryland
45-3058280
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
100 Park Avenue
,
25th Floor
New York
,
New York
10017
(Address of principal executive offices)
(Zip Code)
(212)
418-4700
(Registrant’s telephone number, including area code)
3 Park Avenue
,
36th Floor
,
New York
,
New York
10016
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common stock, par value $0.001 per share
CION
The New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☐
Accelerated filer
☐
Non-accelerated filer
☒
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
☐
No ☒
The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of November 3, 2022 was
55,426,754
.
(in thousands, except share and per share amounts)
September 30,
2022
December 31,
2021
(unaudited)
Assets
Investments, at fair value:
Non-controlled, non-affiliated investments (amortized cost of $
1,629,044
and $
1,617,126
, respectively)
$
1,567,403
$
1,581,124
Non-controlled, affiliated investments (amortized cost of $
138,586
and $
91,476
, respectively)
142,202
81,490
Controlled investments (amortized cost of $
84,347
and $
83,702
, respectively)
97,443
91,425
Total investments, at fair value (amortized cost of $
1,851,977
and $
1,792,304
, respectively)
1,807,048
1,754,039
Cash
43,661
3,774
Interest receivable on investments
26,976
21,549
Receivable due on investments sold and repaid
7,146
2,854
Prepaid expenses and other assets
841
466
Total assets
$
1,885,672
$
1,782,682
Liabilities and Shareholders' Equity
Liabilities
Financing arrangements (net of unamortized debt issuance costs of $
7,014
and $
7,628
, respectively)
$
950,486
$
822,372
Payable for investments purchased
—
11,327
Accounts payable and accrued expenses
1,853
1,922
Interest payable
5,143
4,339
Accrued management fees
6,943
6,673
Accrued subordinated incentive fee on income
5,421
3,942
Accrued administrative services expense
604
1,595
Share repurchases payable
316
—
Total liabilities
970,766
852,170
Commitments and contingencies (Note 4 and Note 11)
Shareholders' Equity
Common stock, $
0.001
par value;
500,000,000
shares authorized;
56,373,217
and
56,958,440
shares issued and
56,262,964
and
56,958,440
shares outstanding, respectively
57
57
Capital in excess of par value
1,053,278
1,059,989
Accumulated distributable losses
(
138,429
)
(
129,534
)
Total shareholders' equity
914,906
930,512
Total liabilities and shareholders' equity
$
1,885,672
$
1,782,682
Net asset value per share of common stock at end of period
$
16.26
$
16.34
See accompanying notes to consolidated financial statements.
1
CĪON Investment Corporation
Consolidated Statements of Operations
(in thousands, except share and per share amounts)
Three Months Ended
September 30,
Nine Months Ended
September 30,
Year Ended
December 31,
2022
2021
2022
2021
2021
(unaudited)
(unaudited)
(unaudited)
(unaudited)
Investment income
Non-controlled, non-affiliated investments
Interest income
$
37,336
$
31,036
$
100,079
$
87,305
$
119,792
Paid-in-kind interest income
6,876
3,969
16,095
13,957
17,306
Fee income
4,542
1,543
8,045
3,356
5,927
Dividend income
57
81
103
254
366
Non-controlled, affiliated investments
Interest income
1,949
1,425
4,517
3,867
4,961
Paid-in-kind interest income
1,174
776
3,493
2,655
3,160
Fee income
19
—
525
—
—
Dividend income
13
3,790
66
5,550
5,576
Controlled investments
Interest income
2,197
—
6,066
—
260
Paid-in-kind interest income
—
—
409
—
—
Total investment income
54,163
42,620
139,398
116,944
157,348
Operating expenses
Management fees
6,942
8,443
20,436
24,469
31,143
Administrative services expense
733
722
2,234
2,103
3,069
Subordinated incentive fee on income
5,421
2,933
13,645
2,933
6,875
General and administrative
2,027
2,709
5,961
7,950
9,805
Interest expense
13,469
8,175
32,769
23,551
31,807
Total operating expenses
28,592
22,982
75,045
61,006
82,699
Net investment income before taxes
25,571
19,638
64,353
55,938
74,649
Income tax expense, including excise tax
14
26
25
41
342
Net investment income after taxes
25,557
19,612
64,328
55,897
74,307
Realized and unrealized gains (losses)
Net realized (losses) gains on:
Non-controlled, non-affiliated investments
4,267
873
4,475
1,344
(
4,100
)
Non-controlled, affiliated investments
(
21,433
)
18,856
(
21,530
)
17,776
8,010
Controlled investments
—
—
—
(
3,067
)
(
3,067
)
Foreign currency
(
3
)
7
(
3
)
(
4
)
(
3
)
Net realized (losses) gains
(
17,169
)
19,736
(
17,058
)
16,049
840
Net change in unrealized appreciation (depreciation) on:
Non-controlled, non-affiliated investments
(
669
)
6,937
(
25,646
)
32,132
25,566
Non-controlled, affiliated investments
18,966
(
21,177
)
13,609
(
4,354
)
7,261
Controlled investments
7,298
—
5,373
3,067
10,790
Net change in unrealized appreciation (depreciation)
25,595
(
14,240
)
(
6,664
)
30,845
43,617
Net realized and unrealized gains (losses)
8,426
5,496
(
23,722
)
46,894
44,457
Net increase in net assets resulting from operations
$
33,983
$
25,108
$
40,606
$
102,791
$
118,764
Per share information—basic and diluted(1)
Net increase in net assets per share resulting from operations
$
0.60
$
0.44
$
0.71
$
1.81
$
2.09
Net investment income per share
$
0.45
$
0.35
$
1.13
$
0.98
$
1.31
Weighted average shares of common stock outstanding
56,816,992
56,774,323
56,910,773
56,758,586
56,808,960
(1)
As discussed in Note 3, the Company completed a two-to-one reverse stock split, effective as of September 21, 2021. The weighted average shares used in the computation of the net increase in net assets per share resulting from operations and net investment income per share reflect the reverse stock split on a retroactive basis.
See accompanying notes to consolidated financial statements.
2
CĪON Investment Corporation
Consolidated Statements of Changes in Net Assets
(in thousands, except share and per share amounts)
Three Months Ended
September 30,
Nine Months Ended
September 30,
Year Ended
December 31,
2022
2021
2022
2021
2021
(unaudited)
(unaudited)
(unaudited)
(unaudited)
Changes in net assets from operations:
Net investment income
$
25,557
$
19,612
$
64,328
$
55,897
$
74,307
Net realized (loss) gain on investments
(
17,166
)
19,729
(
17,055
)
16,053
843
Net realized (loss) gain on foreign currency
(
3
)
7
(
3
)
(
4
)
(
3
)
Net change in unrealized appreciation (depreciation) on investments
25,595
(
14,240
)
(
6,664
)
30,845
43,617
Net increase in net assets resulting from operations
33,983
25,108
40,606
102,791
118,764
Changes in net assets from shareholders' distributions:
Distributions to shareholders
(
17,604
)
(
15,027
)
(
49,501
)
(
45,056
)
(
71,530
)
Net decrease in net assets resulting from shareholders' distributions
(
17,604
)
(
15,027
)
(
49,501
)
(
45,056
)
(
71,530
)
Changes in net assets from capital share transactions:
Reinvestment of shareholders' distributions
—
5,065
—
15,489
15,489
Repurchase of common stock
(
6,711
)
(
13
)
(
6,711
)
(
10,467
)
(
10,467
)
Net (decrease) increase in net assets resulting from capital share transactions
(
6,711
)
5,052
(
6,711
)
5,022
5,022
Total increase (decrease) in net assets
9,668
15,133
(
15,606
)
62,757
52,256
Net assets at beginning of period
905,238
925,880
930,512
878,256
878,256
Net assets at end of period
$
914,906
$
941,013
$
914,906
$
941,013
$
930,512
Net asset value per share of common stock at end of period(1)
$
16.26
$
16.52
$
16.26
$
16.52
$
16.34
Shares of common stock outstanding at end of period(1)
56,262,964
56,958,440
56,262,964
56,958,440
56,958,440
(1)
As discussed in Note 3, the Company completed a two-to-one reverse stock split, effective as of September 21, 2021. The shares outstanding used in the computation of net asset value per share reflect the reverse stock split on a retroactive basis.
See accompanying notes to consolidated financial statements.
3
CĪON Investment Corporation
Consolidated Statements of Cash Flows
(in thousands)
Three Months Ended
September 30,
Nine Months Ended
September 30,
Year Ended
December 31,
2022
2021
2022
2021
2021
(unaudited)
(unaudited)
(unaudited)
(unaudited)
Operating activities:
Net increase in net assets resulting from operations
$
33,983
$
25,108
$
40,606
$
102,791
$
118,764
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities:
Net accretion of discount on investments
(
4,191
)
(
3,360
)
(
9,165
)
(
9,265
)
(
11,738
)
Proceeds from principal repayment of investments
143,291
196,449
305,001
462,420
568,907
Purchase of investments
(
141,276
)
(
165,033
)
(
452,323
)
(
570,765
)
(
920,039
)
Paid-in-kind interest and dividends capitalized
(
8,049
)
(
3,779
)
(
19,997
)
(
16,597
)
(
21,734
)
Decrease (increase) in short term investments, net
4,540
(
67,351
)
78,112
(
42,237
)
(
14,319
)
Proceeds from sale of investments
11,581
26,765
20,456
46,896
259,050
Net realized loss (gain) on investments
17,166
(
19,729
)
17,055
(
16,053
)
(
843
)
Net change in unrealized (appreciation) depreciation on investments
(
25,595
)
14,240
6,664
(
30,845
)
(
43,617
)
Amortization of debt issuance costs
835
670
2,339
2,101
2,800
(Increase) decrease in interest receivable on investments
(
4,077
)
(
1,466
)
(
4,239
)
(
4,280
)
(
4,400
)
(Increase) decrease in dividends receivable on investments
—
52
—
(
90
)
45
(Increase) decrease in receivable due on investments sold and repaid
(
4,433
)
(
10,671
)
(
4,292
)
(
13,366
)
3,339
(Increase) decrease in prepaid expenses and other assets
1,271
(
48
)
(
375
)
1,314
1,322
Increase (decrease) in payable for investments purchased
(
11,635
)
15,422
(
11,327
)
33,227
11,194
Increase (decrease) in accounts payable and accrued expenses
659
1,349
(
69
)
2,815
1,228
Increase (decrease) in interest payable
(
460
)
(
1,347
)
804
338
1,839
Increase (decrease) in accrued management fees
104
200
270
775
(
995
)
Increase (decrease) in accrued administrative services expense
74
234
(
991
)
(
126
)
330
Increase (decrease) in subordinated incentive fee on income payable
1,330
2,933
1,479
(
1,390
)
(
381
)
Increase (decrease) in share repurchase payable
316
—
316
—
—
Net cash provided by (used in) operating activities
15,434
10,638
(
29,676
)
(
52,337
)
(
49,248
)
Financing activities:
Repurchase of common stock
(
6,711
)
(
13
)
(
6,711
)
(
10,467
)
(
10,467
)
Shareholders' distributions paid
(
17,604
)
(
9,962
)
(
49,501
)
(
29,567
)
(
56,041
)
Repayments under financing arrangements
—
(
21,000
)
—
(
146,000
)
(
171,000
)
Borrowings under financing arrangements
10,000
21,000
127,500
226,000
276,000
Debt issuance costs paid
—
—
(
1,725
)
(
5,384
)
(
5,384
)
Net cash (used in) provided by financing activities
(
14,315
)
(
9,975
)
69,563
34,582
33,108
Net increase (decrease) in cash and restricted cash
1,119
663
39,887
(
17,755
)
(
16,140
)
Cash and restricted cash, beginning of period
42,542
1,496
3,774
19,914
19,914
Cash and restricted cash, end of period
$
43,661
$
2,159
$
43,661
$
2,159
$
3,774
Supplemental disclosure of cash flow information:
Cash paid for interest
$
13,080
$
8,842
$
29,591
$
21,100
$
27,129
Supplemental non-cash financing activities:
Reinvestment of shareholders' distributions
$
—
$
5,065
$
—
$
15,489
$
15,489
Restructuring of portfolio investment
$
45,162
$
3,169
$
45,162
$
5,455
$
5,455
Cash interest receivable exchanged for additional securities
$
—
$
—
$
—
$
1,304
$
1,304
See accompanying notes to consolidated financial statements.
4
CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
September 30, 2022
(in thousands)
Portfolio Company(a)
Interest(b)
Maturity
Industry
Principal/
Par Amount/
Units(e)
Cost(d)
Fair
Value(c)
Senior Secured First Lien Debt -
176.7
%
Adapt Laser Acquisition, Inc.(t)(x)
L+
1200
,
1.00
% LIBOR Floor
12/31/2023
Capital Equipment
$
11,081
$
11,081
$
9,696
Adapt Laser Acquisition, Inc.(t)(x)
L+
1200
,
1.00
% LIBOR Floor
12/31/2023
Capital Equipment
2,062
2,057
1,721
Aegis Toxicology Sciences Corp.(m)(x)
L+
550
,
1.00
% LIBOR Floor
5/9/2025
Healthcare & Pharmaceuticals
6,078
6,024
6,086
AHF Parent Holding, Inc.(n)(aa)
S+
625
,
0.75
% SOFR Floor
2/1/2028
Construction & Building
2,963
2,907
2,785
Allen Media, LLC(n)(aa)
S+
550
,
0.00
% SOFR Floor
2/10/2027
Media: Diversified & Production
8,886
8,812
8,442
ALM Media, LLC(m)(n)(x)
L+
650
,
1.00
% LIBOR Floor
11/25/2024
Media: Advertising, Printing & Publishing
17,250
17,088
17,099
Alpine US Bidco, LLC(n)(w)
L+
525
,
1.00
% LIBOR Floor
5/3/2028
Beverage, Food & Tobacco
4,000
3,744
3,800
American Clinical Solutions LLC(m)
7.00
%
12/31/2022
Healthcare & Pharmaceuticals
3,500
3,491
3,308
American Consolidated Natural Resources, Inc.(m)(t)
L+
1600
,
1.00
% LIBOR Floor
9/16/2025
Metals & Mining
109
84
109
American Health Staffing Group, Inc.
0.50
% Unfunded
11/19/2026
Services: Business
3,333
(
27
)
—
American Health Staffing Group, Inc.(m)(y)
L+
600
,
1.00
% LIBOR Floor
11/19/2026
Services: Business
16,583
16,444
16,583
American Teleconferencing Services, Ltd.(o)
0.00
% Unfunded
6/30/2022
Telecommunications
235
—
—
American Teleconferencing Services, Ltd.(q)
Prime+
550
6/30/2022
Telecommunications
3,116
3,116
588
American Teleconferencing Services, Ltd.(q)
Prime+
550
6/8/2023
Telecommunications
16,154
15,621
—
Analogic Corp.(m)(n)(x)
L+
525
,
1.00
% LIBOR Floor
6/21/2024
Healthcare & Pharmaceuticals
4,863
4,830
4,765
Ancile Solutions, Inc.(m)(t)(x)
L+
1000
,
1.00
% LIBOR Floor
6/22/2026
High Tech Industries
11,935
11,629
11,577
Anthem Sports & Entertainment Inc.
0.50
% Unfunded
11/15/2026
Media: Diversified & Production
167
—
(
7
)
Anthem Sports & Entertainment Inc.(m)(t)(x)
L+
900
,
1.00
% LIBOR Floor
11/15/2026
Media: Diversified & Production
36,753
36,585
35,099
Anthem Sports & Entertainment Inc.(x)
L+
950
,
1.00
% LIBOR Floor
11/15/2026
Media: Diversified & Production
3,000
3,000
2,865
Appalachian Resource Company, LLC(w)
L+
1000
,
1.00
% LIBOR Floor
9/10/2023
Metals & Mining
5,000
5,000
5,000
Appalachian Resource Company, LLC(w)
L+
500
,
1.00
% LIBOR Floor
9/10/2023
Metals & Mining
11,137
10,452
10,677
Archer Systems, LLC(m)(aa)
S+
650
,
1.00
% SOFR Floor
8/11/2027
Services: Business
18,095
17,918
17,914
Archer Systems, LLC
S+
650
,
1.00
% SOFR Floor
8/11/2027
Services: Business
214
196
212
Archer Systems, LLC
0.50
% Unfunded
8/11/2027
Services: Business
1,690
—
(
17
)
Associated Asphalt Partners, LLC(m)(n)(x)
L+
525
,
1.00
% LIBOR Floor
4/5/2024
Construction & Building
14,221
14,020
10,974
Atlas Supply LLC
11.00
%
4/29/2025
Healthcare & Pharmaceuticals
5,000
5,000
4,963
Avison Young (USA) Inc.(h)(m)(w)
L+
575
,
0.00
% LIBOR Floor
1/31/2026
Banking, Finance, Insurance & Real Estate
2,672
2,643
2,498
BDS Solutions Intermediateco, LLC(m)(aa)
S+
625
,
1.00
% SOFR Floor
2/7/2027
Services: Business
17,867
17,567
17,510
BDS Solutions Intermediateco, LLC(aa)
S+
625
,
1.00
% SOFR Floor
2/7/2027
Services: Business
2,383
2,326
2,335
BDS Solutions Intermediateco, LLC
0.50
% Unfunded
2/7/2027
Services: Business
474
—
(
9
)
Berlitz Holdings, Inc.(r)(z)
S+
900
,
1.00
% SOFR Floor
2/14/2025
Services: Business
13,800
12,915
13,145
Bradshaw International Parent Corp.
0.50
% Unfunded
10/21/2026
Consumer Goods: Durable
1,076
—
(
28
)
Bradshaw International Parent Corp.(w)
L+
575
,
1.00
% LIBOR Floor
10/21/2026
Consumer Goods: Durable
768
730
748
Bradshaw International Parent Corp.(m)(w)
L+
575
,
1.00
% LIBOR Floor
10/21/2027
Consumer Goods: Durable
13,057
12,767
12,714
See accompanying notes to consolidated financial statements.
5
CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
September 30, 2022
(in thousands)
Portfolio Company(a)
Interest(b)
Maturity
Industry
Principal/
Par Amount/
Units(e)
Cost(d)
Fair
Value(c)
Cabi, LLC(m)(z)
S+
950
,
1.00
% SOFR Floor
2/28/2027
Retail
22,216
21,901
21,882
Cadence Aerospace, LLC(m)(n)(t)(x)
L+
850
,
1.00
% LIBOR Floor
11/14/2023
Aerospace & Defense
39,272
39,079
38,683
Carestream Health, Inc.(r)(z)
S+
750
,
1.00
% SOFR Floor
9/30/2027
Healthcare & Pharmaceuticals
7,596
7,596
7,596
CB URS Holdings Corp.(m)(x)
L+
575
,
1.00
% LIBOR Floor
9/1/2024
Transportation: Cargo
14,958
14,927
12,284
Celerity Acquisition Holdings, LLC(x)
L+
850
,
1.00
% LIBOR Floor
5/28/2026
Services: Business
14,813
14,813
14,664
Cennox, Inc.(m)(x)
L+
600
,
1.00
% LIBOR Floor
5/4/2026
Services: Business
22,564
22,564
22,564
Cennox, Inc.(n)(x)
L+
600
,
1.00
% LIBOR Floor
5/4/2026
Services: Business
11,915
11,853
11,915
Cennox, Inc.
L+
600
,
1.00
% LIBOR Floor
5/4/2026
Services: Business
597
597
597
Cennox, Inc.
1.00
% Unfunded
11/22/2023
Services: Business
7,193
—
—
Cennox, Inc.
0.50
% Unfunded
5/4/2026
Services: Business
2,390
—
—
Charming Charlie LLC(q)(r)
20.00
%
4/24/2023
Retail
662
—
—
CHC Solutions Inc.(n)(t)
12.00
%
7/20/2023
Healthcare & Pharmaceuticals
8,210
8,210
8,210
CION/EagleTree Partners, LLC(h)(s)(t)
14.00
%
12/21/2026
Diversified Financials
62,274
62,274
62,274
CircusTrix Holdings, LLC(m)(n)(w)
L+
550
,
1.00
% LIBOR Floor
1/16/2024
Hotel, Gaming & Leisure
26,885
26,842
26,549
CircusTrix Holdings, LLC(m)(w)
L+
550
,
1.00
% LIBOR Floor
1/16/2024
Hotel, Gaming & Leisure
2,737
2,715
2,703
CircusTrix Holdings, LLC(m)(w)
L+
550
,
1.00
% LIBOR Floor
7/16/2023
Hotel, Gaming & Leisure
1,563
1,513
1,866
Community Tree Service, LLC(aa)
S+
850
,
1.00
% SOFR Floor
6/17/2027
Construction & Building
12,500
12,500
12,438
Country Fresh Holdings, LLC(q)(x)
L+
500
,
1.00
% LIBOR Floor
4/29/2023
Beverage, Food & Tobacco
877
765
92
Country Fresh Holdings, LLC(q)(x)
L+
500
,
1.00
% LIBOR Floor
4/29/2023
Beverage, Food & Tobacco
355
316
37
Coyote Buyer, LLC(m)(n)(x)
L+
600
,
1.00
% LIBOR Floor
2/6/2026
Chemicals, Plastics & Rubber
34,125
33,941
33,528
Coyote Buyer, LLC(n)(x)
L+
800
,
1.00
% LIBOR Floor
8/6/2026
Chemicals, Plastics & Rubber
6,141
6,052
6,141
Coyote Buyer, LLC
0.50
% Unfunded
2/6/2025
Chemicals, Plastics & Rubber
2,500
—
(
44
)
Critical Nurse Staffing, LLC(m)(x)
L+
600
,
1.00
% LIBOR Floor
11/1/2026
Healthcare & Pharmaceuticals
12,961
12,961
12,961
Critical Nurse Staffing, LLC(x)
L+
600
,
1.00
% LIBOR Floor
11/1/2026
Healthcare & Pharmaceuticals
1,002
1,002
1,002
Critical Nurse Staffing, LLC
1.00
% Unfunded
11/1/2026
Healthcare & Pharmaceuticals
4,899
—
—
Critical Nurse Staffing, LLC
0.50
% Unfunded
11/1/2026
Healthcare & Pharmaceuticals
1,000
—
—
David's Bridal, LLC(t)(x)
L+
1000
,
1.00
% LIBOR Floor
5/23/2024
Retail
5,288
5,288
5,156
David's Bridal, LLC(t)(x)
L+
1000
,
1.00
% LIBOR Floor
6/23/2023
Retail
5,832
5,506
5,628
David's Bridal, LLC(t)(w)
L+
600
,
1.00
% LIBOR Floor
6/30/2023
Retail
835
795
250
Deluxe Entertainment Services, Inc.(m)(q)(r)(t)(x)
L+
650
,
1.00
% LIBOR Floor
3/25/2024
Media: Diversified & Production
2,662
2,632
246
Dermcare Management, LLC(m)(z)
L+
575
,
1.00
% LIBOR Floor
4/22/2028
Healthcare & Pharmaceuticals
9,379
9,119
9,380
Dermcare Management, LLC(z)
L+
575
,
1.00
% LIBOR Floor
4/22/2028
Healthcare & Pharmaceuticals
1,333
1,333
1,333
Dermcare Management, LLC
Prime+
475
4/22/2028
Healthcare & Pharmaceuticals
179
179
179
Dermcare Management, LLC
0.50
% Unfunded
10/22/2023
Healthcare & Pharmaceuticals
2,917
—
—
See accompanying notes to consolidated financial statements.
See accompanying notes to consolidated financial statements.
11
CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
September 30, 2022
(in thousands)
Portfolio Company(a)
Interest
Industry
Principal/
Par Amount/
Units(e)
Cost(d)
Fair
Value(c)
STATinMed Parent, LLC, Class A Preferred Units(o)(r)
Healthcare & Pharmaceuticals
6,182
Units
6,182
5,237
STATinMed Parent, LLC, Class B Preferred Units(o)(r)
Healthcare & Pharmaceuticals
51,221
Units
3,193
705
Snap Fitness Holdings, Inc., Class A Common Stock(o)(r)
Services: Consumer
9,858
Units
3,077
4,810
Snap Fitness Holdings, Inc., Warrants(o)(r)
Services: Consumer
3,996
Units
1,247
1,950
WorkGenius, LLC, Class A Units(o)
Services: Business
500
Units
500
506
Total Equity
78,795
112,491
Short Term Investments -
1.1
%(k)
First American Treasury Obligations Fund, Class Z Shares
2.83
%(l)
9,804
9,804
Total Short Term Investments
9,804
9,804
TOTAL INVESTMENTS -
197.5
%
$
1,851,977
1,807,048
LIABILITIES IN EXCESS OF OTHER ASSETS - (
97.5
)%
(
892,142
)
NET ASSETS -
100.0
%
$
914,906
a.
All of the Company’s investments are issued by eligible U.S. portfolio companies, as defined in the Investment Company Act of 1940, as amended, or the 1940 Act, except for investments specifically identified as non-qualifying per note h. below. Unless specifically identified in note t. below, investments do not contain a paid-in-kind, or PIK, interest provision.
b.
The actual London Interbank Offered Rate, or LIBOR, rate for each loan listed may not be the applicable LIBOR rate as of September 30, 2022, as the loan may have been priced or repriced based on a LIBOR rate prior to or subsequent to September 30, 2022. The actual Secured Overnight Financing Rate, or SOFR, rate for each loan listed may not be the applicable SOFR rate as of September 30, 2022, as the loan may have been priced or repriced based on a SOFR rate prior to or subsequent to September 30, 2022.
c.
Fair value determined in good faith by the Company’s board of directors (see Note 9), including via delegation to CIM as the Company’s valuation designee (see Note 2), using significant unobservable inputs unless otherwise noted.
d.
Represents amortized cost for debt securities and cost for equity investments.
e.
Denominated in U.S. dollars unless otherwise noted.
f.
Fair value determined using level 1 inputs.
g.
The CLO subordinated notes are considered equity positions in the CLO vehicles and are not rated. Equity investments are entitled to recurring distributions, which are generally equal to the remaining cash flow of the payments made by the underlying vehicle's securities less contractual payments to debt holders and expenses. The estimated yield indicated is based upon a current projection of the amount and timing of these recurring distributions and the estimated amount of repayment of principal upon termination. Such projections are periodically reviewed and adjusted, and the estimated yield may not ultimately be realized.
h.
The investment or a portion thereof is not a qualifying asset under the 1940 Act. A business development company may not acquire any asset other than qualifying assets, unless, at the time the acquisition is made, qualifying assets represent at least 70% of the company’s total assets as defined under Section 55 of the 1940 Act. As of September 30, 2022,
93.0
% of the Company’s total assets represented qualifying assets.
i.
[Reserved]
j.
In addition to the interest earned based on the stated interest rate of this loan, which is the amount reflected in this schedule, the Company may be entitled to receive additional residual amounts.
k.
Short term investments represent an investment in a fund that invests in highly liquid investments with average original maturity dates of three months or less.
l.
7-day effective yield as of September 30, 2022.
m.
Investment or a portion thereof held within the Company’s wholly-owned consolidated subsidiary, 34th Street Funding, LLC, or 34th Street, and was pledged as collateral supporting the amounts outstanding under the credit facility with JPMorgan Chase Bank, National Association, or JPM, as of September 30, 2022 (see Note 8).
n.
Investment or a portion thereof held within the Company’s wholly-owned consolidated subsidiary, Murray Hill Funding II, LLC, or Murray Hill Funding II, and was pledged as collateral supporting the amounts outstanding under the repurchase agreement with UBS AG, or UBS, as of September 30, 2022 (see Note 8).
o.
Non-income producing security.
p.
The ultimate interest earned on this loan will be determined based on the portfolio company’s EBITDA at a specified trigger event.
q.
Investment or a portion thereof was on non-accrual status as of September 30, 2022.
See accompanying notes to consolidated financial statements.
12
CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
September 30, 2022
(in thousands)
r.
Investment determined to be an affiliated investment as defined in the 1940 Act as the Company owns between 5% and 25% of the portfolio company’s outstanding voting securities but does not control the portfolio company. Fair value as of December 31, 2021 and September 30, 2022, along with transactions during the nine months ended September 30, 2022 in these affiliated investments, were as follows:
Nine Months Ended September 30, 2022
Nine Months Ended September 30, 2022
Non-Controlled, Affiliated Investments
Fair Value at
December 31, 2021
Gross
Additions
(Cost)(1)
Gross
Reductions
(Cost)(2)
Net Unrealized Gain (Loss)
Fair Value at September 30, 2022
Net Realized Gain (Loss)
Interest
Income(3)
Dividend Income
ARC Financial, LLC
Membership Interests
$
—
$
—
$
—
$
416
$
416
$
—
$
—
$
25
Berlitz Holdings, Inc.
First Lien Term Loan
—
13,956
(
13,956
)
—
—
—
392
—
Carestream Health, Inc.
First Lien Term Loan
—
7,596
—
—
7,596
—
2
—
Carestream Health Holdings Inc.
Common Shares
—
21,758
—
—
21,758
—
—
—
Charming Charlie, LLC
Vendor Payment Financing Facility
350
—
(
657
)
307
—
(
657
)
—
—
DESG Holdings, Inc.
First Lien Term Loan
1,787
—
(
298
)
(
1,243
)
246
—
5
—
Second Lien Term Loan
—
—
(
10,017
)
10,017
—
(
10,017
)
—
—
GSC Technologies Inc.
Incremental Term Loan
170
6
(
18
)
—
158
—
17
—
First Lien Term Loan A
2,001
20
—
1
2,022
—
129
—
First Lien Term Loan B
485
47
—
(
129
)
403
—
48
—
Common Shares
—
—
—
—
—
—
—
—
Instant Web Holdings, LLC
Class A Common Units
—
—
—
—
—
—
—
—
Instant Web, LLC
Revolving Loan
—
753
(
649
)
(
2
)
102
—
17
—
Priming Term Loan
—
458
—
(
1
)
457
—
24
—
First Lien Term Loan
—
38,717
—
(
11,075
)
27,642
—
2,215
—
First Lien Delayed Draw Term Loan
—
—
—
(
4
)
(
4
)
—
10
—
Language Education Holdings GP LLC
Common Units
—
—
—
—
—
—
—
—
Language Education Holdings LP
Ordinary Common Units
—
1,125
(
1,125
)
—
—
—
—
—
Lift Brands, Inc.
Term Loan A
23,406
—
(
177
)
117
23,346
—
1,586
—
Term Loan B
5,156
230
—
(
302
)
5,084
—
407
—
Term Loan C
4,700
99
—
(
245
)
4,554
—
99
—
Longview Intermediate Holdings C, LLC
Membership Units
15,127
—
—
7,076
22,203
—
—
—
Longview Power, LLC
First Lien Term Loan
4,504
130
(
1,384
)
(
952
)
2,298
—
1,846
—
Mount Logan Capital Inc.
Common Stock
3,404
—
—
(
1,071
)
2,333
—
—
41
SIMR, LLC
First Lien Term Loan
16,000
1,447
(
21,261
)
3,814
—
(
2,854
)
804
—
SIMR Parent, LLC
Class B Membership Units
—
—
(
8,002
)
8,002
—
(
8,002
)
—
—
Class W Membership Units
—
—
—
—
—
—
—
—
See accompanying notes to consolidated financial statements
13
CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
September 30, 2022
(in thousands)
Nine Months Ended September 30, 2022
Nine Months Ended September 30, 2022
Non-Controlled, Affiliated Investments
Fair Value at
December 31, 2021
Gross
Additions
(Cost)(1)
Gross
Reductions
(Cost)(2)
Net Unrealized Gain (Loss)
Fair Value at September 30, 2022
Net Realized Gain (Loss)
Interest
Income(3)
Dividend Income
Snap Fitness Holdings, Inc.
Class A Stock
3,131
—
—
1,679
4,810
—
—
—
Warrants
1,269
—
—
681
1,950
—
—
—
STATinMED, LLC
First Lien Term Loan
—
9,180
(
250
)
(
44
)
8,886
—
409
—
STATinMed Parent, LLC
Class A Preferred Units
—
6,182
—
(
945
)
5,237
—
—
—
Class B Preferred Units
—
3,193
—
(
2,488
)
705
—
—
—
Totals
$
81,490
$
104,897
$
(
57,794
)
$
13,609
$
142,202
$
(
21,530
)
$
8,010
$
66
(1)
Gross additions include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the amortization of unearned income, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.
(2)
Gross reductions include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.
(3)
Includes PIK interest income.
s.
Investment determined to be a controlled investment as defined in the 1940 Act as the Company is deemed to exercise a controlling influence over the management or policies of the portfolio company due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of such portfolio company. Fair value as of December 31, 2021 and September 30, 2022, along with transactions during the nine months ended September 30, 2022 in these controlled investments, were as follows:
Nine Months Ended September 30, 2022
Nine Months Ended September 30, 2022
Controlled Investments
Fair Value at
December 31, 2021
Gross
Additions
(Cost)(1)
Gross
Reductions
(Cost)(2)
Net
Unrealized
Gain (Loss)
Fair Value at
September 30, 2022
Net Realized
Gain (Loss)
Interest
Income(3)
Dividend Income
CION/EagleTree Partners, LLC
Senior Secured Note
$
61,629
$
645
$
—
$
—
$
62,274
$
—
$
6,475
$
—
Participating Preferred Shares
29,796
—
—
5,373
35,169
—
—
—
Common Shares
—
—
—
—
—
—
—
—
Totals
$
91,425
$
645
$
—
$
5,373
$
97,443
$
—
$
6,475
$
—
(1)
Gross additions include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the amortization of unearned income, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.
(2)
Gross reductions include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.
(3)
Includes PIK interest income
.
See accompanying notes to consolidated financial statements.
14
CĪON Investment Corporation
Consolidated Schedule of Investments (unaudited)
September 30, 2022
(in thousands)
t.
As of September 30, 2022, the following investments contain a PIK interest provision whereby the issuer has either the option or the obligation to make interest payments with the issuance of additional securities:
Interest Rate
Portfolio Company
Investment Type
Cash
PIK
All-in-Rate
Adapt Laser Acquisition, Inc.
Senior Secured First Lien Debt
13.67
%
2.00
%
15.67
%
American Consolidated Natural Resources, Inc.
Senior Secured First Lien Debt
16.08
%
3.00
%
19.08
%
Ancile Solutions, Inc.
Senior Secured First Lien Debt
10.27
%
3.00
%
13.27
%
Anthem Sports & Entertainment Inc.
Senior Secured First Lien Debt
10.42
%
2.25
%
12.67
%
Cadence Aerospace, LLC
Senior Secured First Lien Debt
9.31
%
2.00
%
11.31
%
CHC Solutions Inc.
Senior Secured First Lien Debt
8.00
%
4.00
%
12.00
%
CION/EagleTree Partners, LLC
Senior Secured Note
—
14.00
%
14.00
%
David's Bridal, LLC
Senior Secured First Lien Debt
7.81
%
5.00
%
12.81
%
David's Bridal, LLC
Senior Secured First Lien Debt
1.00
%
8.12
%
9.12
%
Deluxe Entertainment Services, Inc.
Senior Secured First Lien Debt
8.67
%
1.50
%
10.17
%
Deluxe Entertainment Services, Inc.
Senior Secured Second Lien Debt
9.67
%
2.50
%
12.17
%
GSC Technologies Inc.
Senior Secured First Lien Debt
—
7.56
%
7.56
%
GSC Technologies Inc.
Senior Secured First Lien Debt
7.56
%
5.00
%
12.56
%
Hilliard, Martinez & Gonzales, LLP
Senior Secured First Lien Debt
—
14.56
%
14.56
%
Homer City Generation, L.P.
Senior Secured First Lien Debt
—
15.00
%
15.00
%
Independent Pet Partners Intermediate Holdings, LLC
Senior Secured First Lien Debt
—
6.00
%
6.00
%
Independent Pet Partners Intermediate Holdings, LLC
Senior Secured First Lien Debt
—
11.75
%
11.75
%
Independent Pet Partners Intermediate Holdings, LLC
Senior Secured First Lien Debt
—
9.50
%
9.50
%
Instant Web, LLC
Senior Secured First Lien Debt
—
10.12
%
10.12
%
Jenny C Acquisition, Inc.
Senior Secured First Lien Debt
—
12.75
%
12.75
%
LAV Gear Holdings, Inc.
Senior Secured First Lien Debt
7.95
%
2.00
%
9.95
%
Lucky Bucks Holdings LLC
Unsecured Note
—
12.50
%
12.50
%
Moss Holding Company
Senior Secured First Lien Debt
10.31
%
0.50
%
10.81
%
Premiere Global Services, Inc.
Senior Secured Second Lien Debt
0.50
%
11.48
%
11.98
%
Robert C. Hilliard, L.L.P.
Senior Secured First Lien Debt
—
14.56
%
14.56
%
Service Compression, LLC
Senior Secured First Lien Debt
11.80
%
2.00
%
13.80
%
Spinal USA, Inc. / Precision Medical Inc.
Senior Secured First Lien Debt
—
13.25
%
13.25
%
STATinMED, LLC
Senior Secured First Lien Debt
—
12.21
%
12.21
%
Trammell, P.C.
Senior Secured First Lien Debt
—
18.65
%
18.65
%
Vesta Holdings, LLC
Senior Secured First Lien Debt
—
13.14
%
13.14
%
WPLM Acquisition Corp.
Unsecured Note
—
15.00
%
15.00
%
u.
As of September 30, 2022, the index rate for $
2,096
and $
1,943
was 1 Month LIBOR and 3 Month LIBOR, respectively.
v.
[Reserved]
w.
The interest rate on these loans is subject to 1 month LIBOR, which as of September 30, 2022 was 3.14%.
x.
The interest rate on these loans is subject to 3 month LIBOR, which as of September 30, 2022 was 3.75%.
y.
The interest rate on these loans is subject to 6 month LIBOR, which as of September 30, 2022 was 4.23%.
z.
The interest rate on these loans is subject to 1 month SOFR, which as of September 30, 2022 was 3.04%.
aa.
The interest rate on these loans is subject to 3 month SOFR, which as of September 30, 2022 was 3.59%.
See accompanying notes to consolidated financial statements.
15
CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2021
(in thousands)
Portfolio Company(a)
Interest(b)
Maturity
Industry
Principal/
Par Amount/
Units(e)
Cost(d)
Fair
Value(c)
Senior Secured First Lien Debt -
164.1
%
ABB/CON-CISE Optical Group LLC(i)(n)(x)
L+
500
,
1.00
% LIBOR Floor
6/15/2023
Consumer Goods: Non-Durable
$
8,473
$
8,263
$
8,219
Adapt Laser Acquisition, Inc.(t)(w)
L+
1200
,
1.00
% LIBOR Floor
12/31/2023
Capital Equipment
11,181
11,181
9,392
Adapt Laser Acquisition, Inc.(w)
L+
1000
,
1.00
% LIBOR Floor
12/31/2023
Capital Equipment
2,000
2,000
1,680
Aegis Toxicology Sciences Corp.(m)(w)
L+
550
,
1.00
% LIBOR Floor
5/9/2025
Healthcare & Pharmaceuticals
7,186
7,105
7,186
Alchemy US Holdco 1, LLC(m)(v)
L+
550
10/10/2025
Construction & Building
2,287
2,270
2,289
Allen Media, LLC(n)(w)
L+
550
,
0.00
% LIBOR Floor
2/10/2027
Media: Diversified & Production
8,955
8,868
8,955
ALM Media, LLC(m)(n)(w)
L+
700
,
1.00
% LIBOR Floor
11/25/2024
Media: Advertising, Printing & Publishing
18,000
17,774
17,460
American Clinical Solutions LLC(m)
7.00
%
12/31/2022
Healthcare & Pharmaceuticals
3,500
3,462
3,447
American Consolidated Natural Resources, Inc.(m)(t)(w)
L+
1600
,
1.00
% LIBOR Floor
9/16/2025
Metals & Mining
379
284
389
American Health Staffing Group, Inc.(m)(w)
L+
600
,
1.00
% LIBOR Floor
11/19/2026
Services: Business
16,667
16,502
16,500
American Health Staffing Group, Inc.
Prime+
500
11/19/2026
Services: Business
1,000
1,000
990
American Health Staffing Group, Inc.
0.50
% Unfunded
11/19/2026
Services: Business
2,333
(
33
)
(
23
)
American Media, LLC(m)(w)
L+
675
,
1.50
% LIBOR Floor
12/31/2023
Media: Advertising, Printing & Publishing
9,847
9,735
9,847
American Media, LLC(m)
0.50
% Unfunded
12/31/2023
Media: Advertising, Printing & Publishing
1,702
(
17
)
—
American Teleconferencing Services, Ltd.(m)(q)
Prime+
550
6/8/2023
Telecommunications
16,154
15,621
3,211
American Teleconferencing Services, Ltd.(m)
Prime+
550
3/31/2022
Telecommunications
3,116
3,033
3,116
American Teleconferencing Services, Ltd.(m)(o)
0.00
% Unfunded
3/31/2022
Telecommunications
235
—
—
Analogic Corp.(m)(n)(v)
L+
525
,
1.00
% LIBOR Floor
6/21/2024
Healthcare & Pharmaceuticals
4,900
4,853
4,820
Ancile Solutions, Inc.(t)(v)
L+
1000
,
1.00
%LIBOR Floor
6/22/2026
High Tech Industries
12,537
12,194
12,161
Anthem Sports & Entertainment Inc.(m)(t)(w)
L+
900
,
1.00
% LIBOR Floor
11/15/2026
Media: Diversified & Production
37,966
37,758
36,543
Anthem Sports & Entertainment Inc.(w)
L+
950
,
1.00
% LIBOR Floor
11/15/2026
Media: Diversified & Production
1,000
1,000
962
Anthem Sports & Entertainment Inc.
0.50
% Unfunded
11/15/2026
Media: Diversified & Production
1,167
—
(
44
)
Appalachian Resource Company, LLC(v)
L+
500
,
1.00
% LIBOR Floor
9/10/2023
Metals & Mining
11,137
9,959
10,538
Appalachian Resource Company, LLC(o)
0.00
% Unfunded
9/10/2023
Metals & Mining
500
—
—
Associated Asphalt Partners, LLC(m)(n)(v)
L+
525
,
1.00
% LIBOR Floor
4/5/2024
Construction & Building
14,393
14,095
12,666
Avison Young (USA) Inc.(h)(m)(w)
L+
500
,
0.00
% LIBOR Floor
1/31/2026
Banking, Finance, Insurance & Real Estate
2,692
2,658
2,679
Bradshaw International Parent Corp.(m)(v)
L+
575
,
1.00
% LIBOR Floor
10/21/2027
Consumer Goods: Durable
13,156
12,831
12,827
Bradshaw International Parent Corp.(v)
L+
575
,
1.00
% LIBOR Floor
10/21/2026
Consumer Goods: Durable
400
387
390
Bradshaw International Parent Corp.
0.50
% Unfunded
10/21/2026
Consumer Goods: Durable
1,445
(
32
)
(
36
)
Cadence Aerospace, LLC(m)(n)(t)(w)
L+
850
,
1.00
% LIBOR Floor
11/14/2023
Aerospace & Defense
38,960
38,623
38,279
Cardenas Markets LLC(x)
L+
625
,
1.00
% LIBOR Floor
6/3/2027
Retail
10,945
10,840
10,972
CB URS Holdings Corp.(m)(x)
L+
575
,
1.00
% LIBOR Floor
9/1/2024
Transportation: Cargo
15,354
15,310
14,106
Celerity Acquisition Holdings, LLC(v)
L+
850
,
1.00
% LIBOR Floor
5/28/2026
Services: Business
14,925
14,925
14,944
Charming Charlie LLC(q)(r)
20.00
%
4/24/2023
Retail
662
657
350
CHC Solutions Inc.(n)(t)
12.00
%
7/20/2023
Healthcare & Pharmaceuticals
7,966
7,966
7,916
See accompanying notes to consolidated financial statements.
16
CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2021
(in thousands)
Portfolio Company(a)
Interest(b)
Maturity
Industry
Principal/
Par Amount/
Units(e)
Cost(d)
Fair
Value(c)
CION/EagleTree Partners, LLC(h)(s)(t)
14.00
%
12/21/2026
Diversified Financials
61,629
61,629
61,629
CircusTrix Holdings, LLC(m)(n)(t)(v)
L+
800
,
1.00
% LIBOR Floor
1/16/2024
Hotel, Gaming & Leisure
26,754
26,734
25,718
CircusTrix Holdings, LLC(m)(t)(v)
L+
800
,
1.00
% LIBOR Floor
1/16/2024
Hotel, Gaming & Leisure
2,723
2,723
2,618
CircusTrix Holdings, LLC(m)(t)(v)
L+
800
,
1.00
% LIBOR Floor
7/16/2023
Hotel, Gaming & Leisure
1,953
1,836
2,300
Country Fresh Holdings, LLC(q)(w)
L+
500
,
1.00
% LIBOR Floor
4/29/2023
Beverage, Food & Tobacco
1,020
984
168
Country Fresh Holdings, LLC(m)(q)(w)
L+
500
,
1.00
% LIBOR Floor
4/29/2023
Beverage, Food & Tobacco
414
414
68
Coyote Buyer, LLC(m)(n)(w)
L+
600
,
1.00
% LIBOR Floor
2/6/2026
Chemicals, Plastics & Rubber
34,388
34,157
34,302
Coyote Buyer, LLC(n)(w)
L+
800
,
1.00
% LIBOR Floor
8/6/2026
Chemicals, Plastics & Rubber
6,188
6,084
6,188
Coyote Buyer , LLC
0.50
% Unfunded
2/6/2025
Chemicals, Plastics & Rubber
2,500
—
(
6
)
Critical Nurse Staffing, LLC(m)(w)
L+
600
,
1.00
% LIBOR Floor
11/1/2026
Healthcare & Pharmaceuticals
13,059
13,059
13,059
Critical Nurse Staffing, LLC(w)
L+
600
,
1.00
% LIBOR Floor
11/1/2026
Healthcare & Pharmaceuticals
1,009
1,009
1,009
Critical Nurse Staffing, LLC
1.00
% Unfunded
11/1/2026
Healthcare & Pharmaceuticals
4,899
—
—
Critical Nurse Staffing, LLC
0.50
% Unfunded
11/1/2026
Healthcare & Pharmaceuticals
1,000
—
—
David's Bridal, LLC(t)(w)
L+
1000
,
1.00
% LIBOR Floor
6/23/2023
Retail
5,617
5,008
5,617
David's Bridal, LLC(t)(w)
L+
1000
,
1.00
% LIBOR Floor
5/23/2024
Retail
5,093
5,093
5,093
David's Bridal, LLC(t)(w)
L+
600
,
1.00
% LIBOR Floor
6/30/2023
Retail
791
719
791
Deluxe Entertainment Services, Inc.(m)(q)(r)(t)(w)
L+
650
,
1.00
% LIBOR Floor
3/25/2024
Media: Diversified & Production
2,930
2,930
1,787
DMT Solutions Global Corp.(m)(u)
L+
750
,
1.00
% LIBOR Floor
7/2/2024
Services: Business
9,696
9,563
9,503
Entertainment Studios P&A LLC(j)(m)
5.71
%
5/18/2037
Media: Diversified & Production
11,649
11,554
10,047
Entertainment Studios P&A LLC(j)
5.00
%
5/18/2037
Media: Diversified & Production
—
—
2,182
EnTrans International, LLC(m)(v)
L+
600
,
0.00
% LIBOR Floor
11/1/2024
Capital Equipment
24,750
24,617
23,430
Extreme Reach, Inc.(m)(n)(v)
L+
700
,
1.25
% LIBOR Floor
3/29/2024
Media: Diversified & Production
18,774
18,662
18,844
Extreme Reach, Inc.(m)(n)
0.50
% Unfunded
3/29/2024
Media: Diversified & Production
1,744
—
7
Foundation Consumer Healthcare, LLC(m)(n)(w)
L+
638
,
1.00
% LIBOR Floor
2/12/2027
Healthcare & Pharmaceuticals
30,799
30,535
31,145
Foundation Consumer Healthcare, LLC
0.50
% Unfunded
11/2/2023
Healthcare & Pharmaceuticals
2,094
—
24
FuseFX, LLC(m)(n)(v)
L+
575
,
1.00
% LIBOR Floor
10/1/2024
Media: Diversified & Production
20,000
19,800
19,800
Future Pak, LLC(m)(v)
L+
800
,
2.00
% LIBOR Floor
7/2/2024
Healthcare & Pharmaceuticals
33,764
33,565
33,426
Genesis Healthcare, Inc.(h)
0.50
% Unfunded
3/6/2023
Healthcare & Pharmaceuticals
35,000
—
—
GSC Technologies Inc.(r)(w)
L+
500
,
1.00
% LIBOR Floor
9/30/2025
Chemicals, Plastics & Rubber
2,404
2,294
2,001
GSC Technologies Inc.(r)(t)(w)
L+
500
,
1.00
% LIBOR Floor
9/30/2025
Chemicals, Plastics & Rubber
858
814
485
GSC Technologies Inc.(r)(t)(w)
L+
1000
,
1.00
% LIBOR Floor
9/30/2025
Chemicals, Plastics & Rubber
170
170
170
H.W. Lochner, Inc.(w)
L+
625
,
1.00
% LIBOR Floor
7/2/2027
Construction & Building
11,970
11,856
11,910
H.W. Lochner, Inc.(w)
L+
625
,
1.00
% LIBOR Floor
7/2/2027
Construction & Building
725
715
721
H.W. Lochner, Inc.
0.50
% Unfunded
7/2/2027
Construction & Building
275
—
(
1
)
Harland Clarke Holdings Corp.(m)(v)
L+
775
,
1.00
% LIBOR Floor
6/16/2026
Services: Business
9,657
9,641
8,848
See accompanying notes to consolidated financial statements.
17
CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2021
(in thousands)
Portfolio Company(a)
Interest(b)
Maturity
Industry
Principal/
Par Amount/
Units(e)
Cost(d)
Fair
Value(c)
Heritage Power, LLC(x)
L+
600
,
1.00
% LIBOR Floor
7/30/2026
Energy: Oil & Gas
4,854
4,692
3,956
Hilliard, Martinez & Gonzales, LLP(m)(t)(v)
L+
1800
,
2.00
% LIBOR Floor
12/17/2022
Services: Consumer
22,885
22,752
21,947
Homer City Generation, L.P.(m)(t)
15.00
%
4/5/2023
Energy: Oil & Gas
10,173
10,521
7,935
Hoover Group, Inc.(n)(w)
L+
850
,
1.25
% LIBOR Floor
10/1/2024
Services: Business
5,156
5,139
5,079
HUMC Holdco, LLC(m)
9.00
%
1/14/2022
Healthcare & Pharmaceuticals
9,346
9,346
9,323
HW Acquisition, LLC(m)(w)
L+
600
,
1.00
% LIBOR Floor
9/28/2026
Capital Equipment
19,067
18,885
18,828
HW Acquisition, LLC
0.50
% Unfunded
9/28/2026
Capital Equipment
2,933
(
28
)
(
37
)
Independent Pet Partners Intermediate Holdings, LLC(m)(t)
6.00
%
11/20/2023
Retail
10,295
10,235
9,085
Independent Pet Partners Intermediate Holdings, LLC(m)
Prime+
500
12/22/2022
Retail
2,085
2,085
2,085
Independent Pet Partners Intermediate Holdings, LLC(m)(w)
L+
600
,
0.00
% LIBOR Floor
12/22/2022
Retail
264
264
264
InfoGroup Inc.(m)(n)(w)
L+
500
,
1.00
% LIBOR Floor
4/3/2023
Media: Advertising, Printing & Publishing
15,432
15,428
14,815
Inotiv, Inc.(m)(v)
L+
625
,
1.00
% LIBOR Floor
11/5/2026
Healthcare & Pharmaceuticals
9,900
9,709
9,764
Inotiv, Inc.
1.00
% Unfunded
5/5/2023
Healthcare & Pharmaceuticals
2,100
(
41
)
(
29
)
Instant Web, LLC(m)(n)(v)
L+
650
,
1.00
% LIBOR Floor
12/15/2022
Media: Advertising, Printing & Publishing
36,605
36,580
34,042
Instant Web, LLC
0.50
% Unfunded
12/15/2022
Media: Advertising, Printing & Publishing
2,704
—
—
Invincible Boat Company LLC(w)
L+
650
,
1.50
% LIBOR Floor
8/28/2025
Consumer Goods: Durable
14,034
13,937
14,034
Invincible Boat Company LLC
0.50
% Unfunded
8/28/2025
Consumer Goods: Durable
798
—
(
8
)
INW Manufacturing, LLC(n)(w)
L+
575
,
0.75
% LIBOR Floor
5/7/2027
Services: Business
19,625
19,087
19,232
Isagenix International, LLC(m)(w)
L+
575
,
1.00
% LIBOR Floor
6/14/2025
Beverage, Food & Tobacco
16,663
15,160
15,122
Island Medical Management Holdings, LLC(m)(n)(w)
L+
650
,
1.00
% LIBOR Floor
9/1/2023
Healthcare & Pharmaceuticals
11,049
11,028
11,049
Jenny C Acquisition, Inc.(m)(t)(w)
L+
900
,
1.75
% LIBOR Floor
10/1/2024
Services: Consumer
11,123
11,069
10,157
JP Intermediate B, LLC(m)(w)
L+
550
,
1.00
% LIBOR Floor
11/20/2025
Beverage, Food & Tobacco
14,355
14,160
13,458
K&N Parent, Inc.(w)
L+
475
,
1.00
% LIBOR Floor
10/20/2023
Consumer Goods: Durable
11,154
10,779
10,373
KNB Holdings Corp.(m)(x)
L+
550
,
1.00
% LIBOR Floor
4/26/2024
Consumer Goods: Durable
7,854
7,774
5,517
LaserAway Intermediate Holdings II, LLC(m)(w)
L+
575
,
1.00
% LIBOR Floor
10/12/2027
Services: Consumer
10,000
9,805
9,963
LAV Gear Holdings, Inc.(m)(n)(t)(w)
L+
750
,
1.00
% LIBOR Floor
10/31/2024
Services: Business
26,408
26,103
24,988
LAV Gear Holdings, Inc.(m)(n)(t)(w)
L+
750
,
1.00
% LIBOR Floor
10/31/2024
Services: Business
4,555
4,518
4,310
LGC US Finco, LLC(m)(v)
L+
650
,
1.00
% LIBOR Floor
12/20/2025
Capital Equipment
11,760
11,431
11,422
LH Intermediate Corp.(m)(w)
L+
750
,
1.00
% LIBOR Floor
6/2/2026
Consumer Goods: Durable
14,438
14,230
14,257
Lift Brands, Inc.(m)(n)(r) (v)
L+
750
,
1.00
% LIBOR Floor
6/29/2025
Services: Consumer
23,523
23,523
23,406
Lift Brands, Inc.(m)(n)(r)(t)
9.50
%
6/29/2025
Services: Consumer
5,343
5,255
5,156
Lift Brands, Inc.(m)(n)(r)
(p)
6/29/2025
Services: Consumer
5,296
4,814
4,700
Longview Power, LLC(r)(w)
L+
1000
,
1.50
% LIBOR Floor
7/30/2025
Energy: Oil & Gas
4,189
2,624
4,504
MacNeill Pride Group Corp.(m)(w)
L+
625
,
1.00
% LIBOR Floor
4/20/2026
Services: Consumer
14,925
14,790
14,776
MacNeill Pride Group Corp.(w)
L+
625
,
1.00
% LIBOR Floor
4/20/2026
Services: Consumer
4,992
4,947
4,942
Manus Bio Inc.
11.00
%
8/20/2026
Healthcare & Pharmaceuticals
10,000
10,000
10,000
See accompanying notes to consolidated financial statements.
18
CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2021
(in thousands)
Portfolio Company(a)
Interest(b)
Maturity
Industry
Principal/
Par Amount/
Units(e)
Cost(d)
Fair
Value(c)
Marble Point Credit Management LLC(v)
L+
600
,
1.00
% LIBOR Floor
8/11/2028
Diversified Financials
6,418
6,294
6,370
Marble Point Credit Management LLC(v)
L+
600
,
1.00
% LIBOR Floor
8/11/2028
Diversified Financials
250
241
248
Marble Point Credit Management LLC
0.50
% Unfunded
8/11/2028
Diversified Financials
1,250
—
(
9
)
Mimeo.com, Inc.(w)
L+
640
,
1.00
% LIBOR Floor
12/21/2023
Services: Business
23,018
23,018
23,018
Mimeo.com, Inc.(w)
L+
640
,
1.00
% LIBOR Floor
12/21/2023
Services: Business
256
256
256
Mimeo.com, Inc.
1.00
% Unfunded
12/21/2023
Services: Business
5,000
—
—
Molded Devices, Inc.(m)
Prime +
500
11/1/2026
Services: Business
15,574
15,407
15,418
Molded Devices, Inc.
1.00
% Unfunded
11/1/2026
Services: Business
1,771
(
17
)
(
18
)
Molded Devices, Inc.
0.50
% Unfunded
11/1/2026
Services: Business
2,656
—
(
27
)
Moss Holding Company(m)(n)(t)(w)
L+
700
,
1.00
% LIBOR Floor
4/17/2024
Services: Business
19,641
19,506
17,922
Moss Holding Company
0.50
% Unfunded
4/17/2024
Services: Business
2,126
—
—
Moss Holding Company
7.00
% Unfunded
4/17/2024
Services: Business
106
—
—
Napa Management Services Corp.(v)
L+
500
,
1.00
% LIBOR Floor
4/19/2023
Healthcare & Pharmaceuticals
5,318
5,267
5,324
NASCO Healthcare Inc.(m)(x)
L+
550
,
1.00
% LIBOR Floor
6/30/2023
Services: Business
17,458
17,458
17,218
Neptune Flood Inc.(m)(w)
L+
600
,
1.00
% LIBOR Floor
10/21/2026
Banking, Finance, Insurance & Real Estate
9,667
9,596
9,618
NewsCycle Solutions, Inc.(m)(n)(w)
L+
700
,
1.00
% LIBOR Floor
12/29/2022
Media: Advertising, Printing & Publishing
12,064
12,020
12,049
NWN Parent Holdings LLC(w)
L+
650
,
1.00
% LIBOR Floor
5/7/2026
High Tech Industries
13,100
12,980
13,100
NWN Parent Holdings LLC(w)
L+
650
,
1.00
% LIBOR Floor
5/7/2026
High Tech Industries
420
420
421
NWN Parent Holdings LLC
0.50
% Unfunded
5/7/2026
High Tech Industries
1,380
(
18
)
3
Optio Rx, LLC(m)(n)(w)
L+
700
,
0.00
% LIBOR Floor
6/28/2024
Healthcare & Pharmaceuticals
23,344
23,255
22,994
Optio Rx, LLC(n)(w)
L+
1000
,
0.00
% LIBOR Floor
6/28/2024
Healthcare & Pharmaceuticals
2,515
2,498
2,647
Pentec Acquisition Corp.(w)
L+
600
,
1.00
% LIBOR Floor
10/8/2026
Healthcare & Pharmaceuticals
25,000
24,756
24,750
PetroChoice Holdings, Inc.(w)
L+
500
,
1.00
% LIBOR Floor
8/20/2022
Chemicals, Plastics & Rubber
3,896
3,836
3,725
PH Beauty Holdings III. Inc.(m)(w)
L+
500
,
0.00
% LIBOR Floor
9/28/2025
Consumer Goods: Non-Durable
9,675
9,172
9,143
Playboy Enterprises, Inc.(h)(n)(w)
L+
575
,
0.50
% LIBOR Floor
5/25/2027
Consumer Goods: Non-Durable
28,606
28,043
28,320
Polymer Additives, Inc.(m)(w)
L+
600
,
0.00
% LIBOR Floor
7/31/2025
Chemicals, Plastics & Rubber
19,400
19,173
18,963
RA Outdoors, LLC(m)(w)
L+
675
,
1.00
% LIBOR Floor
4/8/2026
Media: Diversified & Production
15,911
15,911
15,772
RA Outdoors, LLC
0.50
% Unfunded
4/8/2026
Media: Diversified & Production
1,049
(
170
)
(
9
)
Retail Services WIS Corp.(m)(w)
L+
775
,
1.00
% LIBOR Floor
5/20/2025
Services: Business
9,924
9,699
9,788
Robert C. Hilliard, L.L.P.(m)(t)(v)
L+
1800
,
2.00
% LIBOR Floor
12/17/2022
Services: Consumer
1,905
1,905
1,827
Rogers Mechanical Contractors, LLC(m)(v)
L+
650
,
1.00
% LIBOR Floor
9/9/2025
Services: Business
17,250
17,250
17,250
Rogers Mechanical Contractors, LLC
0.75
% Unfunded
9/9/2025
Services: Business
2,885
—
—
Rogers Mechanical Contractors, LLC
1.00
% Unfunded
9/9/2022
Services: Business
1,923
—
—
RumbleOn, Inc.(m)(t)(w)
L+
825
,
1.00
% LIBOR Floor
8/31/2026
Automotive
13,965
12,962
13,389
RumbleOn, Inc.(o)
0.00
% Unfunded
2/28/2023
Automotive
6,000
(
56
)
—
Securus Technologies Holdings, Inc.(m)(w)
L+
450
,
1.00
% LIBOR Floor
11/1/2024
Telecommunications
3,908
3,201
3,908
Sequoia Healthcare Management, LLC(m)(n)(q)
12.75
%
8/21/2023
Healthcare & Pharmaceuticals
8,525
8,457
6,394
See accompanying notes to consolidated financial statements.
19
CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2021
(in thousands)
Portfolio Company(a)
Interest(b)
Maturity
Industry
Principal/
Par Amount/
Units(e)
Cost(d)
Fair
Value(c)
SIMR, LLC(r)(t)(v)
L+
1700
,
2.00
% LIBOR Floor
9/7/2023
Healthcare & Pharmaceuticals
19,938
19,813
16,000
Sleep Opco, LLC(m)(w)
L+
650
,
1.00
% LIBOR Floor
10/12/2026
Retail
13,250
12,991
12,985
Sleep Opco, LLC(m)
0.50
% Unfunded
10/12/2026
Retail
1,750
(
34
)
(
35
)
Spinal USA, Inc. / Precision Medical Inc.(m)(w)
L+
950
10/1/2022
Healthcare & Pharmaceuticals
12,526
12,491
11,743
Spinal USA, Inc. / Precision Medical Inc.(m)(t)(w)
L+
950
10/1/2022
Healthcare & Pharmaceuticals
1,054
1,054
991
Spinal USA, Inc. / Precision Medical Inc.(m)(t)(w)
L+
950
10/1/2022
Healthcare & Pharmaceuticals
689
600
644
Spinal USA, Inc. / Precision Medical Inc.(m)(t)(w)
L+
950
10/1/2022
Healthcare & Pharmaceuticals
649
647
609
Spinal USA, Inc. / Precision Medical Inc.(m)(t)(w)
L+
950
10/1/2022
Healthcare & Pharmaceuticals
546
475
560
Tenere Inc.(m)(n)(w)
L+
850
,
1.00
% LIBOR Floor
7/1/2025
Capital Equipment
18,080
18,080
18,080
Tensar Corp.(m)(w)
L+
675
,
1.00
% LIBOR Floor
11/20/2025
Chemicals, Plastics & Rubber
4,950
4,850
4,982
Trademark Global, LLC(v)
L+
600
,
1.00
% LIBOR Floor
7/30/2024
Services: Business
15,346
15,278
15,250
Trademark Global, LLC
1.00
% Unfunded
7/30/2023
Services: Business
4,615
(
21
)
(
29
)
Trammell, P.C.(i)(t)(v)
L+
1800
,
2.00
% LIBOR Floor
6/25/2022
Services: Consumer
18,091
18,091
18,091
USALCO, LLC(m)(w)
L+
600
,
1.00
% LIBOR Floor
10/19/2027
Chemicals, Plastics & Rubber
25,000
24,753
24,875
Vesta Holdings, LLC(m)(t)(v)
L+
1000
,
1.00
% LIBOR Floor
2/25/2024
Banking, Finance, Insurance & Real Estate
24,933
24,933
24,933
Volta Charging, LLC(m)
12.00
%
6/19/2024
Media: Diversified & Production
12,000
11,984
13,095
Volta Charging, LLC(m)
12.00
%
6/19/2024
Media: Diversified & Production
10,500
10,500
11,458
West Dermatology Management Holdings, LLC(m)(n)(w)
L+
600
,
1.00
% LIBOR Floor
2/11/2025
Healthcare & Pharmaceuticals
9,441
9,396
9,417
West Dermatology Management Holdings, LLC(w)
L+
600
,
1.00
% LIBOR Floor
2/11/2025
Healthcare & Pharmaceuticals
3,562
3,553
3,553
West Dermatology Management Holdings, LLC(w)
L+
750
,
1.00
% LIBOR Floor
2/11/2025
Healthcare & Pharmaceuticals
1,179
1,179
1,191
West Dermatology Management Holdings, LLC(m)(w)
L+
600
,
1.00
% LIBOR Floor
2/11/2025
Healthcare & Pharmaceuticals
1,105
1,094
1,102
West Dermatology Management Holdings, LLC(m)
0.50
% Unfunded
2/11/2025
Healthcare & Pharmaceuticals
552
—
(
1
)
West Dermatology Management Holdings, LLC(m)
0.75
% Unfunded
2/11/2022
Healthcare & Pharmaceuticals
5,755
(
13
)
(
8
)
Williams Industrial Services Group, Inc(n)(v)
L+
900
,
1.00
% LIBOR Floor
12/16/2025
Services: Business
9,775
9,775
9,861
Williams Industrial Services Group, Inc
0.50
% Unfunded
12/16/2025
Services: Business
5,000
—
44
Wind River Systems, Inc.(n)(w)
L+
675
,
1.00
% LIBOR Floor
6/24/2024
High Tech Industries
23,684
23,507
23,684
Wok Holdings Inc.(m)(v)
L+
625
,
0.00
% LIBOR Floor
3/1/2026
Beverage, Food & Tobacco
20,340
19,882
20,238
Xenon Arc, Inc.(m)(w)
L+
600
,
0.75
% LIBOR Floor
12/17/2027
High Tech Industries
10,000
9,875
9,875
Total Senior Secured First Lien Debt
1,564,891
1,526,989
Senior Secured Second Lien Debt -
4.1
%
Deluxe Entertainment Services, Inc.(m)(q)(r)(t)(w)
L+
850
,
1.00
% LIBOR Floor
9/25/2024
Media: Diversified & Production
10,534
10,017
—
Global Tel*Link Corp.(n)(v)
L+
825
,
0.00
% LIBOR Floor
11/29/2026
Telecommunications
11,500
11,356
11,471
PetroChoice Holdings, Inc.(w)
L+
875
,
1.00
% LIBOR Floor
8/21/2023
Chemicals, Plastics & Rubber
15,000
14,524
14,175
Premiere Global Services, Inc.(q)(t)(w)
L+
950
,
1.00
% LIBOR Floor
6/6/2024
Telecommunications
3,775
3,435
—
Securus Technologies Holdings, Inc.(w)
L+
825
,
1.00
% LIBOR Floor
11/1/2025
Telecommunications
2,942
2,924
2,943
See accompanying notes to consolidated financial statements.
20
CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2021
(in thousands)
Portfolio Company(a)
Interest(b)
Maturity
Industry
Principal/
Par Amount/
Units(e)
Cost(d)
Fair
Value(c)
TMK Hawk Parent, Corp.(v)
L+
800
,
1.00
% LIBOR Floor
8/28/2025
Services: Business
13,393
13,199
9,994
Total Senior Secured Second Lien Debt
55,455
38,583
Collateralized Securities and Structured Products - Equity -
0.3
%
APIDOS CLO XVI Subordinated Notes(g)(h)
0.00
% Estimated Yield
1/19/2025
Diversified Financials
9,000
2,136
984
Galaxy XV CLO Ltd. Class A Subordinated Notes(g)(h)
5.76
% Estimated Yield
4/15/2025
Diversified Financials
4,000
1,749
2,014
Total Collateralized Securities and Structured Products - Equity
See accompanying notes to consolidated financial statements.
21
CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2021
(in thousands)
Portfolio Company(a)
Interest(b)
Industry
Principal/
Par Amount/
Units(e)
Cost(d)
Fair
Value(c)
SIMR Parent, LLC, Class B Common Units(o)(r)
Healthcare & Pharmaceuticals
12,283,163
Units
8,002
—
SIMR Parent, LLC, Class W Units(o)(r)
Healthcare & Pharmaceuticals
1,778,219
Units
—
—
Snap Fitness Holdings, Inc., Class A Common Stock(o)(r)
Services: Consumer
9,858
Units
3,078
3,131
Snap Fitness Holdings, Inc., Warrants(o)(r)
Services: Consumer
3,996
Units
1,247
1,269
Total Equity
53,379
70,936
Short Term Investments -
9.4
%(k)
First American Treasury Obligations Fund, Class Z Shares
0.01
%(l)
87,917
87,917
Total Short Term Investments
87,917
87,917
TOTAL INVESTMENTS -
188.5
%
$
1,792,304
1,754,039
LIABILITIES IN EXCESS OF OTHER ASSETS - (
88.5
)%
(
823,527
)
NET ASSETS -
100.0
%
$
930,512
a.
All of the Company’s investments are issued by eligible U.S. portfolio companies, as defined in the 1940 Act, except for investments specifically identified as non-qualifying per note h. below. Unless specifically identified in note t. below, investments do not contain a PIK interest provision.
b.
The actual LIBOR rate for each loan listed may not be the applicable LIBOR rate as of December 31, 2021, as the loan may have been priced or repriced based on a LIBOR rate prior to or subsequent to December 31, 2021.
c.
Fair value determined in good faith by the Company’s board of directors (see Note 9) using significant unobservable inputs unless otherwise noted.
d.
Represents amortized cost for debt securities and cost for equity investments.
e.
Denominated in U.S. dollars unless otherwise noted.
f.
Fair value determined using level 1 inputs.
g.
The CLO subordinated notes are considered equity positions in the CLO vehicles and are not rated. Equity investments are entitled to recurring distributions, which are generally equal to the remaining cash flow of the payments made by the underlying vehicle's securities less contractual payments to debt holders and expenses. The estimated yield indicated is based upon a current projection of the amount and timing of these recurring distributions and the estimated amount of repayment of principal upon termination. Such projections are periodically reviewed and adjusted, and the estimated yield may not ultimately be realized.
h.
The investment or a portion thereof is not a qualifying asset under the 1940 Act. A business development company may not acquire any asset other than qualifying assets, unless, at the time the acquisition is made, qualifying assets represent at least 70% of the company’s total assets as defined under Section 55 of the 1940 Act. As of December 31, 2021,
92.6
% of the Company’s total assets represented qualifying assets.
i.
Position or a portion thereof unsettled as of December 31, 2021.
j.
In addition to the interest earned based on the stated interest rate of this loan, which is the amount reflected in this schedule, the Company may be entitled to receive additional residual amounts.
k.
Short term investments represent an investment in a fund that invests in highly liquid investments with average original maturity dates of three months or less.
l.
7-day effective yield as of December 31, 2021.
m.
Investment or a portion thereof held within the Company’s wholly-owned consolidated subsidiary, 34th Street, and was pledged as collateral supporting the amounts outstanding under the credit facility with JPM as of December 31, 2021 (see Note 8).
n.
Investment or a portion thereof held within the Company’s wholly-owned consolidated subsidiary, Murray Hill Funding II, and was pledged as collateral supporting the amounts outstanding under the repurchase agreement with UBS as of December 31, 2021 (see Note 8).
o.
Non-income producing security.
p.
The ultimate interest earned on this loan will be determined based on the portfolio company’s EBITDA at a specified trigger event.
q.
Investment or a portion thereof was on non-accrual status as of December 31, 2021.
See accompanying notes to consolidated financial statements.
22
CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2021
(in thousands)
r.
Investment determined to be an affiliated investment as defined in the 1940 Act as the Company owns between 5% and 25% of the portfolio company’s outstanding voting securities but does not control the portfolio company. Fair value as of December 31, 2020 and 2021, along with transactions during the year ended December 31, 2021 in these affiliated investments, were as follows:
Year Ended December 31, 2021
Year Ended December 31, 2021
Non-Controlled, Affiliated Investments
Fair Value
at December
31, 2020
Gross
Additions
(Cost)(1)
Gross
Reductions
(Cost)(2)
Net
Unrealized
Gain (Loss)
Fair Value
at December
31, 2021
Net Realized
Gain (Loss)
Interest
Income(3)
Dividend
Income
Alert 360 Opco, Inc.
First Lien Term Loan
$
—
$
12,240
$
(
12,240
)
$
—
$
—
$
—
$
796
$
—
Common Stock
—
3,624
(
3,624
)
—
—
(
117
)
—
—
American Clinical Solutions LLC
Tranche I Term Loan
3,124
35
(
3,421
)
262
—
—
282
—
First Amendment Tranche I Term Loan
242
—
(
250
)
8
—
—
18
—
Class A Membership Interests
663
—
(
1,658
)
995
—
3,542
—
—
ARC Financial, LLC
Membership Interests
—
—
—
—
—
—
—
—
BCP Great Lakes Fund LP
Membership Interests
12,611
5,377
(
18,241
)
253
—
33
—
1,078
Charming Charlie, LLC
Vendor Payment Financing Facility
350
—
—
—
350
—
—
—
Conisus Holdings, Inc.
Series B Preferred Stock
16,481
951
(
16,094
)
(
1,338
)
—
—
—
4,428
Common Stock
12,401
—
(
200
)
(
12,201
)
—
19,110
—
—
DESG Holdings, Inc.
First Lien Term Loan
3,978
48
(
1,176
)
(
1,063
)
1,787
180
(
291
)
—
Second Lien Term Loan
—
—
—
—
—
—
—
—
Common Stock
—
—
(
13,675
)
13,675
—
(
13,675
)
—
—
F+W Media, Inc.
First Lien Term Loan B-1
—
—
(
1,115
)
1,115
—
(
1,080
)
—
—
GSC Technologies Inc.
Incremental Term Loan
—
176
(
6
)
—
170
—
5
—
First Lien Term Loan A
2,289
18
(
17
)
(
289
)
2,001
1
165
—
First Lien Term Loan B
755
58
—
(
328
)
485
—
58
—
Common Shares
—
—
—
—
—
—
—
—
Lift Brands, Inc.
Term Loan A
23,642
—
(
118
)
(
118
)
23,406
—
2,036
—
Term Loan B
4,751
502
—
(
97
)
5,156
—
503
—
Term Loan C
4,687
129
—
(
116
)
4,700
—
129
—
Longview Power, LLC
First Lien Term Loan
2,414
2,019
(
26
)
97
4,504
16
581
—
Longview Intermediate Holdings C, LLC
Membership Units
7,988
179
—
6,960
15,127
—
—
—
Mount Logan Capital Inc.
Common Stock
2,409
—
—
995
3,404
—
—
70
SIMR, LLC
First Lien Term Loan
13,347
3,839
—
(
1,186
)
16,000
—
3,839
—
SIMR Parent, LLC
Class B Membership Units
—
—
—
—
—
—
—
—
Class W Membership Units
—
—
—
—
—
—
—
—
Snap Fitness Holdings, Inc.
Class A Stock
3,389
—
—
(
258
)
3,131
—
—
—
Warrants
1,374
—
—
(
105
)
1,269
—
—
—
Totals
$
116,895
$
29,195
$
(
71,861
)
$
7,261
$
81,490
$
8,010
$
8,121
$
5,576
See accompanying notes to consolidated financial statements.
23
CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2021
(in thousands)
(1)
Gross additions include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the amortization of unearned income, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.
(2)
Gross reductions include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.
(3)
Includes PIK interest income.
s.
Investment determined to be a controlled investment as defined in the 1940 Act as the Company is deemed to exercise a controlling influence over the management or policies of the portfolio company due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of such portfolio company. Fair value as of December 31, 2020 and 2021, along with transactions during the year ended December 31, 2021 in these controlled investments, were as follows:
Year Ended December 31, 2021
Year Ended December 31, 2021
Controlled Investments
Fair Value at
December 31, 2020
Gross
Additions
(Cost)(1)
Gross
Reductions
(Cost)(2)
Net
Unrealized
Gain (Loss)
Fair Value at
December 31, 2021
Net Realized
Gain (Loss)
Interest
Income(3)
Dividend Income
CION SOF Funding, LLC
Membership Interests
$
12,472
$
—
$
(
15,539
)
$
3,067
$
—
$
(
3,067
)
$
—
$
—
CION/EagleTree Partners, LLC
Senior Secured Note
—
61,629
—
—
61,629
—
260
—
Participating Preferred Shares
—
22,073
—
7,723
29,796
—
—
—
Common Shares
—
—
—
—
—
—
—
—
Totals
$
12,472
$
83,702
$
(
15,539
)
$
10,790
$
91,425
$
(
3,067
)
$
260
$
—
(1)
Gross additions include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the amortization of unearned income, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.
(2)
Gross reductions include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.
(3)
Includes PIK interest income.
See accompanying notes to consolidated financial statements.
24
CĪON Investment Corporation
Consolidated Schedule of Investments
December 31, 2021
(in thousands)
t.
As of December 31, 2021, the following investments contain a PIK interest provision whereby the issuer has either the option or the obligation to make interest payments with the issuance of additional securities:
Interest Rate
Portfolio Company
Investment Type
Cash
PIK
All-in-Rate
Adapt Laser Acquisition, Inc.
Senior Secured First Lien Debt
11.00
%
2.00
%
13.00
%
American Consolidated Natural Resources, Inc.
Senior Secured First Lien Debt
14.00
%
3.00
%
17.00
%
Ancile Solutions, Inc.
Senior Secured First Lien Debt
8.00
%
3.00
%
11.00
%
Anthem Sports & Entertainment Inc.
Senior Secured First Lien Debt
7.75
%
2.25
%
10.00
%
Cadence Aerospace, LLC
Senior Secured First Lien Debt
7.50
%
2.00
%
9.50
%
CHC Solutions Inc.
Senior Secured First Lien Debt
8.00
%
4.00
%
12.00
%
CION/EagleTree Partners, LLC
Senior Secured Note
—
14.00
%
14.00
%
CircusTrix Holdings, LLC
Senior Secured First Lien Debt
6.50
%
2.50
%
9.00
%
David's Bridal, LLC
Senior Secured First Lien Debt
6.00
%
5.00
%
11.00
%
David's Bridal, LLC
Senior Secured First Lien Debt
1.00
%
6.00
%
7.00
%
Deluxe Entertainment Services, Inc.
Senior Secured First Lien Debt
6.00
%
1.50
%
7.50
%
Deluxe Entertainment Services, Inc.
Senior Secured Second Lien Debt
7.00
%
2.50
%
9.50
%
GSC Technologies Inc.
Senior Secured First Lien Debt
—
6.00
%
6.00
%
GSC Technologies Inc.
Senior Secured First Lien Debt
6.00
%
5.00
%
11.00
%
Hilliard, Martinez & Gonzales, LLP
Senior Secured First Lien Debt
—
20.00
%
20.00
%
Homer City Generation, L.P.
Senior Secured First Lien Debt
—
15.00
%
15.00
%
Independent Pet Partners Intermediate Holdings, LLC
Senior Secured First Lien Debt
—
6.00
%
6.00
%
LAV Gear Holdings, Inc.
Senior Secured First Lien Debt
6.50
%
2.00
%
8.50
%
Lift Brands, Inc.
Senior Secured First Lien Debt
—
9.50
%
9.50
%
Lucky Bucks Holdings LLC
Unsecured Note
—
12.50
%
12.50
%
Moss Holding Company
Senior Secured First Lien Debt
7.50
%
0.50
%
8.00
%
Premiere Global Services, Inc.
Senior Secured Second Lien Debt
0.50
%
10.00
%
10.50
%
Robert C. Hilliard, L.L.P.
Senior Secured First Lien Debt
—
20.00
%
20.00
%
RumbleOn, Inc.
Senior Secured First Lien Debt
8.25
%
1.00
%
9.25
%
SIMR, LLC
Senior Secured First Lien Debt
12.00
%
7.00
%
19.00
%
Spinal USA, Inc. / Precision Medical Inc.
Senior Secured First Lien Debt
—
9.63
%
9.63
%
Trammell, P.C.
Senior Secured First Lien Debt
—
20.00
%
20.00
%
Vesta Holdings, LLC
Senior Secured First Lien Debt
7.00
%
4.00
%
11.00
%
WPLM Acquisition Corp.
Unsecured Note
—
15.00
%
15.00
%
u.
As of December 31, 2021, the index rate for $
4,804
and $
4,892
was 1 Month LIBOR and 3 Month LIBOR, respectively.
v.
The interest rate on these loans is subject to 1 month LIBOR, which as of December 31, 2021 was 0.10%.
w.
The interest rate on these loans is subject to 3 month LIBOR, which as of December 31, 2021 was 0.21%.
x.
The interest rate on these loans is subject to 6 month LIBOR, which as of December 31, 2021 was 0.34%.
See accompanying notes to consolidated financial statements.
25
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Note 1.
Organization and Principal Business
CĪON Investment Corporation, or the Company, was incorporated under the general corporation laws of the State of Maryland on August 9, 2011. On December 17, 2012, the Company successfully raised gross proceeds from unaffiliated outside investors of at least $
2,500
, or the minimum offering requirement, and commenced operations. The Company is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company, or BDC, under the 1940 Act. The Company elected to be treated for federal income tax purposes as a regulated investment company, or RIC, as defined under Subchapter M of the Internal Revenue Code of 1986, as amended, or the Code.
The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation for investors. The Company’s portfolio is comprised primarily of investments in senior secured debt, including first lien loans, second lien loans and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies.
The Company is managed by CION Investment Management, LLC, or CIM, a registered investment adviser and an affiliate of the Company. Pursuant to an investment advisory agreement with the Company, CIM oversees the management of the Company’s activities and is responsible for making investment decisions for the Company’s investment portfolio. On April 5, 2021, the board of directors of the Company, including a majority of the board of directors who are not interested persons, approved the amended and restated investment advisory agreement with CIM for a period of twenty four months, which was subsequently approved by shareholders on August 9, 2021 (as described in further detail below). The Company and CIM previously engaged Apollo Investment Management, L.P., or AIM, a subsidiary of Apollo Global Management, Inc., or, together with its subsidiaries, Apollo, a leading global alternative investment manager, to act as the Company’s investment sub-adviser.
On July 11, 2017, the members of CIM entered into a third amended and restated limited liability company agreement of CIM, or the Third Amended CIM LLC Agreement, for the purpose of creating a joint venture between AIM and CION Investment Group, LLC, or CIG, an affiliate of the Company. Under the Third Amended CIM LLC Agreement, AIM became a member of CIM and was issued a newly-created class of membership interests in CIM pursuant to which AIM, among other things, shares in the profits, losses, distributions and expenses of CIM with the other members in accordance with the terms of the Third Amended CIM LLC Agreement, which results in CIG and AIM each owning a
50
% economic interest in CIM.
On July 10, 2017, the Company’s independent directors unanimously approved the termination of the investment sub-advisory agreement with AIM, effective as of July 11, 2017. Although the investment sub-advisory agreement and AIM's engagement as the Company’s investment sub-adviser were terminated, AIM continues to perform certain services for CIM and the Company. AIM is not paid a separate fee in exchange for such services, but is entitled to receive distributions as a member of CIM as described above.
On December 4, 2017, the members of CIM entered into a fourth amended and restated limited liability company agreement of CIM, or the Fourth Amended CIM LLC Agreement, under which AIM performs certain services for CIM, which include, among other services, providing (a) trade and settlement support; (b) portfolio and cash reconciliation; (c) market pipeline information regarding syndicated deals, in each case, as reasonably requested by CIM; and (d) monthly valuation reports and support for all broker-quoted investments. AIM may also, from time to time, provide the Company with access to potential investment opportunities made available on Apollo's credit platform on a similar basis as other third-party market participants. All of the Company's investment decisions are the sole responsibility of, and are made at the sole discretion of, CIM's investment committee, which consists entirely of CIG senior personnel.
The amended and restated investment advisory agreement was approved by shareholders on August 9, 2021 at the Company’s reconvened 2021 annual meeting of shareholders. As a result, on August 10, 2021, the Company and CIM entered into the amended and restated investment advisory agreement in order to implement the change to the calculation of the subordinated incentive fee payable from the Company to CIM that expresses the hurdle rate required for CIM to earn, and be paid, the incentive fee as a percentage of the Company’s net assets rather than adjusted capital.
On October 5, 2021, the Company's shares of common stock commenced trading on the New York Stock Exchange, or the NYSE, under the ticker symbol "CION", or the Listing. As a result, on October 5, 2021, the Company and CIM entered into the second amended and restated investment advisory agreement in order to implement the changes to the advisory fees payable from the Company to CIM that became effective upon the Listing that (i) reduced the annual base management fee, (ii) amended the structure of the subordinated incentive fee on income payable by the Company to CIM and reduced the hurdle and incentive fee rates, and (iii) reduced the incentive fee on capital gains payable by the Company to CIM (as described in further detail in Notes 2 and 4).
26
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Note 2.
Summary of Significant Accounting Policies
Basis of Presentation and Consolidation
The accompanying unaudited consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and pursuant to the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. For a more complete discussion of significant accounting policies and certain other information, the Company’s interim unaudited consolidated financial statements should be read in conjunction with its audited consolidated financial statements as of December 31, 2021 and for the year then ended included in the Company’s Annual Report on Form 10-K. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year ending December 31, 2022.
The consolidated balance sheet and the consolidated schedule of investments as of December 31, 2021 and the consolidated statements of operations, changes in net assets, and cash flows for the year ended December 31, 2021 are derived from the 2021 audited consolidated financial statements and include the accounts of the Company’s wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company does not consolidate its equity interests in CION SOF Funding, LLC, or CION SOF, or CION/EagleTree Partners, LLC, or CION/EagleTree. See Note 7 for a description of the Company’s investments in CION SOF and CION/EagleTree.
The Company evaluates subsequent events through the date that the consolidated financial statements are issued.
Recently Announced Accounting Pronouncements
In June 2022, the Financial Accounting Standards Board, or the FASB, issued ASU 2022-03,
Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions
, or ASU 2022-03, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2023. The Company is evaluating the potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements.
In March 2020, the FASB issued ASU 2020-04,
Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting
, or ASU 2020-04, which provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU 2020-04 is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is evaluating the potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements.
Cash and Cash Equivalents
Cash and cash equivalents include cash in banks and highly liquid investments with original maturity dates of three months or less. The Company’s cash and cash equivalents are held principally at one financial institution and at times may exceed insured limits. The Company periodically evaluates the creditworthiness of this institution and has not experienced any losses on such deposits.
27
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Foreign Currency Translations
The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the foreign exchange rate on the date of valuation. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.
Short Term Investments
Short term investments include an investment in a U.S. Treasury obligations fund, which seeks to provide current income and daily liquidity by purchasing U.S. Treasury securities and repurchase agreements that are collateralized by such securities. The Company had $
9,804
and $
87,917
of such investments at September 30, 2022 and December 31, 2021, respectively, which are included in investments, at fair value on the accompanying consolidated balance sheets and on the consolidated schedules of investments.
Offering Costs
Offering costs included, among other things, legal fees and other costs pertaining to the preparation of the Company’s registration statements in connection with the continuous public offerings of the Company’s shares. Certain initial offering costs that were funded by CIG on behalf of the Company were submitted by CIG for reimbursement upon meeting the minimum offering requirement on December 17, 2012. These costs were capitalized and amortized over a twelve month period as an adjustment to capital in excess of par value. All other offering costs were expensed as incurred by the Company. The Company's follow-on continuous public offering ended on January 25, 2019.
Income Taxes
The Company elected to be treated for federal income tax purposes as a RIC under Subchapter M of the Code. To qualify and maintain qualification as a RIC, the Company must, among other things, meet certain source of income and asset diversification requirements and distribute to shareholders, for each taxable year, at least 90% of the Company’s “investment company taxable income”, which is generally equal to the sum of the Company’s net ordinary income plus the excess, if any, of realized net short-term capital gains over realized net long-term capital losses. If the Company continues to qualify as a RIC and continues to satisfy the annual distribution requirement, the Company will not be subject to corporate level federal income taxes on any income that the Company distributes to its shareholders. The Company intends to make distributions in an amount sufficient to maintain RIC status each year and to avoid any federal income taxes on income. The Company will also be subject to nondeductible federal excise taxes if the Company does not distribute at least 98.0% of net ordinary income, 98.2% of capital gains, if any, and any recognized and undistributed income from prior years for which it paid no federal income taxes.
Two of the Company’s wholly-owned consolidated subsidiaries, View ITC, LLC and View Rise, LLC, or collectively the Taxable Subsidiaries, have elected to be treated as taxable entities for U.S. federal income tax purposes. As a result, the Taxable Subsidiaries are not consolidated with the Company for income tax purposes and may generate income tax expense or benefit, and the related tax assets and liabilities, as a result of its ownership of certain portfolio investments. The income tax expense or benefit, if any, and the related tax assets and liabilities, where material, are reflected in the Company’s consolidated financial statements. There were no deferred tax assets or liabilities as of September 30, 2022 or December 31, 2021.
Book/tax differences relating to permanent differences are reclassified among the Company’s capital accounts, as appropriate. Additionally, the tax character of distributions is determined in accordance with income tax regulations that may differ from GAAP (see Note 5).
Uncertainty in Income Taxes
The Company evaluates its tax positions to determine if the tax positions taken meet the minimum recognition threshold for the purposes of measuring and recognizing tax liabilities in the consolidated financial statements. Recognition of a tax benefit or liability with respect to an uncertain tax position is required only when the position is “more likely than not” to be sustained assuming examination by the taxing authorities. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statements of operations. The Company did not have any uncertain tax positions during the periods presented herein.
The Company is subject to examination by U.S. federal, New York State, New York City and Maryland income tax jurisdictions for 2018, 2019 and 2020.
28
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
During the first half of 2020, there was a global outbreak of a novel coronavirus, or COVID-19, which spread to over 100 countries, including the United States, and spread to every state in the United States. The World Health Organization designated COVID-19 as a pandemic, and numerous countries, including the United States, declared national emergencies with respect to COVID-19. The global impact of the outbreak has been rapidly evolving, and as cases of COVID-19 continued to be identified in additional countries, many countries reacted by instituting quarantines and restrictions on travel, closing financial markets and/or restricting trading, and limiting operations of non-essential businesses. Although countries, including the United States, have loosened these restrictions, such actions created and will continue to create disruption in global supply chains, and adversely impacted many industries. The outbreak could have a continued adverse impact on economic and market conditions and trigger a period of global economic slowdown. The rapid development and fluidity of this situation precludes any prediction as to the ultimate adverse impact of COVID-19 on economic and market conditions. The Company believes the estimates and assumptions underlying the consolidated financial statements are reasonable and supportable based on the information available as of September 30, 2022; however, uncertainty over the ultimate impact COVID-19 will have on the global economy generally, and the Company’s business in particular, makes any estimates and assumptions as of September 30, 2022 inherently less certain than they would be absent the current and potential impacts of COVID-19, including from new variants, such as Delta and Omicron. Actual results may materially differ from those estimates.
Valuation of Portfolio Investments
The fair value of the Company’s investments is determined quarterly in good faith by the Company’s board of directors pursuant to its consistently applied valuation procedures and valuation process in accordance with Accounting Standards Codification Topic 820, Fair Value Measurements and Disclosure, or ASC 820. In accordance with Rule 2a-5 of the 1940 Act, the Company’s board of directors has designated CIM as the Company’s “valuation designee.” The Company’s board of directors and the audit committee of the board of directors, the latter of which is comprised solely of independent directors, oversees the activities, methodology and processes of the valuation designee. ASC 820 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a three-tier fair value hierarchy that prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Inputs used to measure these fair values are classified into the following hierarchy:
Level 1 -
Quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level 2 -
Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level 3 -
Unobservable inputs for the asset or liability. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes that include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by the disclaimer would result in classification as a Level 3 asset, assuming no additional corroborating evidence.
Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.
Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The level in the fair value hierarchy for each fair value measurement has been determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The level assigned to the investment valuations may not be indicative of the risk or liquidity associated with investing in such investments. Because of the inherent uncertainties of valuation, the values reflected in the consolidated financial statements may differ materially from the value that would be received upon an actual sale of such investments. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses that the Company ultimately realizes on these investments to materially differ from the valuations currently assigned.
29
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
A portion of the Company’s investments consist of debt securities that are traded on a private over-the-counter market for institutional investments. CIM attempts to obtain market quotations from at least two brokers or dealers for each investment (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). CIM typically uses the average midpoint of the broker bid/ask price to determine fair value unless a different point within the range is more representative. Because of the private nature of this marketplace (meaning actual transactions are not publicly reported) and the non-binding nature of consensus pricing and/or quotes, the Company believes that these valuation inputs result in Level 3 classification within the fair value hierarchy. As these quotes are only indicative of fair value, CIM benchmarks the implied fair value yield and leverage against what has been observed in the market. If the implied fair value yield and leverage fall within the range of CIM's market pricing matrix, the quotes are deemed to be reliable and used to determine the investment's fair value.
Notwithstanding the foregoing, if in the reasonable judgment of CIM, the price of any investment held by the Company and determined in the manner described above does not accurately reflect the fair value of such investment, CIM will value such investment at a price that reflects such investment’s fair value and report such change in the valuation to the board of directors or its designee as soon as practicable. Investments that carry certain restrictions on sale will typically be valued at a discount from the public market value of the investment.
Any investments that are not publicly traded or for which a market price is not otherwise readily available are valued at a price that reflects its fair value. With respect to such investments, if CIM is unable to obtain market quotations, the investments are reviewed and valued using one or more of the following types of analyses:
i.
Market comparable statistics and public trading multiples discounted for illiquidity, minority ownership and other factors for companies with similar characteristics.
ii.
Valuations implied by third-party investments in the applicable portfolio companies.
iii.
A benchmarking analysis to compare implied fair value and leverage to comparable market investments.
iv.
Discounted cash flow analysis, including a terminal value or exit multiple.
Determination of fair value involves subjective judgments and estimates. Accordingly, these notes to the Company’s consolidated financial statements refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on the Company’s consolidated financial statements. Below is a description of factors that CIM may consider when valuing the Company’s equity and debt investments where a market price is not readily available:
•
the size and scope of a portfolio company and its specific strengths and weaknesses;
•
prevailing interest rates for like securities;
•
expected volatility in future interest rates;
•
leverage;
•
call features, put features, fees and other relevant terms of the debt;
•
the borrower’s ability to adequately service its debt;
•
the fair market value of the portfolio company in relation to the face amount of its outstanding debt;
•
the quality of collateral securing the Company’s debt investments;
•
multiples of earnings before interest, taxes, depreciation and amortization, or EBITDA, cash flows, net income, revenues or, in some cases, book value or liquidation value; and
•
other factors deemed applicable.
All of these factors may be subject to adjustment based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners, or acquisition, recapitalization, and restructuring expenses or other related or non-recurring items. The choice of analyses and the weight assigned to such factors may vary across investments and may change within an investment if events occur that warrant such a change.
When CIM uses the discounted cash flow model to value the Company's investments, such model deemed appropriate by CIM is prepared for the applicable investments and reviewed by designated members of CIM’s management team. Such models are prepared at least quarterly or on an as needed basis. The model uses the estimated cash flow projections for the underlying investments and an appropriate discount rate is determined based on the latest financial information available for the borrower, prevailing market trends, comparable analysis and other inputs. The model, key assumptions, inputs, and results are reviewed by designated members of CIM’s management team with final approval from the board of directors or its designee.
30
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Consistent with the Company’s valuation policy, the Company evaluates the source of inputs, including any markets in which the Company’s investments are trading, in determining fair value.
The Company periodically benchmarks the broker quotes from the brokers or dealers against the actual prices at which the Company purchases and sells its investments. Based on the results of the benchmark analysis and the experience of the Company’s management in purchasing and selling these investments, the Company believes that these quotes are reliable indicators of fair value. The Company may also use other methods to determine fair value for securities for which it cannot obtain market quotations through brokers or dealers, including the use of an independent valuation firm. Designated members of CIM’s management team and the Company's board of directors or its designee review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation process.
As a practical expedient, the Company used net asset value, or NAV, as the fair value for its equity investments in CION SOF and BCP Great Lakes Fund LP, and the Company uses NAV as the fair value for its equity investments in CION/EagleTree. CION SOF and BCP Great Lakes Fund LP recorded, and CION/EagleTree records, its underlying investments at fair value on a quarterly basis in accordance with ASC 820.
Revenue Recognition
Securities transactions are accounted for on the trade date. The Company records interest and dividend income on an accrual basis beginning on the trade settlement date or the ex-dividend date, respectively, to the extent that the Company expects to collect such amounts. For investments in equity tranches of collateralized loan obligations, the Company records income based on the effective interest rate determined using the amortized cost and estimated cash flows, which is updated periodically. Loan origination fees, original issue discounts, or OID, and market discounts/premiums are recorded and such amounts are amortized as adjustments to interest income over the respective term of the loan using the effective interest rate method. Upon the prepayment of a loan or security, prepayment premiums, any unamortized loan origination fees, OID, or market discounts/premiums are recorded as interest income.
The Company may have investments in its investment portfolio that contain a PIK interest provision. PIK interest is accrued as interest income if the portfolio company valuation indicates that such PIK interest is collectible and recorded as interest receivable up to the interest payment date. On the interest payment dates, the Company will capitalize the accrued interest receivable attributable to PIK as additional principal due from the borrower. Additional PIK securities typically have the same terms, including maturity dates and interest rates, as the original securities. In order to maintain RIC status, substantially all of this income must be paid out to shareholders in the form of distributions, even if the Company has not collected any cash. For additional information on investments that contain a PIK interest provision, see the consolidated schedules of investments as of September 30, 2022 and December 31, 2021.
Loans and debt securities, including those that are individually identified as being impaired under Accounting Standards Codification 310,
Receivables
, or ASC 310, are generally placed on non-accrual status immediately if, in the opinion of management, principal or interest is not likely to be paid, or when principal or interest is past due 90 days or more. Interest accrued but not collected at the date a loan or security is placed on non-accrual status is reversed against interest income. Interest income is recognized on non-accrual loans or debt securities only to the extent received in cash. However, where there is doubt regarding the ultimate collectibility of principal, cash receipts, whether designated as principal or interest, are thereafter applied to reduce the carrying value of the loan or debt security. Loans or securities are restored to accrual status only when interest and principal payments are brought current and future payments are reasonably assured.
Dividend income on preferred equity securities is recorded on an accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.
The Company may receive fees for capital structuring services that are fixed based on contractual terms, are normally paid at the closing of the investment, are generally non-recurring and non-refundable and are recognized as revenue when earned upon closing of the investment. The services that CIM provides vary by investment, but generally include reviewing existing credit facilities, arranging bank financing, arranging equity financing, structuring financing from multiple lenders, structuring financing from multiple equity investors, restructuring existing loans, raising equity and debt capital, and providing general financial advice, which concludes upon closing of the investment. In certain instances where the Company is invited to participate as a co-lender in a transaction and does not provide significant services in connection with the investment, a portion of loan fees paid to the Company in such situations will be deferred and amortized over the estimated life of the loan as interest income.
Other income includes amendment fees that are fixed based on contractual terms and are generally non-recurring and non-refundable and are recognized as revenue when earned upon closing of the transaction. Other income also includes fees for managerial assistance and other consulting services, loan guarantees, commitments, and other services rendered by the Company to its portfolio companies. Such fees are fixed based on contractual terms and are recognized as fee income when earned.
31
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Net Realized Gains or Losses and Net Change in Unrealized Appreciation or Depreciation
Gains or losses on the sale of investments are calculated by using the weighted-average method. The Company measures realized gains or losses by the difference between the net proceeds from the sale and the weighted-average amortized cost of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized upfront fees. Net change in unrealized appreciation or depreciation reflects the change in portfolio investment values during the reporting period, including any reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.
Capital Gains Incentive Fee
Pursuant to the terms of the investment advisory agreement the Company entered into with CIM, the incentive fee on capital gains earned on liquidated investments of the Company’s investment portfolio during operations is determined and payable in arrears as of the end of each calendar year. Prior to October 5, 2021 and under the investment advisory agreement, such fee equaled
20
% of the Company’s incentive fee capital gains (i.e., the Company’s realized capital gains on a cumulative basis from inception, calculated as of the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis), less the aggregate amount of any previously paid capital gains incentive fees. Pursuant to the second amended and restated investment advisory agreement, the incentive fee on capital gains was reduced to
17.5
%, which became effective on October 5, 2021.
On a cumulative basis and to the extent that all realized capital losses and unrealized capital depreciation exceed realized capital gains as well as the aggregate realized net capital gains for which a fee has previously been paid, the Company would not be required to pay CIM a capital gains incentive fee. On a quarterly basis, the Company accrues for the capital gains incentive fee by calculating such fee as if it were due and payable as of the end of such period.
While the investment advisory agreement with CIM neither includes nor contemplates the inclusion of unrealized gains in the calculation of the capital gains incentive fee, pursuant to an interpretation of the American Institute for Certified Public Accountants, or AICPA, Technical Practice Aid for investment companies, the Company accrues capital gains incentive fees on unrealized gains. This accrual reflects the incentive fees that would be payable to CIM if the Company’s entire investment portfolio was liquidated at its fair value as of the balance sheet date even though CIM is not entitled to an incentive fee with respect to unrealized gains unless and until such gains are actually realized.
Net Increase in Net Assets per Share
Net increase in net assets per share is calculated based upon the daily weighted average number of shares of common stock outstanding during the reporting period.
Distributions
Distributions to shareholders are recorded as of the record date. The amount paid as a distribution is declared by the Company's co-chief executive officers and ratified by the board of directors on a quarterly basis. Net realized capital gains, if any, are distributed at least annually.
Note 3.
Share Transactions
The Company’s initial continuous public offering commenced on July 2, 2012 and ended on December 31, 2015. The Company’s follow-on continuous public offering commenced on January 25, 2016 and ended on January 25, 2019.
The following table summarizes transactions with respect to shares of the Company’s outstanding common stock during the nine months ended September 30, 2022 and 2021 and the year ended December 31, 2021:
Nine Months Ended
September 30,
Year Ended
December 31,
2022
2021
2021
Shares
Amount
Shares
Amount
Shares
Amount
Gross shares/proceeds from the offering
—
$
—
—
$
—
—
$
—
Reinvestment of distributions
—
—
970,223
15,489
970,223
15,489
Total gross shares/proceeds
—
—
970,223
15,489
970,223
15,489
Sales commissions and dealer manager fees
—
—
—
—
—
—
Net shares/proceeds
—
—
970,223
15,489
970,223
15,489
Share repurchase program
(
695,476
)
(
6,711
)
(
658,650
)
(
10,467
)
(
658,650
)
(
10,467
)
Net shares/proceeds from share transactions
(
695,476
)
$
(
6,711
)
311,573
$
5,022
311,573
$
5,022
32
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Since commencing its initial continuous public offering on July 2, 2012 and through September 30, 2022, the Company sold
56,262,964
shares of common stock for net proceeds of $
1,153,596
at an average price per share of $
20.50
. The net proceeds include gross proceeds received from reinvested shareholder distributions of $
237,451
, for which the Company issued
13,523,489
shares of common stock, and gross proceeds paid for shares of common stock repurchased of $
239,141
, for which the Company repurchased
14,006,403
shares of common stock. As of September 30, 2022,
13,896,150
shares of common stock repurchased had been retired.
On September 15, 2022, the Company's shareholders approved a proposal that authorizes the Company to issue shares of its common stock at prices below the then current NAV per share of the Company’s common stock in one or more offerings for a
12
-month period following such shareholder approval. As of September 30, 2022, the Company has not issued any such shares.
Distribution Reinvestment Plan
In connection with the Listing of its shares of common stock on the NYSE, on September 15, 2021, the Company terminated its previous fifth amended and restated distribution reinvestment plan, or the Old DRP. The final distribution reinvestment under the Old DRP was made as part of the regular monthly distribution paid on September 14, 2021 to shareholders of record as of September 13, 2021. On September 15, 2021, the Company adopted a new distribution reinvestment plan, or the New DRP, which became effective as of the Listing, and first applied to the reinvestment of distributions paid after October 5, 2021. For additional information regarding the terms of the New DRP, see Note 5.
Reverse Stock Split
Effective on September 21, 2021, every two shares of the Company's common stock then issued and outstanding were automatically combined into one share of the Company's common stock, with the number of issued and outstanding shares reduced from
113,916,869
to
56,958,440
. The reverse stock split amendment also provided that there was no change in the par value of $
0.001
per share as a result of the reverse stock split. In addition, the reverse stock split did not modify the rights or preferences of the Company’s common stock.
Listing and Fractional Shares
On October 5, 2021, the Company's shares of common stock commenced trading on the NYSE under the ticker symbol “CION”. As approved by shareholders on September 7, 2021 at the Company’s final, reconvened 2021 annual meeting of shareholders, the Listing was staggered such that (i) up to 1/3rd of shares held by all shareholders were available for trading upon Listing, (ii) up to 2/3rd of shares held by all shareholders were available for trading starting
180
days after Listing, or April 4, 2022, and (iii) all shares were available for trading starting
270
days after Listing, or July 5, 2022. The Company eliminated all then outstanding fractional shares of its common stock in connection with the Listing, as permitted by the Maryland General Corporation Law, on July 14, 2022.
Pre-Listing Share Repurchase Program
Historically, the Company offered to repurchase shares on a quarterly basis on such terms as determined by the Company’s board of directors in its complete and absolute discretion unless, in the judgment of the independent directors of the Company’s board of directors, such repurchases would not have been in the best interests of the Company’s shareholders or would have violated applicable law.
On July 30, 2021, the Company's board of directors, including the independent directors, determined to suspend the Company's share repurchase program commencing with the third quarter of 2021 in anticipation of the Listing and the concurrent enhanced liquidity the Listing was expected to provide. The share repurchase program ultimately terminated upon the Listing and the Company does not expect to implement a new quarterly share repurchase program in the future.
Historically, the Company generally limited the number of shares to be repurchased during any calendar year to the number of shares it could have repurchased with the proceeds it received from the issuance of shares pursuant to the Old DRP. At the discretion of the Company’s board of directors, it could have also used cash on hand, cash available from borrowings and cash from liquidation of investments as of the end of the applicable period to repurchase shares. The Company offered to repurchase such shares at a price equal to the estimated net asset value per share on each date of repurchase.
Any periodic repurchase offers were subject in part to the Company’s available cash and compliance with the BDC and RIC qualification and diversification rules promulgated under the 1940 Act and the Code, respectively.
33
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Post-Listing Share Repurchase Policy
On September 15, 2021, the Company’s board of directors, including the independent directors, approved a share repurchase policy authorizing the Company to repurchase up to $
50
million of its outstanding common stock after the Listing. On June 24, 2022, the Company’s board of directors, including the independent directors, increased the amount of shares of the Company’s common stock that may be repurchased under the share repurchase policy by $
10
million to up to an aggregate of $
60
million. Under the share repurchase policy, the Company may purchase shares of its common stock through various means such as open market transactions, including block purchases, and privately negotiated transactions. The number of shares repurchased and the timing, manner, price and amount of any repurchases will be determined at the Company's discretion. Factors include, but are not limited to, share price, trading volume and general market conditions, along with the Company’s general business conditions. The policy may be suspended or discontinued at any time and does not obligate the Company to acquire any specific number of shares of its common stock.
On August 16, 2022, as part of the share repurchase policy, the Company entered into a trading plan with an independent broker, Wells Fargo Securities, LLC, or Wells Fargo, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, based in part on historical trading data with respect to the Company’s shares. The 10b5-1 trading plan permits common stock to be repurchased at a time that the Company might otherwise be precluded from doing so under insider trading laws or self-imposed trading restrictions. The 10b5-1 trading plan is subject to price, market volume and timing restrictions.
The following table summarizes the share repurchases completed during the year ended December 31, 2021 and the nine months ended September 30, 2022:
Three Months Ended
Repurchase Date
Shares Repurchased(1)
Percentage of Shares Tendered That Were Repurchased
Repurchase Price Per Share(1)
Aggregate Consideration for Repurchased Shares
2021
March 31, 2021
March 24, 2021
337,731
6
%
$
15.67
$
5,291
June 30, 2021
June 23, 2021
320,127
7
%
16.13
5,163
September 30, 2021(2)
N/A
792
N/A
16.13
13
December 31, 2021
N/A
—
N/A
N/A
—
Total for the year ended December 31, 2021
658,650
$
10,467
2022
March 31, 2022
N/A
—
N/A
N/A
$
—
June 30, 2022
N/A
—
N/A
N/A
—
September 30, 2022
N/A
695,476
N/A
9.65
6,711
Total for the year ended December 31, 2022
695,476
$
6,711
(1)
Shares repurchased and repurchase price per share have been retroactively adjusted to reflect the two to one reverse stock split as discussed in this Note 3.
(2)
Represents an adjustment made during the three months ended September 30, 2021 to shares repurchased during the three months ended June 30, 2021. The Company suspended its share repurchase program on July 30, 2021 as discussed in this Note 3.
From October 1, 2022 to November 3, 2022, the Company repurchased
836,218
shares of common stock under the 10b5-1 trading plan for an aggregate purchase price of $
7,500
, or an average purchase price of $
8.97
per share. As of November 3, 2022,
14,644,205
shares of common stock repurchased by the Company had been retired.
34
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Note 4.
Transactions with Related Parties
For the three and nine months ended September 30, 2022 and 2021 and the year ended December 31, 2021, fees and other expenses incurred by the Company related to CIM and its affiliates were as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
Year Ended December 31,
Entity
Capacity
Description
2022
2021
2022
2021
2021
CIM
Investment adviser
Management fees(1)
$
6,942
$
8,443
$
20,436
$
24,469
$
31,143
CIM
Investment adviser
Incentive fees(1)
5,421
2,933
13,645
2,933
6,875
CIM
Administrative services provider
Administrative services expense(1)
733
722
2,234
2,103
3,069
Apollo Investment Administration, L.P.
Administrative services provider
Transaction costs(1)
—
10
—
95
105
$
13,096
$
12,108
$
36,315
$
29,600
$
41,192
(1)
Amounts charged directly to operations.
The Company has entered into an investment advisory agreement with CIM. On April 5, 2021, the board of directors of the Company, including a majority of the board of directors who are not interested persons, approved the amended and restated investment advisory agreement with CIM for a period of
twenty four months
, which was subsequently approved by shareholders on August 9, 2021. Pursuant to the investment advisory agreement, CIM was paid an annual base management fee equal to
2.0
% of the average value of the Company’s gross assets, less cash and cash equivalents, and an incentive fee based on the Company’s performance, as described below. Pursuant to the second amended and restated investment advisory agreement, which was effective upon the Listing on October 5, 2021, the annual base management fee was reduced to
1.5
% of the average value of the Company’s gross assets (including cash pledged as collateral for the Company’s secured financing arrangements, but excluding other cash and cash equivalents so that investors do not pay the base management fee on such assets), to the extent that the Company’s asset coverage ratio is greater than or equal to
200
% (i.e., $1 of debt outstanding for each $1 of equity); provided that, the annual base management fee will be reduced further to
1.0
% for any such gross assets purchased with leverage resulting in the Company’s asset coverage ratio dropping below
200
%. At the Special Meeting of Shareholders on December 30, 2021, shareholders approved a proposal to reduce the Company’s asset coverage ratio to
150
%. As a result, commencing on December 31, 2021, the Company is required to maintain asset coverage for its senior securities of
150
% (i.e., $2 of debt outstanding for each $1 of equity) rather than
200
%. The base management fee is payable quarterly in arrears and is calculated based on the two most recently completed calendar quarters.
The incentive fee consists of two parts. The first part, which is referred to as the subordinated incentive fee on income, is calculated and payable quarterly in arrears based on “pre-incentive fee net investment income” for the immediately preceding quarter and was subject to a hurdle rate, measured quarterly and expressed as a rate of return on adjusted capital, as defined in the investment advisory agreement, equal to
1.875
% per quarter, or an annualized rate of
7.5
%. Under the investment advisory agreement, the Company paid to CIM
100
% of pre-incentive fee net investment income once the hurdle rate was exceeded until the annualized rate of
9.375
% was exceeded, at which point the Company paid to CIM
20
% of all pre-incentive fee net investment income that exceeded the annualized rate of
9.375
%. Under the amended and restated investment advisory agreement, the change to the calculation of the subordinated incentive fee payable to CIM that expresses the hurdle rate required for CIM to earn, and be paid, the incentive fee as a percentage of the Company's net assets rather than adjusted capital was implemented. Under the second amended and restated investment advisory agreement, the hurdle rate was reduced to
1.625
% per quarter, or an annualized rate of
6.5
%, and the Company pays to CIM
100
% of pre-incentive fee net investment income once the hurdle rate is exceeded until the annualized rate of
7.879
% is exceeded, at which point the Company pays to CIM
17.5
% of all pre-incentive fee net investment income. These changes to the subordinated incentive fee on income were effective upon the Listing, except for the change to the calculation of the subordinated incentive fee payable to CIM that replaced adjusted capital with the Company's net assets, which was effective on August 10, 2021. For the three months ended September 30, 2022 and 2021, the Company recorded subordinated incentive fees on income of $
5,421
and $
2,933
, respectively. As of September 30, 2022 and December 31, 2021, the liabilities recorded for subordinated incentive fees were $
5,421
and $
3,942
, respectively. The second part of the incentive fee, which is referred to as the capital gains incentive fee, is described in Note 2.
The Company accrues the capital gains incentive fee based on net realized gains and net unrealized appreciation; however, under the terms of the investment advisory agreement, the fee payable to CIM is based on net realized gains and unrealized depreciation and no such fee is payable with respect to unrealized appreciation unless and until such appreciation is actually realized. For the three and nine months ended September 30, 2022 and 2021 and the year ended December 31, 2021, the Company had no liability for and did not record any capital gains incentive fees.
35
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
On April 1, 2018, the Company entered into an administration agreement with CIM pursuant to which CIM furnishes the Company with administrative services including accounting, investor relations and other administrative services necessary to conduct its day-to-day operations. CIM is reimbursed for administrative expenses it incurs on the Company’s behalf in performing its obligations, provided that such reimbursement is for the lower of CIM’s actual costs or the amount that the Company would have been required to pay for comparable administrative services in the same geographic location. Such costs are reasonably allocated to the Company on the basis of assets, revenues, time records or other reasonable methods. The Company does not reimburse CIM for any services for which it receives a separate fee or for rent, depreciation, utilities, capital equipment or other administrative items allocated to a person with a controlling interest in CIM. On November 8, 2022, the board of directors of the Company, including a majority of the board of directors who are not interested persons, approved the renewal of the administration agreement with CIM for a period of twelve months commencing December 17, 2022.
On January 1, 2019, the Company entered into a servicing agreement with CIM’s affiliate, Apollo Investment Administration, L.P., or AIA, pursuant to which AIA furnishes the Company with administrative services including, but not limited to, loan and high yield trading services, trade and settlement support, and monthly valuation reports and support for all broker quoted investments. AIA is reimbursed for administrative expenses it incurs on the Company’s behalf in performing its obligations, provided that such reimbursement is reasonable, and costs and expenses incurred are documented. The servicing agreement may be terminated at any time, without the payment of any penalty, by either party, upon
60
days' written notice to the other party.
On January 30, 2013, the Company entered into the expense support and conditional reimbursement agreement with CIG, whereby CIG agreed to provide expense support to the Company in an amount that was sufficient to: (1) ensure that no portion of the Company’s distributions to shareholders was paid from its offering proceeds or borrowings, and/or (2) reduce the Company’s operating expenses until it achieved economies of scale sufficient to ensure that the Company bore a reasonable level of expense in relation to its investment income. On December 16, 2015, the Company further amended and restated the expense support and conditional reimbursement agreement for purposes of including AIM as a party to the agreement. On January 2, 2018, the Company entered into an expense support and conditional reimbursement agreement with CIM for purposes of, among other things, replacing CIG and AIM with CIM as the expense support provider pursuant to the terms of the expense support and conditional reimbursement agreement.
Pursuant to the expense support and conditional reimbursement agreement, the Company had a conditional obligation to reimburse CIM for any amounts funded by CIM under such agreement (i) if expense support amounts funded by CIM exceeded operating expenses incurred during any fiscal quarter, (ii) if the sum of the Company’s net investment income for tax purposes, net capital gains and the amount of any dividends and other distributions paid to the Company on account of investments in portfolio companies (to the extent not included in net investment income or net capital gains for tax purposes) exceeded the distributions paid by the Company to shareholders, and (iii) during any fiscal quarter that occurred within
three years
of the date on which CIM funded such amount. The obligation to reimburse CIM for any expense support provided by CIM under such agreement was further conditioned by the following: (i) in the period in which reimbursement was sought, the ratio of operating expenses to average net assets, when considering the reimbursement, could not have exceeded the ratio of operating expenses to average net assets, as defined, for the period when the expense support was provided; (ii) in the period when reimbursement was sought, the annualized distribution rate could not have fallen below the annualized distribution rate for the period when the expense support was provided; and (iii) the expense support could have only been reimbursed within
three years
from the date the expense support was provided.
Expense support, if any, was determined as appropriate to meet the objectives of the expense support and conditional reimbursement agreement. On December 31, 2021, the Company and CIM allowed the expense support and conditional reimbursement agreement to expire in accordance with its terms. There was no unreimbursed expense support funded by CIM upon such expiration. The specific amount of expense support provided by CIM, if any, was determined at the end of each quarter. For the three and nine months ended September 30, 2021 and the year ended December 31, 2021, the Company did not receive any expense support from CIM. See Note 5 for additional information on the sources of the Company’s distributions. The Company did not record any obligation to repay expense support from CIM and the Company did not repay any expense support to CIM during the three and nine months ended September 30, 2022 and 2021 or the year ended December 31, 2021.
As of September 30, 2022 and December 31, 2021, the total liability payable to CIM and its affiliates was $
13,090
and $
12,332
, respectively, which primarily related to fees earned by CIM during the three months ended September 30, 2022 and December 31, 2021, respectively.
In the event that CIM undertakes to provide investment advisory services to other clients in the future, it will strive to allocate investment opportunities in a fair and equitable manner consistent with the Company’s investment objective and strategies so that the Company will not be disadvantaged in relation to any other client of the investment adviser or its senior management team. However, it is currently possible that some investment opportunities will be provided to other clients of CIM rather than to the Company.
Indemnifications
The investment advisory agreement, the administration agreement and the dealer manager agreement each provide certain indemnifications from the Company to the other relevant parties to such agreements. The Company’s maximum exposure under these agreements is unknown. However, the Company has not experienced claims or losses pursuant to these agreements and believes the risk of loss related to such indemnifications to be remote.
36
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Note 5.
Distributions
From February 1, 2014 through July 17, 2017, the Company’s board of directors authorized and declared on a monthly basis a weekly distribution amount per share of common stock. On July 18, 2017, the Company's board of directors authorized and declared on a quarterly basis a weekly distribution amount per share of common stock. Effective September 28, 2017, the Company's board of directors delegated to management the authority to determine the amount, record dates, payment dates and other terms of distributions to shareholders, which will be ratified by the board of directors, each on a quarterly basis. Beginning on March 19, 2020, management changed the timing of declaring distributions from quarterly to monthly and temporarily suspended the payment of distributions to shareholders commencing with the month ended April 30, 2020, whether in cash or pursuant to the Old DRP. On July 15, 2020, the board of directors determined to recommence the payment of distributions to shareholders in August 2020. On September 15, 2021, management changed the timing of declaring and paying regular distributions to shareholders from monthly to quarterly commencing with the fourth quarter of 2021. Distributions in respect of future quarters will be evaluated by management and the board of directors based on circumstances and expectations existing at the time of consideration. Declared distributions are paid quarterly.
The Company’s board of directors declared or ratified distributions for 11 and 3 record dates during the year ended December 31, 2021 and the nine months ended September 30, 2022, respectively.
The following table presents distributions per share that were declared during the year ended December 31, 2021 and the nine months ended September 30, 2022:
Distributions
Three Months Ended
Per Share
Amount
2021
March 31, 2021 (three record dates)(1)
$
0.2648
$
15,029
June 30, 2021 (three record dates)(1)
0.2648
15,000
September 30, 2021 (three record dates)
0.2648
15,027
December 31, 2021 (two record dates)
0.4648
26,474
Total distributions for the year ended December 31, 2021
$
1.2592
$
71,530
2022
March 31, 2022 (one record date)
$
0.2800
$
15,948
June 30, 2022 (one record date)
0.2800
15,949
September 30, 2022 (one record date)
0.3100
17,604
Total distributions for the nine months ended September 30, 2022
$
0.8700
$
49,501
(1) The per share distribution amount has been retroactively adjusted to reflect the reverse stock split as discussed in Note 3.
On November 8, 2022, the Company’s co-chief executive officers declared a regular quarterly distribution of $
0.31
per share for the fourth quarter of 2022 payable on December 8, 2022 to shareholders of record as of December 1, 2022.
In connection with the Listing of its shares of common stock on the NYSE, on September 15, 2021, the Company terminated the Old DRP. The final distribution reinvestment under the Old DRP was made as part of the regular monthly distribution paid on September 14, 2021 to shareholders of record as of September 13, 2021. On September 15, 2021, the Company adopted the New DRP, which became effective as of the Listing and first applied to the reinvestment of distributions paid on December 8, 2021.
Under the Old DRP and prior to the Listing, distributions to participating shareholders who “opted in” to the Old DRP were reinvested in additional shares of the Company's common stock at a purchase price equal to the estimated net asset value per share of common stock as of the date of issuance.
37
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Upon the Listing, all shareholders were automatically enrolled in the New DRP and will receive distributions as declared by the Company in additional shares of its common stock unless such shareholder affirmatively elects to receive an entire distribution in cash by notifying (i) such shareholder’s financial adviser; or (ii) if such shareholder has a registered account maintained at the Company’s transfer agent, the plan administrator. With respect to distributions to participating shareholders under the New DRP, the Company reserves the right to either issue new shares or cause the plan administrator to purchase shares in the open market in connection with implementation of the New DRP. Unless the Company, in its sole discretion, otherwise directs DST Asset Management Solutions, Inc., the plan administrator, (A) if the per share “market price” (as defined in the New DRP) is equal to or greater than the estimated net asset value per share on the payment date for the distribution, then the Company will issue shares at the greater of (i) the estimated net asset value or (ii)
95
% of the market price, or (B) if the market price is less than the estimated net asset value, then, in the Company’s sole discretion, (i) shares will be purchased in open market transactions for the accounts of participating shareholders to the extent practicable, or (ii) the Company will issue shares at the estimated net asset value. Pursuant to the terms of the New DRP, the number of shares to be issued to a participating shareholder will be determined by dividing the total dollar amount of the distribution payable to a participating shareholder by the price per share at which the Company issues such shares; provided, however, that shares purchased in open market transactions by the plan administrator will be allocated to a participating shareholder based on the weighted average purchase price, excluding any brokerage charges or other charges, of all shares purchased in the open market with respect to such distribution.
If a shareholder receives distributions in the form of common stock pursuant to the New DRP, such shareholder generally will be subject to the same federal, state and local tax consequences as if they elected to receive distributions in cash. If the Company’s common stock is trading at or below net asset value, a shareholder receiving distributions in the form of additional common stock will be treated as receiving a distribution in the amount of cash that such shareholder would have received if they had elected to receive the distribution in cash. If the Company’s common stock is trading above net asset value, a shareholder receiving distributions in the form of additional common stock will be treated as receiving a distribution in the amount of the fair market value of the Company’s common stock. The shareholder’s basis for determining gain or loss upon the sale of common stock received in a distribution will be equal to the total dollar amount of the distribution payable to the shareholder. Any stock received in a distribution will have a holding period for tax purposes commencing on the day following the day on which the shares of common stock are credited to the shareholder’s account.
The Company may fund its distributions to shareholders from any sources of funds available to the Company, including borrowings, net investment income from operations, capital gains proceeds from the sale of assets, non-capital gains proceeds from the sale of assets, and dividends or other distributions paid to it on account of preferred and common equity investments in portfolio companies. Any such distributions can only be sustained if the Company maintains positive investment performance in future periods. There can be no assurances that the Company will maintain such performance in order to sustain these distributions or be able to pay distributions at all. On December 31, 2021, the Company and CIM allowed the expense support and conditional reimbursement agreement to expire in accordance with its terms. As a result, CIM has no obligation to provide expense support to the Company in future periods. For the three months ended September 30, 2021 and the year ended December 31, 2021, none of the Company's distributions resulted from expense support from CIM. The Company has not established limits on the amount of funds it may use from available sources to make distributions.
The following table reflects the sources of distributions on a GAAP basis that the Company has declared on its shares of common stock during the nine months ended September 30, 2022 and 2021 and the year ended December 31, 2021:
Nine Months Ended
September 30,
Year Ended
December 31,
2022
2021
2021
Source of Distribution
Per Share
Amount
Percentage
Per Share(1)
Amount
Percentage
Per Share
Amount
Percentage
Net investment income
$
0.8700
$
49,501
100.0
%
$
0.7944
$
45,056
100.0
%
$
1.2592
$
71,530
100.0
%
Total distributions
$
0.8700
$
49,501
100.0
%
$
0.7944
$
45,056
100.0
%
$
1.2592
$
71,530
100.0
%
(1) The per share amount has been retroactively adjusted to reflect the reverse stock split as discussed in Note 3.
It is the Company's policy to comply with all requirements of the Code applicable to RICs and to distribute at least 90% of its taxable income to its shareholders. In addition, by distributing during each calendar year at least 90% of its “investment company taxable income”, which is generally equal to the sum of the Company’s net ordinary income plus the excess, if any, of realized net short-term capital gains over realized net long-term capital losses, the Company intends not to be subject to corporate level federal income tax. Accordingly, no federal income tax provision was required for the year ended December 31, 2021. The Company will also be subject to nondeductible federal excise taxes of 4% if the Company does not distribute at least 98.0% of net ordinary income, 98.2% of capital gains, if any, and any recognized and undistributed income from prior years for which it paid no federal income taxes.
38
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Income and capital gain distributions are determined in accordance with the Code and federal tax regulations, which may differ from amounts determined in accordance with GAAP. These book/tax differences, which could be material, are primarily due to differing treatments of income and gains on various investments held by the Company. Permanent book/tax differences result in reclassifications to capital in excess of par value, accumulated undistributed net investment income and accumulated undistributed realized gain on investments.
The determination of the tax attributes of the Company’s distributions is made annually as of the end of the Company’s fiscal year based upon the Company’s taxable income for the full year and distributions paid for the full year. The tax characteristics of distributions to shareholders are reported to shareholders annually on Form 1099-DIV. All distributions for 2021 were characterized as ordinary income distributions for federal income tax purposes.
The tax components of accumulated earnings for the current year will be determined at year end. As of December 31, 2021, the components of accumulated losses on a tax basis were as follows:
December 31, 2021
Undistributed ordinary income
$
7,156
Other accumulated losses
(
59,977
)
Net unrealized depreciation on investments
(
76,059
)
Total accumulated losses
$
(
128,880
)
As of September 30, 2022, the aggregate gross unrealized appreciation for all securities in which there was an excess of value over tax cost was $
40,806
; the aggregate gross unrealized depreciation for all securities in which there was an excess of tax cost over value was $
126,757
; the net unrealized depreciation was $
85,951
; and the aggregate cost of securities for Federal income tax purposes was $
1,892,999
.
As of December 31, 2021, the aggregate gross unrealized appreciation for all securities in which there was an excess of value over tax cost was $
28,028
; the aggregate gross unrealized depreciation for all securities in which there was an excess of tax cost over value was $
104,087
; the net unrealized depreciation was $
76,059
; and the aggregate cost of securities for Federal income tax purposes was $
1,830,098
.
39
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Note 6.
Investments
The composition of the Company’s investment portfolio as of September 30, 2022 and December 31, 2021 at amortized cost and fair value was as follows:
September 30, 2022
December 31, 2021
Cost(1)
Fair
Value
Percentage of
Investment
Portfolio
Cost(1)
Fair
Value
Percentage of
Investment
Portfolio
Senior secured first lien debt
$
1,690,919
$
1,616,352
89.8
%
$
1,564,891
$
1,526,989
91.6
%
Senior secured second lien debt
40,988
38,716
2.2
%
55,455
38,583
2.3
%
Collateralized securities and structured products - equity
2,733
1,366
0.1
%
3,885
2,998
0.2
%
Unsecured debt
28,738
28,319
1.6
%
26,777
26,616
1.6
%
Equity
78,795
112,491
6.3
%
53,379
70,936
4.3
%
Subtotal/total percentage
1,842,173
1,797,244
100.0
%
1,704,387
1,666,122
100.0
%
Short term investments(2)
9,804
9,804
87,917
87,917
Total investments
$
1,851,977
$
1,807,048
$
1,792,304
$
1,754,039
(1)
Cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, for debt investments and cost for equity investments.
(2)
Short term investments represent an investment in a fund that invests in highly liquid investments with average original maturity dates of three months or less.
40
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
The following tables show the composition of the Company’s investment portfolio by industry classification and geographic dispersion, and the percentage, by fair value, of the total investment portfolio assets in such industries and geographies as of September 30, 2022 and December 31, 2021:
September 30, 2022
December 31, 2021
Industry Classification
Investments at
Fair Value
Percentage of
Investment Portfolio
Investments at
Fair Value
Percentage of
Investment Portfolio
Services: Business
$
354,725
19.7
%
$
240,316
14.4
%
Healthcare & Pharmaceuticals
279,102
15.5
%
250,049
15.0
%
Media: Diversified & Production
159,236
8.9
%
139,399
8.4
%
Services: Consumer
117,340
6.5
%
119,365
7.2
%
Diversified Financials
106,426
5.9
%
101,032
6.1
%
High Tech Industries
81,364
4.5
%
65,544
3.9
%
Media: Advertising, Printing & Publishing
78,855
4.4
%
94,610
5.7
%
Chemicals, Plastics & Rubber
66,927
3.7
%
109,860
6.6
%
Retail
64,919
3.6
%
56,726
3.4
%
Energy: Oil & Gas
62,688
3.5
%
32,164
1.9
%
Consumer Goods: Durable
61,165
3.4
%
58,124
3.5
%
Hotel, Gaming & Leisure
53,065
3.0
%
50,855
3.0
%
Beverage, Food & Tobacco
49,641
2.8
%
49,054
2.9
%
Construction & Building
42,060
2.3
%
27,585
1.7
%
Capital Equipment
41,183
2.3
%
82,795
5.0
%
Banking, Finance, Insurance & Real Estate
39,631
2.2
%
40,634
2.4
%
Aerospace & Defense
38,683
2.2
%
38,279
2.3
%
Consumer Goods: Non-Durable
35,647
2.0
%
45,682
2.7
%
Telecommunications
18,842
1.0
%
24,649
1.5
%
Automotive
17,259
1.0
%
14,367
0.9
%
Metals & Mining
16,202
0.9
%
10,927
0.7
%
Transportation: Cargo
12,284
0.7
%
14,106
0.8
%
Subtotal/total percentage
1,797,244
100.0
%
1,666,122
100.0
%
Short term investments
9,804
87,917
Total investments
$
1,807,048
$
1,754,039
September 30, 2022
December 31, 2021
Geographic Dispersion(1)
Investments at
Fair Value
Percentage of
Investment Portfolio
Investments at
Fair Value
Percentage of
Investment Portfolio
United States
$
1,787,828
99.5
%
$
1,653,615
99.3
%
Canada
7,414
0.4
%
8,739
0.5
%
Cayman Islands
1,366
0.1
%
2,998
0.2
%
Bermuda
636
—
770
—
Subtotal/total percentage
1,797,244
100.0
%
1,666,122
100.0
%
Short term investments
9,804
87,917
Total investments
$
1,807,048
$
1,754,039
(1)
The geographic dispersion is determined by the portfolio company's country of domicile.
As of September 30, 2022 and December 31, 2021, investments on non-accrual status represented
0.4
% and
0.7
%, respectively, of the Company's investment portfolio on a fair value basis.
The Company’s investment portfolio may contain senior secured investments that are in the form of lines of credit, delayed draw term loans, revolving credit facilities, or unfunded commitments, which may require the Company to provide funding when requested in accordance with the terms of the underlying agreements. As of September 30, 2022 and December 31, 2021, the Company’s unfunded commitments amounted to $
83,853
and $
107,247
, respectively. As of November 3, 2022, the Company’s unfunded commitments amounted to $
80,966
. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. Refer to Note 11 for further details on the Company’s unfunded commitments.
41
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Note 7.
Joint Ventures
CION/EagleTree Partners, LLC
On December 21, 2021, the Company formed CION/EagleTree, an off-balance sheet joint venture partnership with ET-BC Debt Opportunities, LP, or ET-BC, which is an affiliate of EagleTree Capital, LP, or EagleTree. EagleTree made a Firm-level investment with proprietary capital. CION/EagleTree will jointly pursue debt opportunities and special situation, crossover, subordinated and other junior capital investments that leverage the Company's and EagleTree's combined sourcing and portfolio management capabilities.
The Company contributed a portfolio of second lien loans and equity investments and ET-BC contributed proprietary Firm-level cash in exchange for
85
% and
15
%, respectively, of the senior secured notes, participating preferred equity, and common share interests of CION/EagleTree. The Company and ET-BC are not required to make any additional capital contributions to CION/EagleTree. The Company’s equity investment in CION/EagleTree is not redeemable. All portfolio and other material decisions regarding CION/EagleTree must be submitted to its board of managers, which is comprised of
four
members,
two
of whom were selected by the Company and the other
two
were selected by ET-BC. Further, all portfolio and other material decisions require the affirmative vote of at least
one
board member from the Company and
one
board member from ET-BC.
The Company also serves as administrative agent to CION/EagleTree to provide servicing functions and other administrative services. In certain cases, these servicing functions and other administrative services may be performed by CIM.
On December 21, 2021, CION/EagleTree issued senior secured notes of $
61,629
to the Company and $
10,875
to ET-BC, or the CION/EagleTree Notes. The CION/EagleTree Notes bear interest at a fixed rate of
14.0
% per year and are secured by a first priority security interest in all of the assets of CION/EagleTree. The obligations of CION/EagleTree under the CION/EagleTree Notes are non-recourse to the Company.
In accordance with ASU 2015-02, Consolidation, the Company determined that CION/EagleTree is not a variable interest entity, or VIE. However, the Company is not the primary beneficiary and therefore does not consolidate CION/EagleTree. The Company's maximum exposure to losses from CION/EagleTree is limited to its investment in CION/EagleTree.
42
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
The following table sets forth the individual investments in CION/EagleTree's portfolio as of September 30, 2022:
Portfolio Company
Interest(a)
Maturity
Industry
Principal/
Par Amount/
Units
Cost(b)
Fair
Value
Senior Secured First Lien Debt
Berlitz Holdings, Inc.(g)
S+
900
,
1.00
% SOFR Floor
2/14/2025
Services: Business
$
1,200
$
1,118
$
1,143
Community Tree Service, LLC(h)
S+
850
,
1.00
% SOFR Floor
6/17/2027
Construction & Building
500
500
498
Future Pak, LLC(e)
L+
800
,
2.00
% LIBOR Floor
7/2/2024
Healthcare & Pharmaceuticals
1,559
1,543
1,524
Total Senior Secured First Lien Debt
3,161
3,165
Senior Secured Second Lien Debt
Access CIG, LLC(f)
L+
775
,
0.00
% LIBOR Floor
2/27/2026
Services: Business
7,250
7,219
6,915
Dayton Superior Corp.(e)
L+
700
,
2.00
% LIBOR Floor
12/4/2024
Construction & Building
1,014
1,015
1,008
MedPlast Holdings, Inc.(e)
L+
775
,
0.00
% LIBOR Floor
7/2/2026
Healthcare & Pharmaceuticals
6,750
6,103
6,218
Zest Acquisition Corp.(e)
L+
750
,
1.00
% LIBOR Floor
3/14/2026
Healthcare & Pharmaceuticals
15,000
14,810
13,875
Total Senior Secured Second Lien Debt
29,147
28,016
Collateralized Securities and Structured Products - Equity
Ivy Hill Middle Market Credit Fund VIII, Ltd. Subordinated Loan(c)
11.84
% Estimated Yield
2/2/2026
Diversified Financials
10,000
9,874
9,579
Total Collateralized Securities and Structured Products - Equity
9,874
9,579
Equity
American Clinical Solutions LLC, Class A Membership Interests(d)
Healthcare & Pharmaceuticals
6,030,384
Units
5,200
4,583
Anthem Sports and Entertainment Inc., Class A Preferred Stock Warrants(d)
Media: Diversified & Production
1,469
Units
486
1,836
Anthem Sports and Entertainment Inc., Class B Preferred Stock Warrants(d)
Media: Diversified & Production
255
Units
—
320
Anthem Sports and Entertainment Inc., Common Stock Warrants(d)
Media: Diversified & Production
4,746
Units
—
999
BCP Great Lakes Fund LP, Partnership Interests (5.6% ownership)
Diversified Financials
N/A
11,628
11,177
Carestream Health Holdings, Inc., Common Stock(d)
Healthcare & Pharmaceuticals
613,262
Units
21,759
21,759
CHC Medical Partners, Inc., Series C Preferred Stock, 12% Dividend
Healthcare & Pharmaceuticals
2,727,273
Units
7,809
8,495
CTS Ultimate Holdings LLC, Class A Preferred Units(d)
Construction & Building
3,578,701
Units
1,000
930
Dayton HoldCo, LLC, Membership Units(d)
Construction & Building
37,264
Units
8,400
15,345
HDNet Holdco LLC, Preferred Unit Call Option(d)
Media: Diversified & Production
1
Unit
—
206
HW Ultimate Holdings, LP, Class A Membership Units, 4% Dividend
Capital Equipment
2,000,000
Units
2,062
1,600
Language Education Holdings GP LLC, Common Units(d)
Services: Business
133,333
Units
—
—
Language Education Holdings LP, Ordinary Common Units(d)
Services: Business
133,333
Units
300
364
Skillsoft Corp., Class A Common Stock(d)
High Tech Industries
243,425
Units
2,000
446
Spinal USA, Inc. / Precision Medical Inc., Warrants(d)
Healthcare & Pharmaceuticals
20,667,324
Units
—
—
Total Equity
60,644
68,060
TOTAL INVESTMENTS
$
102,826
$
108,820
a.
The actual LIBOR rate for each loan listed may not be the applicable LIBOR rate as of September 30, 2022, as the loan may have been priced or repriced based on a LIBOR rate prior to or subsequent to September 30, 2022. The actual SOFR rate for each loan listed may not be the applicable SOFR rate as of September 30, 2022, as the loan may have been priced or repriced based on a SOFR rate prior to or subsequent to September 30, 2022.
b.
Represents amortized cost for debt securities and cost for equity investments.
c.
The CLO subordinated notes are considered equity positions in the CLO vehicles and are not rated. Equity investments are entitled to recurring distributions, which are generally equal to the remaining cash flow of the payments made by the underlying vehicle's securities less contractual payments to debt holders and expenses. The estimated yield indicated is based upon a current projection of the amount and timing of these recurring distributions and the estimated amount of repayment of principal upon termination. Such projections are periodically reviewed and adjusted, and the estimated yield may not ultimately be realized.
d.
Non-income producing security.
e.
The interest rate on these loans is subject to 1 month LIBOR, which as of September 30, 2022 was 3.14%.
f.
The interest rate on these loans is subject to 3 month LIBOR, which as of September 30, 2022 was 3.75%.
g.
The interest rate on these loans is subject to 1 month SOFR, which as of September 30, 2022 was 3.04%.
h.
The interest rate on these loans is subject to 3 month SOFR, which as of September 30, 2022 was 3.59%.
43
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
The following table sets forth the individual investments in CION/EagleTree's portfolio as of December 31, 2021:
Portfolio Company
Interest(a)
Maturity
Industry
Principal/
Par Amount/
Units
Cost(b)
Fair
Value
Senior Secured Second Lien Debt
Access CIG, LLC(e)
L+
775
,
0.00
% LIBOR Floor
2/27/2026
Services: Business
$
7,250
$
7,214
$
7,256
Carestream Health, Inc.(f)
L+
1250
,
1.00
% LIBOR Floor
8/8/2023
Healthcare & Pharmaceuticals
12,460
12,057
12,242
Dayton Superior Corp.(f)
L+
700
,
2.00
% LIBOR Floor
12/4/2024
Construction & Building
1,477
1,479
1,478
MedPlast Holdings, Inc.(e)
L+
775
,
0.00
% LIBOR Floor
7/2/2026
Healthcare & Pharmaceuticals
6,750
6,004
6,446
Ministry Brands, LLC(e)
L+
925
,
1.00
% LIBOR Floor
6/2/2023
Services: Business
7,000
6,983
7,000
Zest Acquisition Corp.(e)
L+
750
,
1.00
% LIBOR Floor
3/14/2026
Healthcare & Pharmaceuticals
15,000
14,776
14,925
Total Senior Secured Second Lien Debt
48,513
49,347
Collateralized Securities and Structured Products - Equity
Ivy Hill Middle Market Credit Fund VIII, Ltd. Subordinated Loan(c)
11.84
% Estimated Yield
2/2/2026
Diversified Financials
10,000
9,997
9,856
Total Collateralized Securities and Structured Products - Equity
9,997
9,856
Equity
American Clinical Solutions LLC, Class A Membership Interests(d)
Healthcare & Pharmaceuticals
6,030,384
Units
5,200
5,729
Anthem Sports and Entertainment Inc., Class A Preferred Stock Warrants(d)
Media: Diversified & Production
1,469
Units
486
1,704
Anthem Sports and Entertainment Inc., Class B Preferred Stock Warrants(d)
Media: Diversified & Production
255
Units
—
297
Anthem Sports and Entertainment Inc., Common Stock Warrants(d)
Media: Diversified & Production
4,746
Units
—
2,572
BCP Great Lakes Fund LP, Partnership Interests (5.6% ownership)
Diversified Financials
N/A
11,118
11,224
Carestream Health Holdings, Inc., Warrants(d)
Healthcare & Pharmaceuticals
388
Units
500
801
CHC Medical Partners, Inc., Series C Preferred Stock, 12% Dividend
Healthcare & Pharmaceuticals
2,727,273
Units
7,564
7,964
Dayton HoldCo, LLC, Membership Units(d)
Construction & Building
37,264
Units
8,400
11,166
HDNet Holdco LLC, Preferred Unit Call Option(d)
Media: Diversified & Production
1
Unit
—
—
HW Ultimate Holdings, LP, Class A Membership Units, 4% Dividend
Capital Equipment
2,000,000
Units
2,002
2,021
Skillsoft Corp., Class A Common Stock(d)
High Tech Industries
243,425
Units
2,000
2,227
Spinal USA, Inc. / Precision Medical Inc., Warrants(d)
Healthcare & Pharmaceuticals
20,667,324
Units
—
—
Tenere Inc., Warrants(d)
Capital Equipment
N/A
1,166
1,235
Total Equity
38,436
46,940
TOTAL INVESTMENTS
$
96,946
$
106,143
a.
The actual LIBOR rate for each loan listed may not be the applicable LIBOR rate as of December 31, 2021, as the loan may have been priced or repriced based on a LIBOR rate prior to or subsequent to December 31, 2021.
b.
Represents amortized cost for debt securities and cost for equity investments.
c.
The CLO subordinated notes are considered equity positions in the CLO vehicles and are not rated. Equity investments are entitled to recurring distributions, which are generally equal to the remaining cash flow of the payments made by the underlying vehicle's securities less contractual payments to debt holders and expenses. The estimated yield indicated is based upon a current projection of the amount and timing of these recurring distributions and the estimated amount of repayment of principal upon termination. Such projections are periodically reviewed and adjusted, and the estimated yield may not ultimately be realized.
d.
Non-income producing security.
e.
The interest rate on these loans is subject to 1 month LIBOR, which as of December 31, 2021 was
0.10%
.
f.
The interest rate on these loans is subject to 3 month LIBOR, which as of December 31, 2021 was
0.21%
.
44
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
The following table includes selected balance sheet information for CION/EagleTree as of September 30, 2022 and December 31, 2021:
Selected Balance Sheet Information:
September 30, 2022
December 31, 2021
Investments, at fair value (amortized cost of $
102,826
and $
96,946
, respectively)
$
108,820
$
106,143
Cash and other assets
5,684
1,776
Dividend receivable on investments
310
265
Interest receivable on investments
301
109
Total assets
$
115,115
$
108,293
Senior secured notes (net of unamortized debt issuance costs of $
100
and $
0
, respectively)
$
73,164
$
72,504
Other liabilities
369
735
Total liabilities
73,533
73,239
Members' capital
41,582
35,054
Total liabilities and members' capital
$
115,115
$
108,293
The following table includes selected statement of operations information for CION/EagleTree for the three and nine months ended September 30, 2022 and for the period from December 21, 2021 (commencement of operations) through December 31, 2021:
Selected Statement of Operations Information:
Three Months Ended September 30, 2022
Nine Months Ended September 30, 2022
Period From December 21, 2021 (Commencement of Operations) Through December 31, 2021
Total revenues
$
4,237
$
7,960
$
688
Total expenses
2,860
8,382
800
Net realized gain on investments
10,153
10,153
—
Net change in unrealized (depreciation) appreciation on investments
(
3,050
)
(
3,203
)
9,197
Net increase in net assets
$
8,480
$
6,528
$
9,085
CION SOF Funding, LLC
CION SOF was organized on May 21, 2019 as a Delaware limited liability company and commenced operations on October 2, 2019 when the Company and BCP Special Opportunities Fund I, LP, or BCP, entered into the limited liability company agreement of CION SOF for purposes of establishing the manner in which the parties would invest in and co-manage CION SOF. CION SOF invested primarily in senior secured loans of U.S. middle-market companies. The Company and BCP contributed a portfolio of loans to CION SOF representing membership equity of $
31,289
and $
4,470
, respectively, in exchange for
87.5
% and
12.5
% of the membership interests of CION SOF, respectively.
In December 2020, the Company and BCP elected to wind-down the operations of CION SOF. On January 28, 2021, CION SOF sold all of its remaining debt and equity investments to the Company. On March 18, 2021, CION SOF declared final distributions and on March 19, 2021, distributed all remaining capital to the Company and BCP.
The Company and BCP were not required to make any additional capital contributions to CION SOF. The Company’s equity investment in CION SOF was not redeemable. All portfolio and other material decisions regarding CION SOF required approval of its board of managers, which was comprised of
four
members,
two
of whom were selected by the Company and the other
two
were selected by BCP. Further, all portfolio and other material decisions required the affirmative vote of at least
one
board member from the Company and
one
board member from BCP.
The Company also served as administrative agent to CION SOF to provide loan servicing functions and other administrative services. In certain cases, these loan servicing functions and other administrative services were performed by CIM.
45
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
On October 2, 2019, CION SOF entered into a senior secured credit facility, or the SOF Credit Facility, with Morgan Stanley Bank, N.A., or MS, for borrowings of up to a maximum amount of $
75,000
. Advances under the SOF Credit Facility were available through October 2, 2022 and bore interest at a floating rate equal to the three-month LIBOR, plus a spread of (i)
3.0
% per year through October 1, 2022 and (i)
3.5
% per year thereafter through October 2, 2024. CION SOF's obligations to MS under the SOF Credit Facility were secured by a first priority security interest in all of the assets of CION SOF. The obligations of CION SOF under the SOF Credit Facility were non-recourse to the Company. On October 2, 2019, CION SOF drew down $
64,702
of borrowings under the SOF Credit Facility. On December 14, 2020, CION SOF repaid to MS all amounts outstanding under the SOF Credit Facility.
The Company did not record any dividend income from its equity interest in CION SOF for the year ended December 31, 2021 or the nine months ended September 30, 2022.
In accordance with ASU 2015-02,
Consolidation
, the Company determined that CION SOF was a VIE. However, the Company was not the primary beneficiary and therefore did not consolidate CION SOF. The Company's maximum exposure to losses from CION SOF was limited to its equity contribution to CION SOF.
The following table includes selected statement of operations information for CION SOF for the
nine
months ended September 30, 2022 and 2021 and the year ended December 31, 2021:
Nine Months Ended
September 30,
Year Ended December 31,
Selected Statement of Operations Information:
2022
2021
2021
Total revenues
$
—
$
29
$
29
Total expenses
—
29
29
Net increase in net assets
$
—
$
—
$
—
46
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Note 8.
Financing Arrangements
The following table presents summary information with respect to the Company’s outstanding financing arrangements as of September 30, 2022:
Financing Arrangement
Type of Financing Arrangement
Rate
Amount Outstanding
Amount Available
Maturity Date
JPM Credit Facility
Term Loan Credit Facility
L+
3.10
%
$
550,000
$
25,000
May 15, 2024
SOFR+
3.10
%
60,000
40,000
2026 Notes(1)
Note Purchase Agreement
4.50
%
125,000
—
February 11, 2026
UBS Facility
Repurchase Agreement
L+
3.375
%
142,500
7,500
November 19, 2023
2022 More Term Loan
Term Loan Facility Agreement
SOFR+
3.50
%
50,000
—
April 27, 2027
2021 More Term Loan(2)
Term Loan Facility Agreement
5.20
%
30,000
—
September 30, 2024
$
957,500
$
72,500
(1)
As of September 30, 2022, the fair value of the 2026 Notes was $
125,000
, which was based on a yield analysis and discount rate commensurate with the market yields for similar types of debt. The fair value of these debt obligations would be categorized as Level 3 under ASC 820 as of September 30, 2022.
(2)
As of September 30, 2022, the fair value of the 2021 More Term Loan was $
30,000
, which was based on a yield analysis and discount rate commensurate with the market yields for similar types of debt. The fair value of these debt obligations would be categorized as Level 3 under ASC 820 as of September 30, 2022.
JPM Credit Facility
On August 26, 2016, 34th Street entered into a senior secured credit facility with JPM. The senior secured credit facility with JPM, or the JPM Credit Facility, provided for borrowings in an aggregate principal amount of $
150,000
, of which $
25,000
could have been funded as a revolving credit facility, each subject to conditions described in the JPM Credit Facility. On August 26, 2016, 34th Street drew down $
57,000
of borrowings under the JPM Credit Facility.
On September 30, 2016, July 11, 2017, November 28, 2017 and May 23, 2018, 34th Street amended and restated the JPM Credit Facility, or the Amended JPM Credit Facility, with JPM. Under the Amended JPM Credit Facility entered into on September 30, 2016, the aggregate principal amount available for borrowings was increased from $
150,000
to $
225,000
, of which $
25,000
could have been funded as a revolving credit facility, subject to conditions described in the Amended JPM Credit Facility. Under the Amended JPM Credit Facility entered into on July 11, 2017 and November 28, 2017, certain immaterial administrative amendments were made as a result of the termination of AIM as the Company's investment sub-adviser as discussed in Note 1. Under the Amended JPM Credit Facility entered into on May 23, 2018, (i) the aggregate principal amount available for borrowings was increased from $
225,000
to $
275,000
, of which $
25,000
could have been funded as a revolving credit facility, subject to conditions described in the Amended JPM Credit Facility, (ii) the reinvestment period was extended until August 24, 2020 and (iii) the maturity date was extended to August 24, 2021.
On May 15, 2020, 34th Street amended and restated the Amended JPM Credit Facility, or the Second Amended JPM Credit Facility, with JPM in order to fully repay all amounts outstanding under the Company's prior Citibank Credit Facility and MS Credit Facility and repay $
100,000
of advances outstanding under the UBS Facility (as described below). Under the Second Amended JPM Credit Facility, the aggregate principal amount available for borrowings was increased from $
275,000
to $
700,000
, of which $
75,000
may be funded as a revolving credit facility, subject to conditions described in the Second Amended JPM Credit Facility, during the reinvestment period. Under the Second Amended JPM Credit Facility, the reinvestment period was extended until May 15, 2022 and the maturity date was extended to May 15, 2023. Advances under the Second Amended JPM Credit Facility bore interest at a floating rate equal to the three-month LIBOR, plus a spread of
3.25
% per year.
On February 26, 2021, 34th Street amended and restated the Second Amended JPM Credit Facility, or the Third Amended JPM Credit Facility, with JPM. Under the Third Amended JPM Credit Facility, the aggregate principal amount available for borrowings was reduced from $
700,000
to $
575,000
, subject to conditions described in the Third Amended JPM Credit Facility. In addition, under the Third Amended JPM Credit Facility, the reinvestment period was extended from May 15, 2022 to May 15, 2023 and the maturity date was extended from May 15, 2023 to May 15, 2024. Advances under the Third Amended JPM Credit Facility bear interest at a floating rate equal to the three-month LIBOR, plus a spread of
3.10
% per year, which was reduced from a spread of
3.25
% per year. 34th Street incurred certain customary costs and expenses in connection with the Third Amended JPM Credit Facility. No other material terms of the Second JPM Credit Facility were revised in connection with the Third Amended JPM Credit Facility.
47
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
On March 28, 2022, 34th Street entered into a First Amendment to the Third Amended JPM Credit Facility with JPM, or the JPM First Amendment. Under the JPM First Amendment, the aggregate principal amount available for borrowings was increased from $
575,000
to $
675,000
, subject to conditions described in the JPM First Amendment. Additional advances of up to $
100,000
under the JPM First Amendment bear interest at a floating rate equal to the three-month SOFR, plus a credit spread of
3.10
% per year, and a LIBOR to SOFR credit spread adjustment of
0.15
%. 34
th
Street incurred certain customary costs and expenses in connection with the JPM First Amendment. No other material terms of the Third Amended JPM Credit Facility were revised in connection with the JPM First Amendment.
Interest is payable quarterly in arrears. 34th Street may prepay advances pursuant to the terms and conditions of the Third Amended JPM Credit Facility and the JPM First Amendment, subject to a
1
% premium in certain circumstances. In addition, 34th Street will be subject to a non-usage fee of
1.0
% per year on the amount, if any, of the aggregate principal amount available under the Third Amended JPM Credit Facility and the JPM First Amendment that has not been borrowed through May 14, 2023. The non-usage fees, if any, are payable quarterly in arrears.
As of September 30, 2022 and December 31, 2021, the aggregate principal amount outstanding on the Third Amended JPM Credit Facility and the JPM First Amendment was $
610,000
and $
550,000
, respectively.
The Company contributed loans and other corporate debt securities to 34th Street in exchange for
100
% of the membership interests of 34th Street, and may contribute additional loans and other corporate debt securities to 34th Street in the future. 34th Street’s obligations to JPM under the Third Amended JPM Credit Facility and the JPM First Amendment are secured by a first priority security interest in all of the assets of 34th Street. The obligations of 34th Street under the Third Amended JPM Credit Facility and the JPM First Amendment are non-recourse to the Company, and the Company’s exposure under the Third Amended JPM Credit Facility and the JPM First Amendment is limited to the value of the Company’s investment in 34th Street.
In connection with the Third Amended JPM Credit Facility and the JPM First Amendment, 34th Street made certain representations and warranties and is required to comply with a borrowing base requirement, various covenants, reporting requirements and other customary requirements for similar facilities. As of and for the three months ended September 30, 2022, 34th Street was in compliance with all covenants and reporting requirements.
Through September 30, 2022, the Company incurred debt issuance costs of $
12,102
in connection with obtaining and amending the JPM Credit Facility, which were recorded as a direct reduction to the outstanding balance of the Third Amended JPM Credit Facility and the JPM First Amendment, which is included in the Company’s consolidated balance sheet as of September 30, 2022 and will amortize to interest expense over the term of the Third Amended JPM Credit Facility and the JPM First Amendment. At September 30, 2022, the unamortized portion of the debt issuance costs was $
3,712
.
For the three and nine months ended September 30, 2022 and 2021 and the year ended December 31, 2021, the components of interest expense, average borrowings, and weighted average interest rate for the JPM First Amendment, the Third Amended JPM Credit Facility and the Second Amended JPM Credit Facility, as applicable, were as follows:
Three Months Ended September 30,
Nine Months Ended September 30,
Year Ended December 31,
2022
2021
2022
2021
2021
Stated interest expense
$
7,906
$
4,532
$
18,669
$
13,625
$
18,299
Amortization of deferred financing costs
576
464
1,637
1,628
2,119
Non-usage fee
188
64
451
432
457
Total interest expense
$
8,670
$
5,060
$
20,757
$
15,685
$
20,875
Weighted average interest rate(1)
5.32
%
3.28
%
4.33
%
3.41
%
3.36
%
Average borrowings
$
601,739
$
550,000
$
584,066
$
543,681
$
549,110
(1)
Includes the stated interest expense and non-usage fee on the unused portion of the JPM First Amendment, the Third Amended JPM Credit Facility and the Second Amended JPM Credit Facility, as applicable, and is annualized for periods covering less than one year.
2026 Notes
On February 11, 2021, the Company entered into a Note Purchase Agreement with certain purchasers, or the Note Purchase Agreement, in connection with the Company’s issuance of $
125,000
aggregate principal amount of its
4.50
% senior unsecured notes due in 2026, or the 2026 Notes. The net proceeds to the Company were approximately $
122,300
, after the deduction of placement agent fees and other financing expenses, which the Company used to repay debt under its secured financing arrangements.
48
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
The 2026 Notes mature on February 11, 2026. The 2026 Notes bear interest at a rate of
4.50
% per year payable semi-annually on February 11th and August 11th of each year, which commenced on August 11, 2021. The Company has the right to, at its option, redeem all or a part that is not less than
10
% of the 2026 Notes (i) on or before February 11, 2024, at a redemption price equal to
100
% of the principal amount of 2026 Notes to be redeemed plus an applicable “make-whole” amount equal to (x) the discounted value of the remaining scheduled payments with respect to the principal of such 2026 Note that is to be prepaid or becomes due and payable pursuant to the Note Purchase Agreement over (y) the amount of such called principal, plus accrued and unpaid interest, if any, (ii) after February 11, 2024 but on or before February 11, 2025, at a redemption price equal to
102
% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest, if any, (iii) after February 11, 2025 but on or before August 11, 2025, at a redemption price equal to
101
% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest, if any, and (iv) after August 11, 2025, at a redemption price equal to
100
% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest, if any. For any redemptions occurring on or before February 11, 2024, the discounted value portion of the “make whole amount” is calculated by applying a discount rate on the same periodic basis as that on which interest on the 2026 Notes is payable equal to the sum of
0.50
% plus the yield to maturity of the most recently issued U.S. Treasury securities having a maturity equal to the remaining average life of the 2026 Notes, or if there are no such U.S. Treasury securities, using such implied yield to maturity determined in accordance with the terms of the Note Purchase Agreement.
The 2026 Notes are general unsecured obligations of the Company that rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company’s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by certain of the Company’s subsidiaries, financing vehicles or similar facilities.
The Note Purchase Agreement contains other terms and conditions, including, without limitation, affirmative and negative covenants such as (i) information reporting, (ii) maintenance of the Company’s status as a BDC, (iii) minimum shareholders’ equity of
60
% of the Company’s net asset value as of the year ended December 31, 2020 plus
50
% of the net cash proceeds of the sale of certain equity interests by the Company after February 11, 2021, if any, (iv) a minimum asset coverage ratio of not less than
150
%, (v) a minimum interest coverage ratio of
1.25
to 1.00 and (vi) an unencumbered asset coverage ratio of
1.25
to 1.00, provided that (a) first lien senior secured loans and cash represent more than
65
% of the total value of unencumbered assets used by the Company for purposes of the ratio and (b) equity interests or structured products in the aggregate represent less than
15
% of the total value of unencumbered assets used by the Company for purposes of the ratio. As of and for the three months ended September 30, 2022, the Company was in compliance with all covenants and reporting requirements.
The Note Purchase Agreement also contains a “most favored lender” provision in favor of the purchasers in respect of any new unsecured credit facilities, loans or indebtedness in excess of $
25,000
incurred by the Company, which indebtedness contains a financial covenant not contained in, or more restrictive against the Company than those contained, in the Note Purchase Agreement. In addition, the Note Purchase Agreement contains customary events of default with customary cure and notice periods, including, without limitation, nonpayment, incorrect representation in any material respect, breach of covenant, cross-default under other indebtedness or derivative securities of the Company in an outstanding aggregate principal amount of at least $
25,000
, certain judgments and orders, and certain events of bankruptcy.
As of September 30, 2022, the aggregate principal amount of 2026 Notes outstanding was $
125,000
.
Through September 30, 2022, the Company incurred debt issuance costs of $
2,669
in connection with issuing the 2026 Notes, which were recorded as a direct reduction to the outstanding balance of the 2026 Notes, which is included in the Company’s consolidated balance sheet as of September 30, 2022 and will amortize to interest expense over the term of the 2026 Notes. At September 30, 2022, the unamortized portion of the debt issuance costs was $
1,797
.
For the three months ended September 30, 2022 and 2021, for the nine months ended September 30, 2022, for the period from February 11, 2021 through September 30, 2021 and for the period from February 11, 2021 through December 31, 2021, the components of interest expense, average borrowings, and weighted average interest rate for the 2026 Notes were as follows:
Three Months Ended September 30, 2022
Three Months Ended September 30, 2021
Nine Months Ended September 30, 2022
For the Period From February 11, 2021 Through September 30, 2021
For the Period From February 11, 2021 Through December 31, 2021
Stated interest expense
$
1,406
$
1,437
$
4,234
$
3,625
$
5,062
Amortization of deferred financing costs
135
135
399
339
473
Total interest expense
$
1,541
$
1,572
$
4,633
$
3,964
$
5,535
Weighted average interest rate(1)
4.50
%
4.50
%
4.50
%
4.50
%
4.50
%
Average borrowings
$
125,000
$
125,000
$
125,000
$
125,000
$
125,000
(1)
Includes the stated interest expense on the 2026 Notes and is annualized for periods covering less than one year.
49
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
UBS Facility
On May 19, 2017, the Company, through two newly-formed, wholly-owned, special-purpose financing subsidiaries, entered into a financing arrangement with UBS pursuant to which up to $
125,000
was made available to the Company.
Pursuant to the financing arrangement, assets in the Company's portfolio may be contributed from time to time to Murray Hill Funding II through Murray Hill Funding, LLC, or Murray Hill Funding, each a newly-formed, wholly-owned, special-purpose financing subsidiary of the Company. On May 19, 2017, the Company contributed assets to Murray Hill Funding II. The assets held by Murray Hill Funding II secure the obligations of Murray Hill Funding II under Class A-1 Notes, or the Notes, issued by Murray Hill Funding II. Pursuant to an Indenture, dated May 19, 2017, between Murray Hill Funding II and U.S. Bank National Association, or U.S. Bank, as trustee, or the Indenture, the aggregate principal amount of Notes that may be issued by Murray Hill Funding II from time to time was $
192,308
. Murray Hill Funding purchased the Notes issued by Murray Hill Funding II at a purchase price equal to their par value. Murray Hill Funding makes capital contributions to Murray Hill Funding II to, among other things, maintain the value of the portfolio of assets held by Murray Hill Funding II.
Principal on the Notes will be due and payable on the stated maturity date of May 19, 2027. Pursuant to the Indenture, Murray Hill Funding II made certain representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar transactions. The Indenture contains events of default customary for similar transactions, including, without limitation: (a) the failure to make principal payments on the Notes at their stated maturity or any earlier redemption date or to make interest payments on the Notes and such failure is not cured within three business days; (b) the failure to disburse amounts in accordance with the priority of payments and such failure is not cured within three business days; and (c) the occurrence of certain bankruptcy and insolvency events with respect to Murray Hill Funding II or Murray Hill Funding. As of and for the three months ended September 30, 2022, Murray Hill Funding II was in compliance with all covenants and reporting requirements.
Murray Hill Funding, in turn, entered into a repurchase transaction with UBS, pursuant to the terms of a Global Master Repurchase Agreement and the related Annex and Master Confirmation thereto, each dated May 19, 2017, or collectively, the UBS Facility. Pursuant to the UBS Facility, on May 19, 2017 and June 19, 2017, UBS purchased Notes held by Murray Hill Funding for an aggregate purchase price equal to
65
% of the principal amount of Notes purchased. Subject to certain conditions, the maximum principal amount of Notes that may be purchased under the UBS Facility was $
192,308
. Accordingly, the aggregate maximum amount payable to Murray Hill Funding under the UBS Facility would not exceed $
125,000
. Murray Hill Funding was required to repurchase the Notes sold to UBS under the UBS Facility by no later than May 19, 2020. The repurchase price paid by Murray Hill Funding to UBS will be equal to the purchase price paid by UBS for the repurchased Notes (giving effect to any reductions resulting from voluntary partial prepayment(s)). The financing fee under the UBS Facility was equal to the three-month LIBOR plus a spread of up to
3.50
% per year for the relevant period.
On December 1, 2017, Murray Hill Funding II amended and restated the Indenture, or the Amended Indenture, pursuant to which the aggregate principal amount of Notes that may be issued by Murray Hill Funding II was increased from $
192,308
to $
266,667
. On December 1, 2017, Murray Hill Funding entered into a First Amended and Restated Master Confirmation to the Global Master Repurchase Agreement, or the Amended Master Confirmation, which sets forth the terms of the repurchase transaction between Murray Hill Funding and UBS under the UBS Facility. As part of the Amended Master Confirmation, on December 15, 2017 and April 2, 2018, UBS purchased the increased aggregate principal amount of Notes held by Murray Hill Funding for an aggregate purchase price equal to
75
% of the principal amount of Notes issued. As a result of the Amended Master Confirmation, the aggregate maximum amount payable to Murray Hill Funding and made available to the Company under the UBS Facility was increased from $
125,000
to $
200,000
. No other material terms of the UBS Facility were revised in connection with the amended UBS Facility, or the Amended UBS Facility.
On May 19, 2020, Murray Hill Funding entered into a Second Amended and Restated Master Confirmation to the Global Master Repurchase Agreement, or the Second Amended Master Confirmation, which extended the date that Murray Hill Funding will be required to repurchase the Notes sold to UBS under the Amended UBS Facility from May 19, 2020 to November 19, 2020, and increased the spread on the financing fee from
3.50
% to
3.90
% per year.
On May 19, 2020, Murray Hill Funding also repurchased Notes in the aggregate principal amount of $
133,333
from UBS for an aggregate repurchase price of $
100,000
, which was then repaid by Murray Hill Funding II. The repurchase of the Notes on May 19, 2020 resulted in a repayment of one-half of the outstanding amount of borrowings under the Amended UBS Facility as of May 19, 2020. As of December 31, 2020, Notes remained outstanding in the aggregate principal amount of $
133,333
, which was purchased by Murray Hill Funding from Murray Hill Funding II and subsequently sold to UBS under the Amended UBS Facility for aggregate proceeds of $
100,000
.
On November 12, 2020, Murray Hill Funding entered into a Third Amended and Restated Master Confirmation to the Global Master Repurchase Agreement, or the Third Amended Master Confirmation, to further extend the date that Murray Hill Funding will be required to repurchase the Notes to December 18, 2020.
50
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
On December 17, 2020, Murray Hill Funding entered into a Fourth Amended and Restated Master Confirmation to the Global Master Repurchase Agreement, or the Fourth Amended Master Confirmation, which further extended the date that Murray Hill Funding will be required to repurchase the Notes sold to UBS under the Amended UBS Facility from December 18, 2020 to November 19, 2023, and decreased the spread on the financing fee from
3.90
% to
3.375
% per year. No other material terms of the Amended UBS Facility were revised in connection with the Fourth Amended Master Confirmation.
On December 17, 2020, Murray Hill Funding also entered into a Revolving Credit Note Agreement, or the Revolving Note Agreement, with Murray Hill Funding II, UBS and U.S. Bank, as note agent and trustee, which provides for a revolving credit facility in an aggregate principal amount of $
50,000
, subject to compliance with a borrowing base. Murray Hill Funding II will issue Class A-R Notes, or the Class A-R Notes, in exchange for advances under the Revolving Note Agreement. Principal on the Class A-R Notes will be due and payable on the stated maturity date of May 19, 2027, which is the same stated maturity date as the Notes.
The Class A-R Notes will be issued pursuant to a Second Amended and Restated Indenture, dated December 17, 2020, between Murray Hill Funding II and U.S. Bank, as trustee, or the Second Amended Indenture. Under the Second Amended Indenture, the aggregate principal amount of Notes and Class A-R Notes that may be issued by Murray Hill Funding II from time to time is $
150,000
. Murray Hill Funding, in turn, entered into a repurchase transaction with UBS pursuant to the terms of the related Annex and Master Confirmation, dated December 17, 2020, to the Global Master Repurchase Agreement, dated May 19, 2017, related to the Class A-R Notes. Murray Hill Funding is required to repurchase the Class A-R Notes that will be sold to UBS by no later than November 19, 2023. The financing fee for the funded Class A-R Notes is equal to the three-month LIBOR plus a spread of
3.375
% per year while the financing fee for the unfunded Class A-R Notes is equal to
0.75
% per year.
Pursuant to the Amended UBS Facility, on July 1, 2021, December 14, 2021 and April 19, 2022, UBS purchased Class A-R Notes held by Murray Hill Funding for an aggregate purchase price equal to
100
% of the principal amount of Class A-R Notes purchased, which was $
21,000
, $
25,000
and $
17,500
, respectively. On August 20, 2021, Murray Hill Funding repurchased Class A-R Notes in the aggregate principal amount of $
21,000
from UBS for an aggregate repurchase price of $
21,000
, which was then repaid by Murray Hill Funding II. The repurchase of the A-R Notes on August 20, 2021 resulted in a repayment of $
21,000
of the outstanding amount of borrowings under the Amended UBS Facility.
UBS may require Murray Hill Funding to post cash collateral if, without limitation, the sum of the market value of the portfolio of assets and the cash and eligible investments held by Murray Hill Funding II, together with any posted cash collateral, is less than the required margin amount under the Amended UBS Facility; provided, however, that Murray Hill Funding will not be required to post cash collateral with UBS until such market value has declined at least
10
% from the initial market value of the portfolio assets.
The Company has no contractual obligation to post any such cash collateral or to make any payments to UBS on behalf of Murray Hill Funding. The Company may, but is not obligated to, increase its investment in Murray Hill Funding for the purpose of funding any cash collateral or payment obligations for which Murray Hill Funding becomes obligated in connection with the Amended UBS Facility. The Company’s exposure under the Amended UBS Facility is limited to the value of the Company’s investment in Murray Hill Funding.
Pursuant to the Amended UBS Facility, Murray Hill Funding made certain representations and warranties and is required to comply with a borrowing base requirement, various covenants, reporting requirements and other customary requirements for similar transactions. The Amended UBS Facility contains events of default customary for similar financing transactions, including, without limitation: (a) failure to transfer the Notes to UBS on the applicable purchase date or repurchase the Notes from UBS on the applicable repurchase date; (b) failure to pay certain fees and make-whole amounts when due; (c) failure to post cash collateral as required; (d) the occurrence of insolvency events with respect to Murray Hill Funding; and (e) the admission by Murray Hill Funding of its inability to, or its intention not to, perform any of its obligations under the Amended UBS Facility. As of and for the three months ended September 30, 2022, Murray Hill Funding was in compliance with all covenants and reporting requirements.
Murray Hill Funding paid an upfront fee and incurred certain other customary costs and expenses totaling $
2,637
in connection with obtaining the Amended UBS Facility, which were recorded as a direct reduction to the outstanding balance of the Amended UBS Facility, which is included in the Company’s consolidated balance sheets and amortized to interest expense over the term of the Amended UBS Facility. At September 30, 2022, all upfront fees and other expenses were fully amortized.
As of September 30, 2022, Notes in the aggregate principal amount of $
142,500
had been purchased by Murray Hill Funding from Murray Hill Funding II and subsequently sold to UBS under the Amended UBS Facility for aggregate proceeds of $
142,500
. The carrying amount outstanding under the Amended UBS Facility approximates its fair value. The Company funded each purchase of Notes by Murray Hill Funding through a capital contribution to Murray Hill Funding. As of September 30, 2022, the amount due at maturity under the Amended UBS Facility was $
142,500
. The Notes issued by Murray Hill Funding II and purchased by Murray Hill Funding eliminate in consolidation on the Company’s consolidated financial statements.
As of September 30, 2022, the fair value of assets held by Murray Hill Funding II was $
264,248
.
51
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
For the three and nine months ended September 30, 2022 and 2021 and the year ended December 31, 2021, the components of interest expense, average borrowings, and weighted average interest rate for the Amended UBS Facility were as follows:
Three Months Ended September 30,
Nine Months Ended September 30,
Year Ended December 31,
2022
2021
2022
2021
2021
Stated interest expense
$
2,006
$
1,000
$
4,686
$
2,795
$
3,731
Non-usage fee
14
74
82
263
349
Total interest expense
$
2,020
$
1,074
$
4,768
$
3,058
$
4,080
Weighted average interest rate(1)
5.58
%
3.78
%
4.64
%
3.88
%
3.86
%
Average borrowings
$
142,500
$
111,413
$
135,577
$
103,846
$
104,110
(1)
Includes the stated interest expense and non-usage fee on the unused portion of the Amended UBS Facility and is annualized for periods covering less than one year.
2022 More Term Loan
On April 27, 2022, the Company entered into an Unsecured Term Loan Facility Agreement, or the More Term Loan Agreement, with More Provident Funds and Pension Ltd., or More Provident, as lender, which provided for an unsecured term loan to the Company in an aggregate principal amount of $
50,000
, or the 2022 More Term Loan. On April 27, 2022, the Company drew down $
50,000
of borrowings under the 2022 More Term Loan. After the deduction of fees and other financing expenses, the Company received net borrowings of approximately $
49,000
, which it used for working capital and other general corporate purposes.
Advances under the 2022 More Term Loan bear interest at a floating rate equal to the three-month SOFR, plus a credit spread of
3.50
% per year and subject to a
1.0
% SOFR floor, payable quarterly in arrears. Advances under the 2022 More Term Loan mature on April 27, 2027. The Company has the right to, at its option, prepay all or any portion of advances then outstanding together with a prepayment fee equal to the higher of (i) zero, or (ii) the discounted present value of all remaining interest payments that would have been paid by the Company through the maturity date with respect to the principal amount of such advance that is to be prepaid or becomes due and payable pursuant to the More Term Loan Agreement. The discounted present value portion of the prepayment fee is calculated by applying a discount rate on the same periodic basis as that on which interest on advances is payable equal to the three-month SOFR plus
2.00
%.
Advances under the 2022 More Term Loan are general unsecured obligations of the Company that rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company’s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by certain of the Company’s subsidiaries, financing vehicles or similar facilities.
The More Term Loan Agreement contains other terms and conditions, including, without limitation, affirmative and negative covenants such as (i) information reporting, (ii) maintenance of the Company’s status as a BDC within the meaning of the 1940 Act, (iii) minimum shareholders’ equity of
60
% of the Company’s net asset value as of the year ended December 31, 2021 plus
50
% of the net cash proceeds of the sale of certain equity interests by the Company after April 27, 2022, if any, (iv) a minimum asset coverage ratio of not less than
150
%, and (v) an unencumbered asset coverage ratio of
1.25
to 1.00, provided that (a) first lien senior secured loans and cash represent more than
65
% of the total value of unencumbered assets used by the Company for purposes of the ratio and (b) equity interests or structured products in the aggregate represent less than
15
% of the total value of unencumbered assets used by the Company for purposes of the ratio. In addition, the More Term Loan Agreement contains customary events of default with customary cure and notice periods, including, without limitation, nonpayment, incorrect representation in any material respect, breach of covenant, cross-default under other indebtedness or derivative securities of the Company in an outstanding aggregate principal amount of at least $
25,000
, certain judgments and orders, and certain events of bankruptcy. As of and for the three months ended September 30, 2022, the Company was in compliance with all covenants and reporting requirements.
Through September 30, 2022, the Company incurred debt is
suance costs of $
1,025
in connection with obtaining the 2022 More Term Loan, which were recorded as a direct reduction to the outstanding balance of the 2022 More Term Loan, which is included in the Company’s consolidated balance sheet as of September 30, 2022 and will amortize to interest expense over the term of the 2022 More Term Loan. At September 30, 2022, the unamortized portion of the debt issuance costs was $
936
.
52
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
For the three months ended
September 30, 2022 and for t
he
period from April 27, 2022 through September 30, 2022
, the components of interest expense, average borrowings, and weighted average interest rate for the 2022 More Term Loan were as follows:
Three Months Ended September 30, 2022
For the Period From April 27, 2022 Through September 30, 2022
Stated interest expense
$
715
$
1,125
Amortization of deferred financing costs
52
88
Total interest expense
$
767
$
1,213
Weighted average interest rate(1)
5.59
%
5.16
%
Average borrowings
$
50,000
$
50,000
(1) Includes the stated interest expense on the 2022 More Term Loan and is annualized for periods covering less than one year.
2021 More Term Loan
On April 14, 2021, the Company entered into an Unsecured Term Loan Facility Agreement, or the Term Loan Agreement, with More Provident Funds Ltd., or More, as lender. The Term Loan Agreement with More, or the 2021 More Term Loan, provided for an unsecured term loan to the Company in an aggregate principal amount of $
30,000
. On April 20, 2021, the Company drew down $
30,000
of borrowings under the 2021 More Term Loan. After the deduction of fees and other financing expenses, the Company received net borrowings of approximately $
29,000
, which the Company used for working capital and other general corporate purposes.
Advances under the 2021 More Term Loan mature on September 30, 2024, and bear interest at a rate of
5.20
% per year payable quarterly in arrears. The Company has the right to, at its option, prepay all or any portion of advances then outstanding together with a prepayment fee equal to the higher of (i) zero, or (ii) the discounted present value of all remaining interest payments that would have been paid by the Company through the maturity date with respect to the principal amount of such advance that is to be prepaid or becomes due and payable pursuant to the Term Loan Agreement. The discounted present value portion of the prepayment fee is calculated by applying a discount rate on the same periodic basis as that on which interest on advances is payable equal to the sum of
2.00
% plus the yield to maturity of the most recently issued U.S. Treasury securities having a maturity equal to the remaining average life of the 2021 More Term Loan, or if there are no such U.S. Treasury securities, using such implied yield to maturity determined in accordance with the terms of the Term Loan Agreement.
Advances under the 2021 More Term Loan are general unsecured obligations of the Company that rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by certain of the Company's subsidiaries, financing vehicles or similar facilities.
The Term Loan Agreement contains other terms and conditions, including, without limitation, affirmative and negative covenants such as (i) information reporting, (ii) maintenance of the Company's status as a BDC within the meaning of the 1940 Act, (iii) minimum shareholders’ equity of
60
% of the Company’s net asset value as of the year ended December 31, 2020 plus
50
% of the net cash proceeds of the sale of certain equity interests by the Company after April 14, 2021, if any, (iv) a minimum asset coverage ratio of not less than
150
%, and (v) an unencumbered asset coverage ratio of
1.25
to 1.00, provided that (a) first lien senior secured loans and cash represent more than
65
% of the total value of unencumbered assets used by the Company for purposes of the ratio and (b) equity interests or structured products in the aggregate represent less than
15
% of the total value of unencumbered assets used by the Company for purposes of the ratio. In addition, the Term Loan Agreement contains customary events of default with customary cure and notice periods, including, without limitation, nonpayment, incorrect representation in any material respect, breach of covenant, cross default under other indebtedness or derivative securities of the Company in an outstanding aggregate principal amount of at least $
25,000
, certain judgments and orders, and certain events of bankruptcy. As of and for the three months ended September 30, 2022, the Company was in compliance with all covenants and reporting requirements.
Through
September 30, 2022
, the Company incurred debt issuance costs of $
992
in connection with obtaining the 2021 More Term Loan, which were recorded as a direct reduction to the outstanding balance of the 2021 More Term Loan, which is included in the Company’s consolidated balance sheet as of
September 30, 2022
and will amortize to i
nterest expense over the term of the 2021 More Term Loan. At September 30, 2022, the unamortized portion of the debt issuance costs was $
569
.
53
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
For the three months ended
September 30, 2022 and 2021, for the nine months ended September 30, 2022, for the period from April 14, 2021 through September 30, 2021
and for the period from April 14, 2021 through December 31, 2021, the components of interest expense, average borrowings, and weighted average interest rate for the 2021 More Term Loan were as follows:
Three Months Ended September 30, 2022
Three Months Ended September 30, 2021
Nine Months Ended September 30, 2022
For the Period From April 14, 2021 Through September 30, 2021
For the Period From April 14, 2021 Through December 31, 2021
Stated interest expense
$
399
$
399
$
1,183
$
711
$
1,109
Amortization of deferred financing costs
72
71
215
134
208
Total interest expense
$
471
$
470
$
1,398
$
845
$
1,317
Weighted average interest rate(1)
5.20
%
5.20
%
5.20
%
5.20
%
5.20
%
Average borrowings
$
30,000
$
30,000
$
30,000
$
30,000
$
30,000
(1) Includes the stated interest expense on the 2021 More Term Loan and is annualized for periods covering less than one year.
Note 9.
Fair Value of Financial Instruments
The following table presents fair value measurements of the Company’s portfolio investments as of September 30, 2022 and December 31, 2021, according to the fair value hierarchy:
September 30, 2022(1)
December 31, 2021(2)
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Senior secured first lien debt
$
—
$
—
$
1,616,352
$
1,616,352
$
—
$
—
$
1,526,989
$
1,526,989
Senior secured second lien debt
—
—
38,716
38,716
—
—
38,583
38,583
Collateralized securities and structured products - equity
—
—
1,366
1,366
—
—
2,998
2,998
Unsecured debt
—
—
28,319
28,319
—
—
26,616
26,616
Equity
2,333
—
74,989
77,322
3,404
—
37,736
41,140
Short term investments
9,804
—
—
9,804
87,917
—
—
87,917
Total Investments
$
12,137
$
—
$
1,759,742
$
1,771,879
$
91,321
$
—
$
1,632,922
$
1,724,243
(1)
Excludes the Company's $
35,169
investment in CION/EagleTree, which is measured at NAV.
(2)
Excludes the Company's $
29,796
investment in CION/EagleTree, which is measured at NAV.
The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three and nine months ended September 30, 2022 and 2021:
Three Months Ended
September 30, 2022
Senior Secured First Lien Debt
Senior Secured Second Lien Debt
Collateralized Securities and Structured Products - Equity
Unsecured Debt
Equity
Total
Beginning balance, June 30, 2022
$
1,660,828
$
27,086
$
1,602
$
27,994
$
42,885
$
1,760,395
Investments purchased(2)
142,620
18,109
—
677
32,148
193,554
Net realized gain (loss)
10,452
(
19,339
)
24
—
(
8,303
)
(
17,166
)
Net change in unrealized (depreciation) appreciation
(
2,615
)
13,379
(
128
)
(
356
)
8,522
18,802
Accretion of discount
4,170
17
—
4
—
4,191
Sales and principal repayments
(
199,103
)
(
536
)
(
132
)
—
(
263
)
(
200,034
)
Ending balance, September 30, 2022
$
1,616,352
$
38,716
$
1,366
$
28,319
$
74,989
$
1,759,742
Change in net unrealized (depreciation) appreciation on investments still held as of September 30, 2022(1)
$
(
7,793
)
$
(
3
)
$
(
128
)
$
(
356
)
$
205
$
(
8,075
)
(1)
Included in net change in unrealized appreciation (depreciation) on investments in the consolidated statements of operations.
(2)
Investments purchased includes PIK interest.
54
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Nine Months Ended
September 30, 2022
Senior Secured First Lien Debt
Senior Secured Second Lien Debt
Collateralized Securities and Structured Products - Equity
Unsecured Debt
Equity
Total
Beginning balance, December 31, 2021
$
1,526,989
$
38,583
$
2,998
$
26,616
$
37,736
$
1,632,922
Investments purchased(2)
460,119
19,945
—
1,950
34,281
516,295
Net realized gain (loss)
10,345
(
19,325
)
24
—
(
8,099
)
(
17,055
)
Net change in unrealized (depreciation) appreciation
(
36,665
)
14,600
(
480
)
(
258
)
11,837
(
10,966
)
Accretion of discount
8,705
449
—
11
—
9,165
Sales and principal repayments
(
353,141
)
(
15,536
)
(
1,176
)
—
(
766
)
(
370,619
)
Ending balance, September 30, 2022
$
1,616,352
$
38,716
$
1,366
$
28,319
$
74,989
$
1,759,742
Change in net unrealized (depreciation) appreciation on investments still held as of September 30, 2022(1)
$
(
43,281
)
$
798
$
(
480
)
$
(
257
)
$
3,442
$
(
39,778
)
(1)
Included in net change in unrealized appreciation (depreciation) on investments in the consolidated statements of operations.
(2)
Investments purchased includes PIK interest.
Three Months Ended
September 30, 2021
Senior Secured First Lien Debt
Senior Secured Second Lien Debt
Collateralized Securities and Structured Products - Equity
Unsecured Debt
Equity
Total
Beginning balance, June 30, 2021
$
1,407,224
$
141,710
$
14,095
$
5,508
$
92,357
$
1,660,894
Investments purchased
167,208
244
—
—
3,642
171,094
Net realized gain (loss)
563
619
(
309
)
—
18,856
19,729
Net change in unrealized (depreciation) appreciation
(
2,075
)
(
461
)
126
39
(
12,187
)
(
14,558
)
Accretion of discount
3,185
171
—
4
—
3,360
Sales and principal repayments(1)
(
147,549
)
(
42,784
)
(
900
)
—
(
35,150
)
(
226,383
)
Ending balance, September 30, 2021
$
1,428,556
$
99,499
$
13,012
$
5,551
$
67,518
$
1,614,136
Change in net unrealized (depreciation) appreciation on investments still held as of September 30, 2021(2)
$
(
430
)
$
140
$
(
536
)
$
39
$
10,145
$
9,358
(1)
Includes non-cash restructured securities.
(2)
Included in net change in unrealized appreciation (depreciation) on investments in the consolidated statements of operations.
55
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Nine Months Ended
September 30, 2021
Senior Secured First Lien Debt
Senior Secured Second Lien Debt
Collateralized Securities and Structured Products - Equity
Unsecured Debt
Equity
Total
Beginning balance, December 31, 2020
$
1,223,268
$
151,506
$
12,131
$
5,464
$
75,913
$
1,468,282
Investments purchased(1)
580,641
1,885
—
—
7,783
590,309
Net realized (loss) gain
(
851
)
619
(
309
)
—
19,661
19,120
Net change in unrealized appreciation
17,599
592
2,908
76
5,373
26,548
Accretion of discount
8,742
512
—
11
—
9,265
Sales and principal repayments(1)
(
400,843
)
(
55,615
)
(
1,718
)
—
(
41,212
)
(
499,388
)
Ending balance, September 30, 2021
$
1,428,556
$
99,499
$
13,012
$
5,551
$
67,518
$
1,614,136
Change in net unrealized appreciation (depreciation) on investments still held as of September 30, 2021(2)
$
14,459
$
(
880
)
$
1,962
$
76
$
19,858
$
35,475
(1)
Includes non-cash restructured securities.
(2)
Included in net change in unrealized appreciation (depreciation) on investments in the consolidated statements of operations.
Significant Unobservable Inputs
The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of investments as of September 30, 2022 and December 31, 2021 were as follows:
September 30, 2022
Fair Value
Valuation Techniques/
Methodologies
Unobservable
Inputs
Range
Weighted Average(1)
Senior secured first lien debt
$
1,494,773
Discounted Cash Flow
Discount Rates
6.5
%
—
32.0
%
13.5
%
82,525
Broker Quotes
Broker Quotes
N/A
N/A
14,330
Market Comparable Approach
Revenue Multiple
0.27
x
—
1.65
x
1.47
x
4,699
$ per kW
$
131.85
N/A
3,610
EBITDA Multiple
3.00
x
—
4.75
x
3.20
x
16,415
Other(2)
Other(2)
N/A
N/A
Senior secured second lien debt
38,716
Discounted Cash Flow
Discount Rates
8.8
%
—
20.8
%
16.1
%
Collateralized securities and structured products - equity
1,366
Discounted Cash Flow
Discount Rates
21.0
%
N/A
Unsecured debt
28,319
Discounted Cash Flow
Discount Rates
13.7
%
—
16.5
%
14.3
%
Equity
34,188
Market Comparable Approach
EBITDA Multiple
3.75
x
—
14.55
x
6.70
x
22,203
$ per kW
$
387.5
N/A
17,169
Revenue Multiple
0.13
x
—
5.25
x
2.70
x
1,279
Broker Quotes
Broker Quotes
N/A
N/A
150
Options Pricing Model
Expected Volatility
61.1
%
—
90.0
%
89.4
%
Total
$
1,759,742
(1)
Weighted average amounts are based on the estimated fair values.
(2)
Fair value is based on the expected outcome of proposed corporate transactions and/or other factors.
56
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
December 31, 2021
Fair Value
Valuation Techniques/
Methodologies
Unobservable
Inputs
Range
Weighted Average(1)
Senior secured first lien debt
$
1,292,635
Discounted Cash Flow
Discount Rates
5.5
%
—
24.7
%
9.9
%
183,768
Broker Quotes
Broker Quotes
N/A
N/A
27,557
Market Comparable Approach
EBITDA Multiple
3.50
x
—
6.00
x
4.98
x
6,327
Revenue Multiple
2.25
x
N/A
16,702
Other(2)
Other(2)
N/A
N/A
Senior secured second lien debt
24,408
Discounted Cash Flow
Discount Rates
8.5
%
—
18.6
%
12.7
%
14,175
Broker Quotes
Broker Quotes
N/A
N/A
Collateralized securities and structured products - equity
2,998
Discounted Cash Flow
Discount Rates
16.0
%
N/A
Unsecured debt
26,616
Discounted Cash Flow
Discount Rates
12.7
%
16.2
%
13.6
%
Equity
17,596
Market Comparable Approach
EBITDA Multiple
3.25
x
—
21.50
x
9.88
x
15,127
$ per kW
$
325
N/A
4,032
Revenue Multiple
0.68
x
—
2.00
x
1.87
x
981
Options Pricing Model
Expected Volatility
73.0
%
—
84.2
%
73.0
%
Total
$
1,632,922
(1)
Weighted average amounts are based on the estimated fair values.
(2)
Fair value is based on the expected outcome of proposed corporate transactions and/or other factors.
The significant unobservable inputs used in the fair value measurement of the Company’s senior secured first lien debt, senior secured second lien debt, collateralized securities and structured products, unsecured debt and equity are discount rates, EBITDA multiples, revenue multiples, broker quotes and expected volatility. A significant increase or decrease in discount rates would result in a significantly lower or higher fair value measurement, respectively. A significant increase or decrease in the EBITDA multiples, revenue multiples, expected proceeds from proposed corporate transactions, broker quotes and expected volatility would result in a significantly higher or lower fair value measurement, respectively.
Note 10.
General and Administrative Expense
General and administrative expense consisted of the following items for the three and nine months ended September 30, 2022 and 2021 and the year ended December 31, 2021:
Three Months Ended September 30,
Nine Months Ended September 30,
Year Ended December 31,
2022
2021
2022
2021
2021
Professional fees
$
223
$
1,355
$
1,375
$
3,833
$
4,214
Transfer agent expense
296
316
890
991
1,290
Dues and subscriptions
112
120
727
316
411
Printing and marketing expense
672
235
705
634
990
Insurance expense
157
135
662
404
612
Valuation expense
199
191
590
712
904
Accounting and administrative costs
180
194
482
606
759
Director fees and expenses
162
151
477
365
516
Other expenses
26
12
53
89
109
Total general and administrative expense
$
2,027
$
2,709
$
5,961
$
7,950
$
9,805
57
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Note 11.
Commitments and Contingencies
The Company entered into certain contracts with related and other parties that contain a variety of indemnifications. The Company’s maximum exposure under these arrangements is unknown. However, the Company has not experienced claims or losses pursuant to these contracts and believes the risk of loss related to such indemnifications to be remote.
As of September 30, 2022 and December 31, 2021, the Company’s unfunded commitments were as follows:
Unfunded Commitments
September 30, 2022(1)
December 31, 2021(1)
Cennox, Inc.
$
9,583
$
—
Service Compression, LLC
6,977
—
Critical Nurse Staffing, LLC
5,899
5,899
Instant Web, LLC
5,845
2,704
Thrill Holdings LLC
5,000
—
Rogers Mechanical Contractors, LLC
4,808
4,808
Trademark Global, LLC
4,615
4,615
Dermcare Management, LLC
4,081
—
Homer City Holdings LLC
4,000
—
American Health Staffing Group, Inc.
3,333
2,333
Mimeo.com, Inc.
3,000
5,000
Coyote Buyer, LLC
2,500
2,500
Moss Holding Company
2,232
2,232
HW Acquisition, LLC
2,200
2,933
Inotiv, Inc.
2,100
2,100
Foundation Consumer Healthcare, LLC
2,094
2,094
MacNeill Pride Group Corp.
2,017
—
RumbleOn, Inc.
1,775
6,000
Sleep Opco, LLC
1,750
1,750
Extreme Reach, Inc.
1,744
1,744
Archer Systems, LLC
1,690
—
Optio Rx, LLC
1,530
—
Bradshaw International Parent Corp.
1,076
1,445
RA Outdoors, LLC
1,049
1,049
NWN Parent Holdings LLC
990
1,380
OpCo Borrower, LLC
625
—
BDS Solutions Intermediateco, LLC
474
—
Invincible Boat Company LLC
239
798
American Teleconferencing Services, Ltd.
235
235
H.W. Lochner, Inc.
225
275
Anthem Sports & Entertainment Inc.
167
1,167
Genesis Healthcare, Inc.
—
35,000
West Dermatology Management Holdings, LLC
—
6,308
Williams Industrial Services Group, Inc.
—
5,000
Molded Devices, Inc.
—
4,426
American Media, Inc.
—
1,702
Marble Point Credit Management LLC
—
1,250
Appalachian Resource Company, LLC
—
500
Total
$
83,853
$
107,247
(1)
Unless otherwise noted, the funding criteria for these unfunded commitments had not been met at the date indicated.
58
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Unfunded commitments to provide funds to companies are not recorded on the Company’s consolidated balance sheets. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. The Company intends to use cash on hand, short-term investments, proceeds from borrowings, and other liquid assets to fund these commitments should the need arise. For information on the companies to which the Company is committed to fund additional amounts as of September 30, 2022 and December 31, 2021, refer to the table above and the consolidated schedules of investments. As of November 3, 2022, the Company was committed, upon the satisfaction of certain conditions, to fund an additi
onal
$
80,966
.
The Company will fund its unfunded commitments from the same sources it uses to fund its investment commitments that are funded at the time they are made (i.e., advances from its financing arrangements and/or cash flows from operations). The Company will not fund its unfunded commitments from future net proceeds generated by securities offerings, if any. The Company follows a process to manage its liquidity and ensure that it has available capital to fund its unfunded commitments. Specifically, the Company prepares detailed analyses of the level of its unfunded commitments relative to its then available liquidity on a daily basis. These analyses are reviewed and discussed on a weekly basis by the Company's executive officers and senior members of CIM (including members of the investment committee) and are updated on a “real time” basis in order to ensure that the Company has adequate liquidity to satisfy its unfunded commitments.
Note 12.
Fee Income
Fee income consists of amendment fees, capital structuring and other fees, conversion fees and administrative agent fees.
The following table summarizes the Company’s fee income for the three and nine months ended September 30, 2022 and 2021 and the year ended December 31, 2021:
Three Months Ended
September 30,
Nine Months Ended
September 30,
Year Ended
December 31,
2022
2021
2022
2021
2021
Capital structuring and other fees
$
894
$
1,470
$
3,908
$
2,554
$
4,973
Conversion fees
2,365
—
2,365
—
—
Amendment fees
1,302
73
2,272
747
869
Administrative agent fees
—
—
25
55
85
Total
$
4,561
$
1,543
$
8,570
$
3,356
$
5,927
Administrative agent fees are recurring income as long as the Company remains the administrative agent for the related investment. Income from all other fees was non-recurring.
59
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
Note 13.
Financial Highlights
The following is a schedule of financial highlights as of and for the nine months ended September 30, 2022 and 2021 and the year ended December 31, 2021:
Nine Months Ended
September 30,
Year Ended
December 31,
2022
2021
2021
Per share data:(1)
Net asset value at beginning of period
$
16.34
$
15.50
$
15.50
Results of operations:
Net investment income
1.13
0.98
1.31
Net realized (loss) gain and net change in unrealized (depreciation) appreciation on investments and (loss) gain on foreign currency(2)
(
0.42
)
0.83
0.79
Net increase in net assets resulting from operations(2)
0.71
1.81
2.10
Shareholder distributions:
Distributions from net investment income
(
0.87
)
(
0.79
)
(
1.26
)
Net decrease in net assets resulting from shareholders' distributions
(
0.87
)
(
0.79
)
(
1.26
)
Capital share transactions:
Issuance of common stock above net asset value(3)
—
—
—
Repurchases of common stock below net asset value(4)
0.08
—
—
Net increase in net assets resulting from capital share transactions
0.08
—
—
Net asset value at end of period
$
16.26
$
16.52
$
16.34
Shares of common stock outstanding at end of period
56,262,964
56,958,440
56,958,440
Total investment return-net asset value(5)
7.43
%
11.98
%
14.43
%
Total investment return-market value(6)
(
29.81
)
%
—
3.87
%
Net assets at beginning of period
$
930,512
$
878,256
$
878,256
Net assets at end of period
$
914,906
$
941,013
$
930,512
Average net assets
$
922,203
$
911,856
$
918,824
Ratio/Supplemental data:
Ratio of net investment income to average net assets
6.98
%
6.13
%
8.09
%
Ratio of gross operating expenses to average net assets(7)
8.14
%
6.69
%
9.04
%
Ratio of net operating expenses to average net assets
8.14
%
6.69
%
9.04
%
Portfolio turnover rate(8)
18.66
%
32.40
%
52.04
%
Total amount of senior securities outstanding
$
957,500
$
805,000
$
830,000
Asset coverage ratio(9)
1.96
2.17
2.12
(1)
The per share data for the nine months ended September 30, 2022 and 2021 and the year ended December 31, 2021 was derived by using the weighted average shares of common stock outstanding during each period. The share information utilized to determine per share data in this table has been retroactively adjusted to reflect the reverse stock split discussed in Note 3.
(2)
The amount shown for net realized (loss) gain, net change in unrealized (depreciation) appreciation on investments and (loss) gain on foreign currency is the balancing figure derived from the other figures in the schedule. The amount shown at this caption for a share outstanding throughout the period may not agree with the change in the aggregate gains and losses in portfolio securities for the period because of the timing of sales and repurchases of the Company’s shares in relation to fluctuating market values for the portfolio. As a result, net increase in net assets resulting from operations in this schedule may vary from the consolidated statements of operations.
60
CĪON Investment Corporation
Notes to Consolidated Financial Statements
(unaudited)
September 30, 2022
(in thousands, except share and per share amounts)
(3)
The continuous issuance of shares of common stock may have caused an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share impact of the continuous issuance of shares of common stock was an increase to net asset value of less than $
0.01
per share during the nine months ended September 30, 2022 and 2021 and the year ended December 31, 2021. The Company's follow-on continuous public offering ended on January 25, 2019.
(4)
Repurchases of common stock may have caused an incremental decrease or increase in net asset value per share due to the repurchase of shares at a price in excess of or below net asset value per share, respectively, on each repurchase date. The per share impact of repurchases of common stock was a decrease to net asset value of less than $
0.01
per share during the nine months ended September 30, 2021 and the year ended December 31, 2021.
(5)
Total investment return-net asset value is a measure of the change in total value for shareholders who held the Company’s common stock at the beginning and end of the period, including distributions paid or payable during the period. Total investment return-net asset value is based on (i) the beginning period net asset value per share on the first day of the period, (ii) the net asset value per share on the last day of the period of (A) one share plus (B) any fractional shares issued in connection with the reinvestment of distributions, and (iii) the value of distributions payable, if any, on the last day of the period. The total investment return-net asset value calculation assumes that distributions are reinvested in accordance with the Company's distribution reinvestment plan then in effect as described in Note 5. The total investment return-net asset value does not consider the effect of the sales load from the sale of the Company’s common stock. The total investment return-net asset value includes the effect of the issuance of shares at a net offering price that is greater than net asset value per share, which causes an increase in net asset value per share. Total returns covering less than a full year are not annualized.
(6)
Total investment return-market value for the nine months ended September 30, 2022 was calculated by taking the change in the market price of the Company's common stock since the first day of the period, and including the impact of distributions reinvested in accordance with the Company’s New DRP. Total investment return-market value does not consider the effect of any sales commissions or charges that may be incurred in connection with the sale of shares of the Company’s common stock. The historical calculation of total investment return-market value in the table should not be considered a representation of the Company’s future total return based on market value, which may be greater or less than the return shown in the table due to a number of factors, including the Company’s ability or inability to make investments in companies that meet its investment criteria, the interest rates payable on the debt securities the Company acquires, the level of the Company’s expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which the Company encounters competition in its markets, general economic conditions and fluctuations in per share market value. As a result of these factors, results for any previous period should not be relied upon as being indicative of performance in future periods.
(7)
Ratio of gross operating expenses to average net assets does not include expense support provided by CIM, if any.
(8)
Portfolio turnover rate is calculated using the lesser of year-to-date sales or purchases over the average of the invested assets at fair value, excluding short term investments, and is not annualized.
(9)
Asset coverage ratio is equal to (i) the sum of (a) net assets at the end of the period and (b) total senior securities outstanding at the end of the period (excluding unfunded commitments), divided by (ii) total senior securities outstanding at the end of the period.
61
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
As used in this Quarterly Report on Form 10-Q, “we,” “us,” “our” or similar terms include CĪON Investment Corporation and its consolidated subsidiaries. In addition, the term "portfolio companies" refers to companies in which we have invested, either directly or indirectly through our consolidated subsidiaries.
The following discussion should be read in conjunction with our unaudited consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2021. In addition to historical information, the following discussion and other parts of this Quarterly Report on Form 10-Q contain forward-looking information that involves risks and uncertainties. Amounts and percentages presented herein may have been rounded for presentation and all dollar amounts, excluding share and per share amounts, are presented in thousands unless otherwise noted. In addition, all share and per share amounts have been retroactively adjusted to reflect the reverse stock split discussed below and in Note 3 to our consolidated financial statements included in this report.
Forward-Looking Statements
Some of the statements within this Quarterly Report on Form 10-Q constitute forward-looking statements because they relate to future events or our future performance or financial condition. The forward-looking statements contained in this Quarterly Report on Form 10-Q involve numerous risks and uncertainties, including statements as to:
•
our future operating results;
•
our business prospects and the prospects of our portfolio companies, including our and their ability to achieve our respective objectives as a result of COVID-19, inflation, rising interest rates, supply-chain disruptions and the risk of recession;
•
the impact of the investments that we expect to make;
•
the ability of our portfolio companies to achieve their objectives;
•
our current and expected financings and investments;
•
the adequacy of our cash resources, financing sources and working capital;
•
the use of borrowed money to finance a portion of our investments;
•
the timing of cash flows, if any, from the operations of our portfolio companies;
•
our contractual arrangements and relationships with third parties;
•
the actual and potential conflicts of interest with CIM and its affiliates;
•
the ability of CIM's investment professionals to locate suitable investments for us and the ability of CIM to monitor and administer our investments;
•
the ability of CIM and its affiliates to attract and retain highly talented professionals;
•
the dependence of our future success on the general economy and its impact on the industries in which we invest, including COVID-19, inflation, rising interest rates and supply-chain disruptions and the related economic disruptions caused thereby;
•
the effects of a changing interest rate environment;
•
our ability to source favorable private investments;
•
our tax status;
•
the effect of changes to tax legislation and our tax position;
•
the tax status of the companies in which we invest; and
•
the timing and amount of distributions and dividends from the companies in which we invest.
62
In addition, words such as “anticipate,” “believe,” “expect” and “intend” indicate a forward-looking statement, although not all forward-looking statements include these words. The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth in “Risk Factors” in Item 1A of Part II of this Quarterly Report on Form 10-Q. Other factors that could cause actual results to differ materially include:
•
changes in the economy;
•
risks associated with possible disruption in our operations or the economy generally due to terrorism, pandemics, or natural disasters; and
•
future changes in laws or regulations and conditions in our operating areas;
•
the price at which shares of our common stock may trade on and volume fluctuations in the NYSE; and
•
the costs associated with being a publicly traded company.
We have based the forward-looking statements on information available to us on the date of this Quarterly Report on Form 10-Q. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised to review any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. The forward-looking statements contained in this Quarterly Report on Form 10-Q are excluded from the safe harbor protection provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.
Overview
We were incorporated under the general corporation laws of the State of Maryland on August 9, 2011 and commenced operations on December 17, 2012 upon raising proceeds of $2,500 from persons not affiliated with us, CIM or its affiliates. We are an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a BDC under the 1940 Act. We elected to be treated for federal income tax purposes as a RIC, as defined under Subchapter M of the Code.
Our investment objective is to generate current income and, to a lesser extent, capital appreciation for investors. Our portfolio is comprised primarily of investments in senior secured debt, including first lien loans, second lien loans and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. In connection with our debt investments, we may receive equity interests such as warrants or options as additional consideration. We may also purchase equity interests in the form of common or preferred stock in our target companies, either in conjunction with one of our debt investments or through a co-investment with a financial sponsor.
On October 5, 2021, shares of our common stock began trading on the NYSE under the ticker symbol “CION”. The Listing accomplished our goal of providing our shareholders with greatly enhanced liquidity.
We are managed by CIM, our affiliate and a registered investment adviser. Pursuant to an investment advisory agreement with us, CIM oversees the management of our activities and is responsible for making investment decisions for our portfolio. On April 5, 2021, our board of directors, including a majority of directors who are not interested persons, approved the amended and restated investment advisory agreement with CIM for a period of twenty four months, which was subsequently approved by shareholders on August 9, 2021 (as described in further detail below). We and CIM previously engaged AIM to act as our investment sub-adviser.
On July 11, 2017, the members of CIM entered into the Third Amended CIM LLC Agreement for the purpose of creating a joint venture between AIM and CIG. Under the Third Amended CIM LLC Agreement, AIM became a member of CIM and was issued a newly-created class of membership interests in CIM pursuant to which AIM, among other things, shares in the profits, losses, distributions and expenses of CIM with the other members in accordance with the terms of the Third Amended CIM LLC Agreement, which results in CIG and AIM each owning a 50% economic interest in CIM.
On July 10, 2017, our independent directors unanimously approved the termination of the investment sub-advisory agreement with AIM, effective as of July 11, 2017, as part of the new and ongoing relationship among us, CIM and AIM. Although the investment sub-advisory agreement and AIM's engagement as our investment sub-adviser were terminated, AIM continues to perform certain services for CIM and us. AIM is not paid a separate fee in exchange for such services, but is entitled to receive distributions as a member of CIM as described above.
63
On December 4, 2017, the members of CIM entered into the Fourth Amended CIM LLC Agreement under which AIM performs certain services for CIM, which include, among other services, providing (a) trade and settlement support; (b) portfolio and cash reconciliation; (c) market pipeline information regarding syndicated deals, in each case, as reasonably requested by CIM; and (d) monthly valuation reports and support for all broker-quoted investments. AIM may also, from time to time, provide us with access to potential investment opportunities made available on Apollo's credit platform on a similar basis as other third-party market participants. All of our investment decisions are the sole responsibility of, and are made at the sole discretion of, CIM's investment committee, which consists entirely of CIG personnel.
The amended and restated investment advisory agreement was approved by shareholders on August 9, 2021 at our reconvened 2021 annual meeting of shareholders. As a result, on August 10, 2021, we and CIM entered into the amended and restated investment advisory agreement in order to implement the change to the calculation of the subordinated incentive fee payable from us to CIM that expresses the hurdle rate required for CIM to earn, and be paid, the incentive fee as a percentage of our net assets rather than adjusted capital.
Upon the occurrence of the Listing on October 5, 2021, we and CIM entered into the second amended and restated investment advisory agreement in order to implement the changes to the advisory fees payable from us to CIM that (i) reduced the annual base management fee, (ii) amended the structure of the subordinated incentive fee on income payable from us to CIM and reduced the hurdle and incentive fee rates, and (iii) reduced the incentive fee on capital gains payable from us to CIM (as described in further detail in Notes 2 and 4 to our consolidated financial statements included in this report).
On September 21, 2021, we effected a two to one reverse split of our shares of common stock under which every two shares of our common stock issued and outstanding were automatically combined into one share of our common stock, with the number of then issued and outstanding shares reduced from 113,916,869 to 56,958,440. The reverse stock split amendment also provided that there was no change in the par value of $0.001 per share as a result of the reverse stock split. The reverse stock split did not modify the rights or preferences of our common stock.
We seek to meet our investment objective by utilizing the experienced management team of CIM, which includes its access to the relationships and human capital of its affiliates in sourcing, evaluating and structuring transactions, as well as monitoring and servicing our investments. We focus primarily on the senior secured debt of private and thinly-traded U.S. middle-market companies, which we define as companies that generally possess annual EBITDA of $75 million or less, with experienced management teams, significant free cash flow, strong competitive positions and potential for growth.
Revenue
We primarily generate revenue in the form of interest income on the debt securities that we hold and capital gains on debt or other equity interests that we acquire in portfolio companies. The majority of our senior debt investments bear interest at a floating rate. Interest on debt securities is generally payable quarterly or monthly. In some cases, some of our investments may provide for deferred interest payments or PIK interest. The principal amount of the debt securities and any accrued, but unpaid, interest generally will become due at the maturity date. In addition, we may generate revenue in the form of commitment and capital structuring fees, monitoring fees, fees for providing managerial assistance and possibly consulting fees and performance-based fees. Any such fees generated in connection with our investments will be recognized when earned.
Operating Expenses
Our primary operating expenses are the payment of management fees and subordinated incentive fees on income under the investment advisory agreement and interest expense on our financing arrangements. Our investment advisory fees compensate CIM for its work in identifying, evaluating, negotiating, executing, monitoring and servicing our investments. We bear all other expenses of our operations and transactions.
Recent Developments
Share Repurchase Policy
On August 16, 2022, as part of our $60 million share repurchase policy, we entered into a trading plan with an independent broker, Wells Fargo, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, based in part on historical trading data with respect to our shares. The 10b5-1 trading plan permits common stock to be repurchased at a time that we might otherwise be precluded from doing so under insider trading laws or self-imposed trading restrictions. The 10b5-1 trading plan is subject to price, market volume and timing restrictions.
Declaration of Q4 2022 Distribution
On November 8, 2022, our co-chief executive officers declared a regular quarterly distribution of $0.31 per share for the fourth quarter of 2022 payable on December 8, 2022 to shareholders of record as of December 1, 2022.
64
Portfolio Investment Activity for the Three Months Ended September 30, 2022 and 2021 and the Year Ended December 31, 2021
The following table summarizes our investment activity, excluding short term investments and PIK securities, for the three months ended September 30, 2022 and 2021 and the year ended December 31, 2021:
Three Months Ended
September 30,
Year Ended
December 31,
Net Investment Activity
2022
2021
2021
Purchases and drawdowns
Senior secured first lien debt
$
119,789
$
160,124
$
868,031
Senior secured second lien debt
18,108
—
—
Unsecured debt
—
—
20,000
Equity
3,379
4,909
32,008
Sales and principal repayments
(154,872)
(223,214)
(827,958)
Net portfolio activity
$
(13,596)
$
(58,181)
$
92,081
The following tables summarize the composition of our investment portfolio at amortized cost and fair value as of September 30, 2022 and December 31, 2021:
September 30, 2022
Investments Cost(1)
Investments Fair
Value
Percentage of
Investment
Portfolio
Senior secured first lien debt
$
1,690,919
$
1,616,352
89.8
%
Senior secured second lien debt
40,988
38,716
2.2
%
Collateralized securities and structured products - equity
2,733
1,366
0.1
%
Unsecured debt
28,738
28,319
1.6
%
Equity
78,795
112,491
6.3
%
Subtotal/total percentage
1,842,173
1,797,244
100.0
%
Short term investments(2)
9,804
9,804
Total investments
$
1,851,977
$
1,807,048
Number of portfolio companies
119
Average annual EBITDA of portfolio companies
$57.2 million
Median annual EBITDA of portfolio companies
$37.3 million
Purchased at a weighted average price of par
97.19
%
Gross annual portfolio yield based upon the purchase price(3)
10.33
%
(1)
Represents amortized cost for debt investments and cost for equity investments. Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on our investments.
(2)
Short term investments represent an investment in a fund that invests in highly liquid investments with average original maturity dates of three months or less.
(3)
The gross annual portfolio yield does not represent and may be higher than an actual investment return to shareholders because it excludes our expenses and all sales commissions and dealer manager fees and does not consider the cost of leverage.
65
December 31, 2021
Investments Cost(1)
Investments Fair
Value
Percentage of
Investment
Portfolio
Senior secured first lien debt
$
1,564,891
$
1,526,989
91.6
%
Senior secured second lien debt
55,455
38,583
2.3
%
Collateralized securities and structured products - equity
3,885
2,998
0.2
%
Unsecured debt
26,777
26,616
1.6
%
Equity
53,379
70,936
4.3
%
Subtotal/total percentage
1,704,387
1,666,122
100.0
%
Short term investments(2)
87,917
87,917
Total investments
$
1,792,304
$
1,754,039
Number of portfolio companies
113
Average annual EBITDA of portfolio companies
$50.4 million
Median annual EBITDA of portfolio companies
$36.3 million
Purchased at a weighted average price of par
98.13
%
Gross annual portfolio yield based upon the purchase price(3)
8.62
%
(1)
Represents amortized cost for debt investments and cost for equity investments. Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on our investments.
(2)
Short term investments represent an investment in a fund that invests in highly liquid investments with average original maturity dates of three months or less.
(3)
The gross annual portfolio yield does not represent and may be higher than an actual investment return to shareholders because it excludes our expenses and all sales commissions and dealer manager fees and does not consider the cost of leverage.
The following table summarizes the composition of our investment portfolio by the type of interest rate as of September 30, 2022 and December 31, 2021, excluding short term investments of $9,804 and $87,917, respectively:
September 30, 2022
December 31, 2021
Interest Rate Allocation
Investments Cost
Investments Fair Value
Percentage of
Investment
Portfolio
Investments Cost
Investments Fair Value
Percentage of
Investment
Portfolio
Floating interest rate investments
$
1,561,760
$
1,489,416
82.9
%
$
1,454,429
$
1,403,097
84.2
%
Fixed interest rate investments
193,971
188,045
10.5
%
176,326
172,162
10.3
%
Non-income producing investments
75,261
110,018
6.1
%
49,845
67,532
4.1
%
Other income producing investments
11,181
9,765
0.5
%
23,787
23,331
1.4
%
Total investments
$
1,842,173
$
1,797,244
100.0
%
$
1,704,387
$
1,666,122
100.0
%
66
The following table shows the composition of our investment portfolio by industry classification and the percentage, by fair value, of the total assets in such industries as of September 30, 2022 and December 31, 2021:
September 30, 2022
December 31, 2021
Industry Classification
Investments Fair Value
Percentage of
Investment Portfolio
Investments Fair Value
Percentage of
Investment Portfolio
Services: Business
$
354,725
19.7
%
$
240,316
14.4
%
Healthcare & Pharmaceuticals
279,102
15.5
%
250,049
15.0
%
Media: Diversified & Production
159,236
8.9
%
139,399
8.4
%
Services: Consumer
117,340
6.5
%
119,365
7.2
%
Diversified Financials
106,426
5.9
%
101,032
6.1
%
High Tech Industries
81,364
4.5
%
65,544
3.9
%
Media: Advertising, Printing & Publishing
78,855
4.4
%
94,610
5.7
%
Chemicals, Plastics & Rubber
66,927
3.7
%
109,860
6.6
%
Retail
64,919
3.6
%
56,726
3.4
%
Energy: Oil & Gas
62,688
3.5
%
32,164
1.9
%
Consumer Goods: Durable
61,165
3.4
%
58,124
3.5
%
Hotel, Gaming & Leisure
53,065
3.0
%
50,855
3.0
%
Beverage, Food & Tobacco
49,641
2.8
%
49,054
2.9
%
Construction & Building
42,060
2.3
%
27,585
1.7
%
Capital Equipment
41,183
2.3
%
82,795
5.0
%
Banking, Finance, Insurance & Real Estate
39,631
2.2
%
40,634
2.4
%
Aerospace & Defense
38,683
2.2
%
38,279
2.3
%
Consumer Goods: Non-Durable
35,647
2.0
%
45,682
2.7
%
Telecommunications
18,842
1.0
%
24,649
1.5
%
Automotive
17,259
1.0
%
14,367
0.9
%
Metals & Mining
16,202
0.9
%
10,927
0.7
%
Transportation: Cargo
12,284
0.7
%
14,106
0.8
%
Subtotal/total percentage
1,797,244
100.0
%
1,666,122
100.0
%
Short term investments
9,804
87,917
Total investments
$
1,807,048
$
1,754,039
Our investment portfolio may contain senior secured investments that are in the form of lines of credit, delayed draw term loans, revolving credit facilities, or unfunded commitments, which may require us to provide funding when requested in accordance with the terms of the underlying agreements. As of September 30, 2022 and December 31, 2021, our
unfunded commitments amounted to $83,853 and
$107,247
, respectively. As of November 3, 2022, our unfunded commitments amount
ed to $80,966,000. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for us. Refer to the section “Commitments and Contingencies” for further details on our unfunded commitments.
Investment Portfolio Asset Quality
CIM uses an investment rating system to characterize and monitor our expected level of returns on each investment in our portfolio. These ratings are just one of several factors that CIM uses to monitor our portfolio, are not in and of themselves determinative of fair value or revenue recognition and are presented for indicative purposes. CIM rates the credit risk of all investments on a scale of 1 to 5 no less frequently than quarterly. This system is intended primarily to reflect the underlying risk of a portfolio investment relative to our initial cost basis in respect of such portfolio investment (i.e., at the time of acquisition), although it may also take into account under certain circumstances the performance of the portfolio company’s business, the collateral coverage of the investment and other relevant factors.
67
The following is a description of the conditions associated with each investment rating used in this ratings system:
Investment Rating
Description
1
Indicates the least amount of risk to our initial cost basis. The trends and risk factors for this investment since origination or acquisition are generally favorable, which may include the performance of the portfolio company or a potential exit.
2
Indicates a level of risk to our initial cost basis that is similar to the risk to our initial cost basis at the time of origination or acquisition. This portfolio company is generally performing in accordance with our analysis of its business and the full return of principal and interest or dividend is expected.
3
Indicates that the risk to our ability to recoup the cost of such investment has increased since origination or acquisition, but full return of principal and interest or dividend is expected. A portfolio company with an investment rating of 3 requires closer monitoring.
4
Indicates that the risk to our ability to recoup the cost of such investment has increased significantly since origination or acquisition, including as a result of factors such as declining performance and noncompliance with debt covenants, and we expect some loss of interest, dividend or capital appreciation, but still expect an overall positive internal rate of return on the investment.
5
Indicates that the risk to our ability to recoup the cost of such investment has increased materially since origination or acquisition and the portfolio company likely has materially declining performance. Loss of interest or dividend and some loss of principal investment is expected, which would result in an overall negative internal rate of return on the investment.
For investments rated 3, 4, or 5, CIM enhances its level of scrutiny over the monitoring of such portfolio company.
The following table summarizes the composition of our investment portfolio based on the 1 to 5 investment rating scale at fair value as of September 30, 2022 and December 31, 2021, excluding short term investments of $9,804 and $87,917, respectively:
September 30, 2022
December 31, 2021
Investment Rating
Investments
Fair Value
Percentage of
Investment Portfolio
Investments
Fair Value
Percentage of
Investment Portfolio
1
$
63,230
3.5
%
$
47,221
2.8
%
2
1,521,269
84.7
%
1,373,509
82.5
%
3
204,993
11.4
%
233,223
14.0
%
4
7,035
0.4
%
8,201
0.5
%
5
717
—
3,968
0.2
%
$
1,797,244
100.0
%
$
1,666,122
100.0
%
The amount of the investment portfolio in each rating category may vary substantially from period to period resulting primarily from changes in the composition of such portfolio as a result of new investment, repayment and exit activities. In addition, changes in the rating of investments may be made to reflect our expectation of performance and changes in investment values.
68
Current Investment Portfolio
The following table summarizes the composition of our investment portfolio at fair value as of November 3, 2022:
Investments Fair
Value
Percentage of
Investment
Portfolio
Senior secured first lien debt
$
1,625,390
90.0
%
Senior secured second lien debt
38,716
2.1
%
Collateralized securities and structured products - equity
1,366
0.1
%
Unsecured debt
28,319
1.6
%
Equity
112,459
6.2
%
Subtotal/total percentage
1,806,250
100.0
%
Short term investments(2)
15,885
Total investments
$
1,822,135
Number of portfolio companies
119
Average annual EBITDA of portfolio companies
$56.9 million
Median annual EBITDA of portfolio companies
$39.3 million
Purchased at a weighted average price of par
97.93
%
Gross annual portfolio yield based upon the purchase price(2)
10.35
%
(1)
Short term investments represent an investment in a fund that invests in highly liquid investments with average original maturity dates of three months or less.
(2)
The gross annual portfolio yield does not represent and may be higher than an actual investment return to shareholders because it excludes our expenses and all sales commissions and dealer manager fees and does not consider the cost of leverage.
Results of Operations for the Three Months Ended September 30, 2022 and 2021
Our results of operations for the three months ended September 30, 2022 and 2021 were as follows:
Three Months Ended
September 30,
2022
2021
Investment income
$
54,163
$
42,620
Operating expenses and income taxes
28,606
23,008
Net investment income after taxes
25,557
19,612
Net realized (loss) gain on investments and foreign currency
(17,169)
19,736
Net change in unrealized appreciation (depreciation) on investments
25,595
(14,240)
Net increase in net assets resulting from operations
$
33,983
$
25,108
Investment Income
For the three months ended September 30, 2022 and 2021, we generated investment income of $54,163 and $42,620, respectively, consisting primarily of interest income on investments in senior secured debt, collateralized securities and structured products, and unsecured debt of 116 and 128 portfolio companies held during each respective period. Our average investment portfolio size, excluding our short term investments, increased $141,167, from $1,653,009 for the three months ended September 30, 2021 to $1,794,176 for the three months ended September 30, 2022. In addition, higher LIBOR and SOFR rates during the three months ended September 30, 2022 compared to the three months ended September 30, 2021 also contributed to the increase in interest income generated on our investments.
69
Operating Expenses and Income Taxes
The composition of our operating expenses and income taxes for the three months ended September 30, 2022 and 2021 was as follows:
Three Months Ended
September 30,
2022
2021
Management fees
$
6,942
$
8,443
Administrative services expense
733
722
Subordinated incentive fee on income
5,421
2,933
General and administrative
2,027
2,709
Interest expense
13,469
8,175
Income tax expense, including excise tax
14
26
Total operating expenses and income taxes
$
28,606
$
23,008
The increase in interest expense was primarily the result of (a) higher average borrowings under our financing arrangements during the three months ended September 30, 2022 compared to the three months ended September 30, 2021, and (b) higher LIBOR and SOFR rates during the three months ended September 30, 2022 compared to the three months ended September 30, 2021. The increase in subordinated incentive fee on income was primarily the result of entering into (i) the amended and restated investment advisory agreement in August 2021, which changed the calculation of the subordinated incentive fee to express the hurdle rate required for CIM to earn, and be paid, the incentive fee as a percentage of our net assets rather than adjusted capital, and (ii) the second amended and restated investment advisory agreement in October 2021, which reduced the hurdle rate applicable to the subordinated incentive fee. The decrease in management fees was also primarily due to entering into the second amended and restated investment advisory agreement in October 2021, which among other things, reduced the annual rate from 2.0% to 1.5%.
The composition of our general and administrative expenses for the three months ended September 30, 2022 and 2021 was as follows:
Three Months Ended
September 30,
2022
2021
Printing and marketing expense
$
672
$
235
Transfer agent expense
296
316
Professional fees
223
1,355
Valuation expense
199
191
Accounting and administrative costs
180
194
Director fees and expenses
162
151
Insurance expense
157
135
Dues and subscriptions
112
120
Other expenses
26
12
Total general and administrative expense
$
2,027
$
2,709
Net Investment Income After Taxes
Our net investment income after taxes totaled $25,557 and $19,612 for the three months ended September 30, 2022 and 2021, respectively. The increase in net investment income was a result of an increase in our investment income during the three months ended September 30, 2022 as compared to the three months ended September 30, 2021, which was partially offset by an increase in our operating expenses during the same period, which was driven primarily by increases in the subordinated incentive fee on income and interest expense.
Net Realized (Loss) Gain on Investments and Foreign Currency
Our net realized (loss) gain on investments and foreign currency totaled $(17,169) and $19,736 for the three months ended September 30, 2022 and 2021, respectively. This change was driven primarily by the write-off of certain investments during the three months ended September 30, 2022 as compared to realized gains recognized on the exit of our investment in Conisus Holdings, Inc. during the three months ended September 30, 2021.
70
Net Change in Unrealized Appreciation (Depreciation) on Investments
The net change in unrealized appreciation (depreciation) on our investments totaled $25,595 and $(14,240) for the three months ended September 30, 2022 and 2021, respectively. This change was driven primarily by the realization of previously unrealized losses on certain investment write-offs and restructurings during the three months ended September 30, 2022 compared to the realization of certain previously unrealized gains and the continued recovery of loan prices during the three months ended September 30, 2021.
Net Increase in Net Assets Resulting from Operations
For the three months ended September 30, 2022 and 2021, we recorded a net increase in net assets resulting from operations of $33,983 and $25,108, respectively, as a result of our operating activity for the respective periods.
Results of Operations for the Nine Months Ended September 30, 2022 and 2021
Our results of operations for the nine months ended September 30, 2022 and 2021 were as follows:
Nine Months Ended
September 30,
2022
2021
Investment income
$
139,398
$
116,944
Operating expenses and income taxes
75,070
61,047
Net investment income after taxes
64,328
55,897
Net realized (loss) gain on investments and foreign currency
(17,058)
16,049
Net change in unrealized (depreciation) appreciation on investments
(6,664)
30,845
Net increase in net assets resulting from operations
$
40,606
$
102,791
Investment Income
For the nine months ended September 30, 2022 and 2021, we generated investment income of $139,398 and $116,944, respectively, consisting primarily of interest income on investments in senior secured debt, collateralized securities and structured products, and unsecured debt of 128 and 135 portfolio companies held during each respective period. Our average investment portfolio size, excluding our short term investments, increased $168,564, from $1,563,119 for the nine months ended September 30, 2021 to $1,731,683 for the nine months ended September 30, 2022. Additionally, the increase in LIBOR and SOFR rates during the nine months ended September 30, 2022 as compared to the nine months ended September 30, 2021 also contributed to the increase in interest income generated on our investments.
Operating Expenses and Income Taxes
The composition of our operating expenses and income taxes for the nine months ended September 30, 2022 and 2021 was as follows:
Nine Months Ended
September 30,
2022
2021
Management fees
$
20,436
$
24,469
Administrative services expense
2,234
2,103
Subordinated incentive fee on income
13,645
2,933
General and administrative
5,961
7,950
Interest expense
32,769
23,551
Income tax expense, including excise tax
25
41
Total operating expenses and income taxes
$
75,070
$
61,047
71
The increase in subordinated incentive fee on income was primarily the result of entering into (i) the amended and restated investment advisory agreement in August 2021, which changed the calculation of the subordinated incentive fee to express the hurdle rate required for CIM to earn, and be paid, the incentive fee as a percentage of our net assets rather than adjusted capital, and (ii) the second amended and restated investment advisory agreement in October 2021, which reduced the hurdle rate applicable to the subordinated incentive fee. The increase in interest expense was primarily the result of (a) higher average borrowings under our financing arrangements during the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021, and (b) higher LIBOR and SOFR rates during the nine months ended September 30, 2022 compared to the nine months ended September 30, 2021. The decrease in management fees was also primarily due to entering into the second amended and restated investment advisory agreement in October 2021, which, among other things, reduced the annual rate from 2.0% to 1.5%.
The composition of our general and administrative expenses for the nine months ended September 30, 2022 and 2021 was as follows:
Nine Months Ended
September 30,
2022
2021
Professional fees
$
1,375
$
3,833
Transfer agent expense
890
991
Dues and subscriptions
727
316
Printing and marketing expense
705
634
Insurance expense
662
404
Valuation expense
590
712
Accounting and administrative costs
482
606
Director fees and expenses
477
365
Other expenses
53
89
Total general and administrative expense
$
5,961
$
7,950
The decrease in general and administrative expenses was primarily the result of (i) higher professional fees incurred during the nine months ended September 30, 2021 associated with the listing of our shares on the NYSE with no comparable listing-related fees during the nine months ended September 30, 2022, and (ii) higher dues and subscriptions paid during the nine months ended September 30, 2021 compared to the nine months ended September 30, 2022 associated with the listing of our shares on the NYSE.
Net Investment Income After Taxes
Our net investment income after taxes totaled $64,328 and $55,897 for the nine months ended September 30, 2022 and 2021, respectively. The increase in our net investment income was a result of an increase in our investment income during the nine months ended September 30, 2022 as compared to the nine months ended September 30, 2021, which was partially offset by an increase in our operating expenses during the same period, which was driven primarily by increases in the subordinated incentive fee on income and interest expense.
Net Realized (Loss) Gain on Investments and Foreign Currency
Our net realized (loss) gain on investments and foreign currency totaled $(17,058) and $16,049 for the nine months ended September 30, 2022 and 2021, respectively. This change was driven primarily by the write-off of certain investments during the nine months ended September 30, 2022 compared to realized gains recognized on the exit of our investment in Conisus Holdings, Inc. during the nine months ended September 30, 2021.
Net Change in Unrealized (Depreciation) Appreciation on Investments
The net change in unrealized (depreciation) appreciation on our investments totaled $(6,664) and $30,845 for the nine months ended September 30, 2022 and 2021, respectively. This change was primarily driven by widening credit spreads and decreased multiples in equity markets that negatively impacted the fair value of certain of our investments during the nine months ended September 30, 2022, which was partially offset by the realization of previously unrealized losses on certain investment write-offs and restructurings. This compares to tightening credit spreads and increased multiples in equity markets that positively impacted the fair value of certain of our investments during the nine months ended September 30, 2021, which was partially offset by the realization of certain previously unrealized gains.
Net Increase in Net Assets Resulting from Operations
For the nine months ended September 30, 2022 and 2021, we recorded a net increase in net assets resulting from operations of $40,606 and $102,791, respectively, as a result of our operating activity for the respective periods.
72
Financial Condition, Liquidity and Capital Resources
We generate cash primarily from cash flows from interest, fees and dividends earned from our investments as well as principal repayments and proceeds from sales of our investments. We also employ leverage to seek to enhance our returns as market conditions permit and at the discretion of CIM and pursuant to the 1940 Act. As a result, we also generate cash from our existing financing arrangements and may generate cash from future borrowings, as well as future offerings of securities including public and/or private issuances of debt and/or equity securities. We use cash primarily to (i) purchase investments in new and existing portfolio companies, (ii) pay for the cost of operations (including paying or reimbursing CIM), (iii) make debt service payments related to any of our financing arrangements and (iv) pay cash distributions to the holders of our shares.
On March 23, 2018, an amendment to Section 61(a) of the 1940 Act was signed into law to permit BDCs to reduce the minimum “asset coverage” ratio from 200% to 150% and, as a result, to potentially increase the ratio of a BDC’s debt to equity from a maximum of 1-to-1 to a maximum of 2-to-1, so long as certain approval and disclosure requirements are satisfied. As a result of receiving shareholder approval on December 30, 2021, effective December 31, 2021, we are required to maintain asset coverage for our senior securities of 150% rather than 200%, which allows us to increase the maximum amount of leverage that we are permitted to incur. We may from time to time enter into additional financing arrangements or increase the size of our existing financing arrangements. Any such increase to our leverage would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors.
As of September 30, 2022 and December 31, 2021, our asset coverage ratio was 1.96 and 2.12, respectively. We seek to carefully consider our unfunded commitments for the purpose of planning our ongoing financial leverage.
On September 15, 2022, our shareholders authorized us to issue shares of our common stock at prices below the then current NAV per share in one or more offerings for a 12-month period following such shareholder approval. As of the date of this report, we are not engaged in discussions to issue any such shares.
As of September 30, 2022, we had cash of $43,661 and short term investments of $9,804 invested in a fund that primarily invests in U.S. government securities. Cash and short term investments as of September 30, 2022, taken together with our available debt, is expected to be sufficient for our investing activities and to conduct our operations in the near term. As of September 30, 2022, we had $72 million available under our financing arrangements.
Our short-term cash needs include the funding of additional portfolio investments, the payment of operating expenses including interest expense, management fees, incentive fees, administrative services expense and general and administrative expenses, as well as paying distributions to our shareholders. Our long-term cash needs will include principal payments on outstanding financing arrangements and funding of additional portfolio investments. Funding for short and long-term cash needs will come from cash provided from operating activities and/or unused net proceeds from financing activities. We believe that our liquidity and sources of capital are adequate to satisfy our short and long-term cash requirements. We cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to us in sufficient amounts in the future.
Post-Listing Share Repurchase Policy
On September 15, 2021, our board of directors, including the independent directors, approved a share repurchase policy authorizing us to repurchase up to $50 million of our outstanding common stock after the Listing. On June 24, 2022, our board of directors, including the independent directors, increased the amount of shares of our common stock that may be repurchased under the share repurchase policy by $10 million to up to an aggregate of $60 million. Under the share repurchase policy, we may purchase shares of our common stock through various means such as open market transactions, including block purchases, and privately negotiated transactions. The number of shares repurchased and the timing, manner, price and amount of any repurchases will be determined at our discretion. Factors include, but are not limited to, share price, trading volume and general market conditions, along with our general business conditions. The policy may be suspended or discontinued at any time and does not obligate us to acquire any specific number of shares of our common stock.
On August 16, 2022, as part of the share repurchase policy, we entered into a trading plan with an independent broker, Wells Fargo, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, based in part on historical trading data with respect to our shares. The 10b5-1 trading plan permits common stock to be repurchased at a time that we might otherwise be precluded from doing so under insider trading laws or self-imposed trading restrictions. The 10b5-1 trading plan is subject to price, market volume and timing restrictions.
During the three months ended September 30, 2022, we repurchased an aggregate of 695,476 shares under the 10b5-1 trading plan for an aggregate purchase price of $6,711, or an average purchase price of $9.65 per share.
From October 1, 2022 to November 3, 2022, we repurchased an aggregate of 836,218 shares of common stock under the 10b5-1 trading plan for an aggregate purchase price of $7,500, or an average purchase price of $8.97 per share.
73
Distributions
To qualify for and maintain RIC tax treatment, we must, among other things, distribute in respect of each taxable year at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. We will incur an excise tax of 4% imposed on RICs to the extent we do not distribute in respect of each calendar year an amount at least equal to the sum of (1) 98.0% of our net ordinary income (taking into account certain deferrals and elections) for the calendar year, (2) 98.2% of our capital gains in excess of capital losses, or capital gain net income (adjusted for certain ordinary losses), for the one-year period ending on October 31 of the calendar year and (3) any net ordinary income and capital gain net income from preceding years that were not distributed during such years and on which we paid no federal income tax.
We intend to make distributions in an amount sufficient to maintain RIC status each year and to avoid any federal income taxes on income. Therefore, subject to applicable legal restrictions and the sole discretion of our board of directors, we intend to authorize, declare, and pay regular distributions on a quarterly basis. Regular and special distributions in respect of future periods will be evaluated by management and our board of directors based on circumstances and expectations existing at the time of consideration.
The following table presents distributions per share that were declared during the year ended December 31, 2021 and the nine months ended September 30, 2022:
Distributions
Three Months Ended
Per Share
Amount
2021
March 31, 2021 (three record dates)(1)
$
0.2648
$
15,029
June 30, 2021 (three record dates)(1)
0.2648
15,000
September 30, 2021 (three record dates)
0.2648
15,027
December 31, 2021 (two record dates)
0.4648
26,474
Total distributions for the year ended December 31, 2021
$
1.2592
$
71,530
2022
March 31, 2022 (one record date)
$
0.2800
$
15,948
June 30, 2022 (one record date)
0.2800
15,949
September 30, 2022 (one record date)
0.3100
17,604
Total distributions for the nine months ended September 30, 2022
$
0.8700
$
49,501
(1) The per share distribution amount has been retroactively adjusted to reflect the reverse stock split as discussed in Note 3.
On November 8, 2022, our co-chief executive officers declared a regular quarterly distribution of $0.31 per share for the fourth quarter of 2022 payable on December 8, 2022 to shareholders of record as of December 1, 2022. For an additional discussion of our RIC status and distributions, refer to Note 2 and Note 5, respectively, of our consolidated financial statements included in this report.
74
JPM Credit Facility
As of September 30, 2022 and November 3, 2022, our aggregate outstanding borrowings under the JPM Credit Facility were $610,000 and the aggregate unfunded principal amount in connection with the JPM Credit Facility was $65,000. For a detailed discussion of our JPM Credit Facility, refer to Note 8 to our consolidated financial statements included in this report.
UBS
Facility
As of September 30, 2022 and November 3, 2022, our outstanding borrowings under the Amended UBS Facility were $142,500 and the aggregate unfunded principal amount in connection with the Amended UBS Facility was $7,500. For a detailed discussion of our Amended UBS Facility, refer to Note 8 to our consolidated financial statements included in this report.
2026 Notes
As of September 30, 2022 and November 3, 2022, we had $125,000 in aggregate principal amount of 2026 Notes outstanding and there was no unfunded principal amount in connection with the 2026 Notes. For a detailed discussion of our 2026 Notes, refer to Note 8 to our consolidated financial statements included in this report.
2021 More Term Loan
As of September 30, 2022 and November 3, 2022, our outstanding borrowings under the 2021 More Term Loan were $30,000 and there was no unfunded principal amount in connection with the 2021 More Term Loan. For a detailed discussion of our 2021 More Term Loan, refer to Note 8 to our consolidated financial statements included in this report.
2022 More Term Loan
As of September 30, 2022 and November 3, 2022, our outstanding borrowings under the 2022 More Term Loan were $50,000 and there was no unfunded principal amount in connection with the 2022 More Term Loan. For a detailed discussion of our 2022 More Term Loan, refer to Note 8 to our consolidated financial statements included in this report.
Unfunded Commitments
As of September 30, 2022 and November 3, 2022, our unfunded commitments amounted to $83,853 and $80,966,000, respectively. For a detailed discussion of our unfunded commitments, refer to Note 11 to our consolidated financial statements included in this report.
Recent Accounting Pronouncements
See Note 2 to our consolidated financial statements included in this report for a discussion of certain recent accounting pronouncements that are applicable to us.
75
Critical Accounting Policies
Our consolidated financial statements are prepared in conformity with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Critical accounting policies are those that require the application of management’s most difficult, subjective or complex judgments, often because of the need to make estimates about the effect of matters that are inherently uncertain and that may change in subsequent periods. In preparing the consolidated financial statements, we also utilize available information, including our past history, industry standards and the current economic environment, among other factors, in forming our estimates and judgments, giving due consideration to materiality. Actual results may differ from these estimates. In addition, other companies may utilize different estimates, which may impact the comparability of our results of operations to those of companies in similar businesses.
Valuation of Portfolio Investments
The value of our assets is determined quarterly and at such other times that an event occurs that materially affects the valuation. The valuation is made pursuant to Section 2(a)(41) of the 1940 Act, which requires that we value our assets as follows: (i) the market price for those securities for which a market quotation is readily available, and (ii) for all other securities and assets, at fair value, as determined in good faith by our board of directors. As a BDC, Section 2(a)(41) of the 1940 Act requires the board of directors to determine in good faith the fair value of portfolio securities for which a market price is not readily available, and it does so in conjunction with the application of our valuation procedures by CIM. In accordance with Rule 2a-5 of the 1940 Act, our board of directors has designated CIM as our “valuation designee.” Our board of directors and the audit committee of our board of directors, which is comprised solely of our independent directors, oversees the activities, methodology and processes of the valuation designee.
There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each asset while employing a valuation process that is consistently followed. Determinations of fair value involve subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations in our consolidated financial statements.
Valuation Methods
With respect to investments for which market quotations are not readily available, CIM, as the valuation designee of our board of directors, undertakes a multi-step valuation process each quarter, as described below:
•
the quarterly valuation process generally begins with each portfolio company or investment either being sent directly to an independent valuation firm or initially valued by certain of CIM’s investment professionals and certain members of its management team, with such valuation taking into account information received from various sources, including independent valuation firms, if applicable;
•
preliminary valuation conclusions are then documented and discussed by members of CIM’s management team;
•
designated members of CIM’s management team review the preliminary valuation, and, if applicable, deliver such preliminary valuation to an independent valuation firm for its review;
•
designated members of CIM’s management team and, if appropriate, the relevant investment professionals meet with the independent valuation firm to discuss the preliminary valuation;
•
designated members of CIM’s management team respond and supplement the preliminary valuation to reflect any comments provided by the independent valuation firm;
•
our audit committee meets with members of CIM’s management team and the independent valuation firms to discuss the assistance provided and the results of the independent valuation firms' review; and
•
our board of directors and our audit committee provide oversight with respect to this valuation process, including requesting such materials as they may determine appropriate.
76
We shall promptly (but no later than five business days after we become aware) report to our board of directors in writing on the occurrence of matters that materially affect the fair value of the designated portfolio of investments. Material matters in this instance include a significant deficiency or material weakness in the design or effectiveness of CIM’s fair value determination process resulting in a material error in the calculation of net asset value of $0.01 per share or greater.
In addition to the foregoing, certain investments for which a market price is not readily available are evaluated on a quarterly basis by an independent valuation firm and certain other investments are on a rotational basis reviewed by an independent valuation firm. Finally, certain investments are not evaluated by an independent valuation firm unless certain aspects of such investments in the aggregate meet certain criteria.
Given the expected types of investments, excluding short term investments and stock of publicly traded companies that are classified as Level 1, management expects our portfolio holdings to be classified as Level 3. Due to the uncertainty inherent in the valuation process, particularly for Level 3 investments, such fair value estimates may differ significantly from the values that would have been used had an active market for the investments existed. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses that we ultimately realize on these investments to materially differ from the valuations currently assigned. Inputs used in the valuation process are subject to variability in the future and can result in materially different fair values.
For an additional discussion of our investment valuation process, refer to Note 2 to our consolidated financial statements included in this report.
Related Party Transactions
For a discussion of our relationship with related parties including CIM, CIG, and AIA and amounts incurred under agreements with such related parties, refer to Note 4 to our consolidated financial statements included in this report.
Contractual Obligations
On August 26, 2016, 34th Street entered into the JPM Credit Facility with JPM, as amended and restated on September 30, 2016, July 11, 2017, November 28, 2017, May 23, 2018, May 15, 2020, February 26, 2021 and March 28, 2022. See Note 8 to our consolidated financial statements for a more detailed description of the JPM Credit Facility.
On May 19, 2017, Murray Hill Funding II entered into the UBS Facility with UBS, as amended on December 1, 2017, May 19, 2020, November 12, 2020 and December 17, 2020. See Note 8 to our consolidated financial statements for a more detailed description of the UBS Facility.
On February 11, 2021, we entered into the Note Purchase Agreement with purchasers of the 2026 Notes. See Note 8 to our consolidated financial statements for a more detailed description of the 2026 Notes.
On April 14, 2021, we entered into the 2021 More Term Loan with More. See Note 8 to our consolidated financial statements for a more detailed description of the 2021 More Term Loan.
On April 27, 2022, we entered into the 2022 More Term Loan with More Provident. See Note 8 to our consolidated financial statements for a more detailed description of the 2022 More Term Loan.
Commitments and Contingencies
We have entered into certain contracts with other parties that contain a variety of indemnifications. Our maximum exposure under these arrangements is unknown. However, we have not experienced claims or losses pursuant to these contracts and believe the risk of loss related to such indemnifications to be remote.
Our investment portfolio may contain debt investments that are in the form of lines of credit, delayed draw term loans, revolving credit facilities, or other unfunded commitments, which may require us to provide funding when requested in accordance with the terms of the underlying agreements. For further details on such debt investments, refer to Note 11 to our consolidated financial statements included in this report.
We currently have no off-balance sheet arrangements, except for those discussed in Note 7 and Note 11 to our consolidated financial statements included in this report.
77
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are subject to financial market risks, including changes in interest rates. As of September 30, 2022, 82.9% of our investments paid variable interest rates. A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments, especially to the extent that we hold variable rate investments, and to declines in the value of any fixed rate investments we may hold. To the extent that a majority of our investments may be in variable rate investments, an increase in interest rates could make it easier for us to meet or exceed our incentive fee hurdle rate, as defined in our investment advisory agreement, and may result in a substantial increase in our net investment income, and also to the amount of incentive fees payable to CIM with respect to our pre-incentive fee net investment income.
As of September 30, 2022, under the terms of the Third Amended JPM Credit Facility, advances bear interest at a floating rate equal to the three-month LIBOR, plus a spread of 3.10% per year. Under the terms of the JPM First Amendment, additional advances of up to $100,000 bear interest at a floating rate equal to the three-month SOFR, plus a credit spread of 3.10% per year, and a LIBOR to SOFR credit spread adjustment of 0.15%. Pursuant to the terms of the Amended UBS Facility, we currently pay a financing fee equal to the three-month LIBOR, plus a spread of 3.375% per year. Pursuant to the terms of the 2022 More Term Loan, advances bear interest at a floating rate equal to the three-month SOFR, plus a credit spread of 3.50% per year and subject to a 1.0% SOFR floor. In addition, we may seek to further borrow funds in order to make additional investments. Our net investment income will be impacted, in part, by the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we would be subject to risks relating to changes in market interest rates. In periods of rising interest rates when we have debt outstanding, our cost of funds would increase, which could reduce our net investment income, especially to the extent we hold fixed rate investments. We expect that our long-term investments will be financed primarily with equity and long-term debt. Our interest rate risk management techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. Adverse developments resulting from changes in interest rates could have a material adverse effect on our business, financial condition and results of operations.
The following table shows the effect over a twelve month period of changes in interest rates on our net interest income, excluding short term investments, assuming no changes in our investment portfolio, the Third Amended JPM Credit Facility (including the JPM First Amendment), the Amended UBS Facility or the 2022 More Term Loan in effect as of September 30, 2022:
Basis Point Change in Interest Rates
(Decrease) Increase in Net Interest Income(1)
Percentage Change in Net Interest Income
Down 300 basis points
$
(7,733)
(6.6)
%
Down 200 basis points
(10,866)
(9.3)
%
Down 100 basis points
(6,390)
(5.5)
%
Down 50 basis points
(3,247)
(2.8)
%
No change to current base rate (3.16% as of September 30, 2022)
—
—
Up 50 basis points
3,341
2.9
%
Up 100 basis points
6,824
5.8
%
Up 200 basis points
13,791
11.8
%
Up 300 basis points
20,757
17.8
%
(1)
This table assumes no change in defaults or prepayments by portfolio companies over the next twelve months.
The interest rate sensitivity analysis presented above does not consider the potential impact of the changes in fair value of our fixed rate debt investments, our fixed rate borrowings (the 2026 Notes and the 2021 More Term Loan), or the net asset value of our common stock in the event of sudden changes in interest rates. Approximately 10.5% of our investments paid fixed interest rates as of September 30, 2022. Rising market interest rates will most likely lead to fair value declines for fixed interest rate investments and fixed interest rate borrowings and a decline in the net asset value of our common stock, while declining market interest rates will most likely lead to an increase in the fair value of fixed interest rate investments and fixed interest rate borrowings and an increase in the net asset value of our common stock.
In addition, we may have risk regarding portfolio valuation as discussed in Note 2 to our consolidated financial statements included in this report.
Inflation and Supply Chain Risk
Economic activity has continued to accelerate across sectors and regions. Nevertheless, due to global supply chain issues, geopolitical events, a rise in energy prices and strong consumer demand as economies continue to reopen, inflation is showing signs of acceleration in the U.S. and globally. Inflation is likely to continue in the near to medium-term, particularly in the U.S., with the possibility that monetary policy may tighten in response. Persistent inflationary pressures could affect our portfolio companies' respective profit margins.
Credit markets continued to be under pressure during the first half of 2022 amid a risk-off environment and sustained macro-economic uncertainty due to record-high inflation, tighter financial conditions and growing recession risk. Central banks have remained focused on restoring price stability by raising interest rates and have signaled that growth may be hindered until inflation comes under control.
78
Item 4. Controls and Procedures
Evaluation of disclosure controls and procedures
In connection with the preparation of this Quarterly Report on Form 10-Q for the three months ended September 30, 2022, we carried out an evaluation, under the supervision and with the participation of our management, including our Co-Chief Executive Officers and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report pursuant to Rule 13a-15(b) and Rule 15d-15(b) of the Securities Exchange Act of 1934, as amended. Based on the foregoing evaluation, the Co-Chief Executive Officers and the Chief Financial Officer concluded that our disclosure controls and procedures were effective.
In designing and evaluating our disclosure controls and procedures, we recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Our disclosure controls and procedures have been designed to meet reasonable assurance standards. Disclosure controls and procedures cannot detect or prevent all error and fraud. Some inherent limitations in disclosure controls and procedures include costs of implementation, faulty decision-making, simple error and mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all anticipated and unanticipated future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with established policies or procedures.
Evaluation of internal control over financial reporting
There have been no changes in our internal control over financial reporting during the three months ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
79
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
We are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us. From time to time, we may be party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies and other third parties. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that any such proceedings will have a material effect upon our financial condition or results of operations.
Item 1A. Risk Factors
There have been no material changes from the risk factors disclosed in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2021.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
We did not engage in any unregistered sales of equity securities during the three months ended September 30, 2022.
The table below provides information concerning our repurchases of shares of our common stock during the three months ended September 30, 2022 pursuant to our share repurchase policy.
Period
Total Number of Shares Purchased
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Maximum Number of Shares That May Yet Be Purchased Under the Plans or Programs
July 1 to July 31, 2022
—
$
—
—
—
August 1 to August 31, 2022
170,424
10.52
170,424
(1)
September 1 to September 30, 2022
525,052
9.37
525,052
(1)
Total
695,476
$
9.65
695,476
(1)
(1)
A description of the shares of our common stock that may be repurchased is set forth in a discussion of our share repurchase program in Note 3 to our unaudited consolidated financial statements contained in this Quarterly Report on Form 10-Q.
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).
* Filed herewith.
82
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Customers and Suppliers of CION Investment Corp
Beta
No Customers Found
No Suppliers Found
Bonds of CION Investment Corp
Price Graph
Price
Yield
Insider Ownership of CION Investment Corp
company Beta
Owner
Position
Direct Shares
Indirect Shares
AI Insights
Summary Financials of CION Investment Corp
Beta
(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)